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Introduction and aims
Recent changes to legislation across Australia have meant that state and territory statutory 
child protection services now have involvement with pregnant women: these services accept 
reports on, and are able to work with, pregnant women, with particular attention paid to 
substance use in pregnancy and the risk this may pose to the child once born. Some juris-
dictions are developing intensive support programs for pregnant mothers, to ensure early 
intervention and planning are provided, which aim to minimise the likelihood that a statu-
tory child protection intervention will be necessary after the birth of the child. An increased 
emphasis has also been placed by antenatal services on the early identification of substance 
use in pregnancy by screening for substance use as part of antenatal care. However, some 
authors and practitioners have expressed concerns about an apparent increasing tendency 
to make pregnant women’s bodies the subject of state surveillance, potentially leading to 
situations where the rights of the foetus are deemed superior to that of the mother (Meurk, 
Lucke & Hall, 2014).
Little information, however, is available on the impacts of these new policies and practices 
or on the outcomes of identifying alcohol and other drug (AOD) use during pregnancy on 
women, their partners and their children. This report aims to explore these issues and their 
adoption into policy and practice in Australia. It is focused particularly on the outcomes of 
this screening activity and the current legislative, policy and practice responses to pregnant 
women. That is, does screening for AOD use lead to better outcomes for pregnant women, 
their partners and their children; and, what is the impact of involvement by the child protec-
tion system in the identification of AOD use by pregnant women, particularly in relation to 
bringing infants into statutory care once they are born?
Methods
The methods used to answer the research questions consisted of (i) an online review of the 
legislation and policies in each Australian jurisdiction related to maternal screening for AOD 
use in pregnant women and prenatal reporting to child protection services; (ii) telephone or 
face-to-face semi-structured interviews with policy staff members who work in the prenatal 
reporting area of statutory child protection services and health departments, in each of the 
eight states and territories, and a variety of other key stakeholders; and (iii) a review of the 
published and grey literature, overseen by a project reference group, which provided expert 
advice on the project.
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Findings
Research evidence on the outcomes of maternal screening for AOD use 
on pregnant women, their partners and their babies as well as on the 
impact of statutory notification to child protection services
The purpose of screening for substance use in pregnancy is to identify potential substance 
misuse problems that may affect women and their foetuses. This then enables decisions to 
be made as to whether further assessment on the frequency and quantity of substance use 
needs to be undertaken, and to determine appropriate intervention responses. This interven-
tion response may take the form of referral to treatment and may involve reporting to child 
protection services because of concerns that the pregnant substance-using women may not 
be able to safely care for their newborns.
Parental substance use can affect children developmentally from the point of conception, 
after birth and across the lifespan. Pregnancy has been described as the opportune time to 
address maternal AOD use, but represents a brief window within which to address ‘the mul-
tiple intersecting and complex issues that led to substance use initiation and  continuation’ 
(Jones & Kaltenbach, 2013).
Infants and children develop within the context of complex social and environmental con-
ditions, which also influence functional and behavioural capacities, making it difficult to 
ascertain a drug-specific effect on developmental processes (Bandstra, Morrow, Mansoor & 
Accornero, 2010).
Parental substance misuse can be associated with child maltreatment and is a common 
characteristic of families involved with the child protection system. Mothers with an AOD use 
problem who are involved with the child protection system are more likely to have mental 
health problems, be younger, have more children, have greater economic problems, have a 
history of homelessness, and have fewer social supports. The greater the number of adversi-
ties, the less likely they are to be caring for their children.
Although the evidence is limited, universal screening for AOD use in pregnancy (including 
tobacco) is recommended: it reduces the targeted screening of marginalised groups, stigma, 
and the under-identification of AOD use in pregnancy. Screening should be undertaken by 
health professionals in a non-judgmental manner at antenatal visits.
There is some evidence that if pregnant women’s partners are encouraged by antenatal services 
to reduce their substance use, the women are also more likely to reduce their substance use. 
Other family members may also be an important source of support.
A reported professional and ethical tension in risk assessment is between the risk manage-
ment approach within a child protection framework where the focus is on the safety of 
children, and the health system which focuses on the health of mothers and development 
of their foetuses.
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Available data on prenatal reporting are limited. In 2012–13, 1427 ‘unborn children’ had 
substantiated reports of abuse in six Australian jurisdictions, plus another 4356 children 
under 12 months of age nationally (Australian Institute of Health and Welfare, 2014). Only 
New South Wales publishes more detailed data. In New South Wales, 2389 ‘unborn children’ 
were assessed as being at risk of significant harm in 2012–13. Definitional differences and 
the use of ‘reports’, ‘substantiations’ and ‘entry into out-of-home care’ as proxy measures 
of child abuse and neglect, rather than outcomes involving child harm or parenting quality, 
are an issue.
It is estimated that around 10 per cent (range 7.6–15.0%) of the babies of women who use 
substances in pregnancy have their babies removed from their care around the time of birth 
(see Section 3.1.8h).
Research evidence on best practice in the management of pregnant 
women using AOD in relation to child protection risks
One of the strongest messages from research is the need for a coordinated service response 
in addressing parental substance misuse in a child protection context. The service response 
should be multidisciplinary, comprehensive and collaborative in scope, use coordinated and 
evidence-based strategies that incorporate support, and include comprehensive health and 
social services that are responsive to women’s and children’s needs. There is some evidence 
that combining family-based interventions with AOD treatment services has positive effects 
on children of substance users.
Following on from a screening outcome that shows risky or dependent substance use, a 
brief intervention, referral to pharmacological treatment (where women are dependent on 
opioids), residential treatment or counselling is recommended.
Case planning, case management and family group conferencing are all strategies aimed at 
bringing services together with families to discuss decisions and strategies with the aim of 
working collaboratively to reduce risks to children.
Programs that integrate services, such as antenatal care, parenting programs and child-
related services with substance use treatment, address the barriers to accessing care and 
the unique needs of pregnant women who misuse substances. Meta-analyses of integrated 
programs show their positive impact on maternal mental health and birth outcomes, but 
limited improvements in parenting skills.
A recent systematic review found that, although individual studies reported a significant 
reduction in involvement with child protection services, there was insufficient evidence to 
recommend the routine use of home visits for pregnant or post-partum women with an AOD 
problem (Turnbull & Osborn, 2012).
Contingency management approaches have shown effectiveness for improving retention and 
drug abstinence among substance abusers in treatment, thereby allowing clients to benefit 
from other components of clinical services.
Executive sum
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Residential treatment programs for substance-using pregnant and parenting women that 
focus on simultaneously treating the substance use and supporting the mother–baby rela-
tionship have been shown to be efficacious. Women become more engaged, obtain greater 
benefit from treatment, and have higher retention when they are permitted to bring their 
children into the residential treatment setting (Haug, Duffy & McCaul, 2014). Women-only 
residential treatment services are associated with increased length of stay compared with 
mixed-gender substance abuse treatment programs, and treatment focused on gender-
specific needs results in longer stays and improved continuity of care (Ashley, Marsden & 
Brady, 2003; Haug et al., 2014).
In Australia, there is little evidence on the extent to which pregnant women gain access to 
appropriate services in a timely manner.
Policies in Australian jurisdictions relating to the identification of 
maternal AOD use in pregnancy
Current Australian policy and practice can be characterised as taking a clinical approach to 
managing AOD use during pregnancy, which emphasises the health of newborns, rather than 
the enforcement of the laws in relation to substance use.
Six jurisdictions have legislated for the reporting of unborn children to statutory authori-
ties. Only Tasmania has mandated prenatal reporting, meaning that prescribed persons must 
inform statutory child protection authorities of their belief, suspicion or knowledge that a 
child once born is reasonably likely to suffer abuse or neglect, or require medical treatment.
Most jurisdictions have developed routine screening and assessment processes for bio-
psychosocial risks prenatally, including for AOD use. All jurisdictions reported that child 
protection interventions are generally initiated only when there are multiple risk factors, and 
that substance use in isolation is not necessarily a trigger for child protection involvement.
Recent initiatives have had a strong focus on reducing the use of alcohol in pregnancy 
following the adoption of new guidelines by the National Health and Medical Research 
Council (2009): Australian Guidelines to Reduce Health Risks from Drinking Alcohol. Some 
lack of understanding and consistency in relation to the identification and advice around 
alcohol use in pregnancy was reported in the consultations, along with reports of staff’s 
limited understanding of foetal alcohol spectrum disorder (FASD) diagnosis and prevalence.
The AOD screening tools known as ASSIST and AUDIT–C are used and recommended by 
several jurisdictions. A recurring theme in the consultations was the difficulties that some 
health practitioners experience in having conversations about AOD use with pregnant women. 
A tension exists between the need to identify and respond to risk factors, and maintaining 
engagement of women throughout their pregnancies.
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Operation of pathways into AOD treatment services, support services 
and statutory child protection services for parents and their unborn 
children in Australia
Identification of any substance use issues at the antenatal visit results in referral to specialist 
drug use in pregnancy service where further assessments are then undertaken.
No jurisdictional legislation or policies provide for statutory powers to investigate harm or risk 
of harm until children are born. With the important exception of sharing information about 
mothers and unborn children across information-sharing entities (such as child protection, 
welfare and health services), all interventions, including drug testing, require the consent of 
the mother until the child is born. Policies and guidelines enable the mobilisation of support 
and treatment services that are not statutory protective interventions.
Stakeholders expressed concerns about AOD-using pregnant women presenting late to ante-
natal services due to stigma, fear of child protection involvement, lack of access to primary 
health care, and chaotic lifestyles. Within at least two jurisdictions, prenatal case conferenc-
ing was reported as being used as a strategy to plan and implement support for pregnant 
women. Actively participating in the support services offered (or not) and demonstrating 
change are key factors in any subsequent child protection interventions at birth.
Early engagement of pregnant substance-using women by antenatal and support services 
was seen as a critical factor for better outcomes for unborn children, their mothers and 
families. Early child protection involvement allows more time to support women to address 
their risk factors.
Stakeholders were concerned that if support is prematurely terminated, outcomes will be 
poor and increase the possibility that babies will be taken into care at a later date. There 
are some reports of removals increasing by six months post-birth, supporting the need for 
longer-term support. Stakeholders expressed concern about the impact on mothers and 
families of the removal of babies at birth and the resulting distress, which may manifest in 
increased AOD use.
The need for cross-disciplinary training, education and support of staff, and better collabora-
tion and relationships across sectors and services was identified in the consultations. A lack 
of comprehensive accessible services for pregnant AOD-using women, particularly residential 
services, was also identified as an issue.
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Key implications for policy and practice
Screening for risk but assessing for need
Although generally supportive, some stakeholders expressed reservations about the focus on 
a universal screening approach, due to the level of resources required to implement such a 
strategy and the limited capacity to provide differentiated responses. In some jurisdictions, 
there is considerable effort expended on identifying AOD use, but with little consistency 
or commitment to providing a service response. There is only limited evidence that women 
receive the services they need, and it is thought that increased identification through screening 
may contribute to the targeting and stigmatising of already-marginalised women, such as 
those already known to services. Simply put, screening for AOD risk in isolation from service 
provision appears to be of limited benefit.
Integrated systems of support
Jurisdictional policy and practice, along with the research evidence, point to the need for 
health and child protection sectors to work together better, in order to support pregnant 
women, improve outcomes for mothers and babies after birth, and contribute to reducing 
the number of removals of babies at birth. Women with issues such as AOD misuse,  domestic 
and family violence, and mental health issues are more likely to face other difficulties, such 
as homelessness and severe financial disadvantage. Such complexity and multifaceted dis-
advantage require strong intersectoral partnerships, and responsive programs, to provide the 
intensive sustained support that is required, beginning in early pregnancy.
Engaging women, engaging early and staying engaged
Concerns have been raised in both the published literature and during the consultations with 
key stakeholders that the consequences of prenatal reporting to child protection services 
are: (i) disengagement from, or avoidance of, health services by pregnant women; (ii) later 
presentations at antenatal care; (iii) increased marginalisation; through to (iv) increased 
involvement with the child protection system.
Late presentations at antenatal services, as well as carrying significant obstetric risks, mean 
there is a very short window in which pregnant substance-using women can demonstrate the 
change that child protection services require, to assess them as able to safely care for their 
newborns. There is some evidence that early engagement in services and strategies such as 
case conferencing provides promising mechanisms to develop sustainable plans to support 
women to safely care for their newborns at home.
Unless support is continued for longer periods of time, there is evidence that women may 
have their babies removed later as supports fall away. There are good examples of antenatal 
services and specialist services within Australia that aim to link and maintain women to 
services and programs within the community on a longer-term basis.
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Lack of data on prenatal reports and removals at birth
Limited data are available on the number of pregnant women and their families, who are 
screened or identified for AOD use in pregnancy, and/or are affected by prenatal reporting. 
Furthermore, data are limited on the number of newborns removed by the child protection 
system and on their longer-term outcomes. In the absence of such data, and without longi-
tudinal research on the impacts of prenatal reporting and removals of newborns, we were 
unable to make assessments about the impacts of these policies and practices.
What will be the future prenatal legislation, policies and practices?
Currently, Australian legislation and policies around prenatal reporting are focused on the early 
identification of risk in pregnancy, and the provision of appropriate services and supports. 
The extent to which this is realised in practice is unclear. There are emerging indications of 
a weakening of this supportive focus in some Australian jurisdictions and a leaning towards 
adopting the more punitive responses currently evident in some states in the United States 
of America, where the rights of the foetus can be deemed superior to that of the mother, 
and the state’s assumed authority to protect the foetus overrules the interests of the mother 
(Meurk et al., 2014). What is clear, is that the rights and needs of both pregnant women and 
their foetuses are critically important, and ethical and legal positions need to be considered 
in addition to their health needs.
Introduction
1
1 . Introduction
In recent years, increasing attention has been paid to the use of alcohol and other drugs 
(AOD) by women during pregnancy, and the effects of such AOD use on their foetuses and 
on the ability of the mothers to care for themselves and their infants.
There is evidence that substance use during pregnancy can affect the developing foetus. 
An association between maternal substance use and negative foetal outcomes, including 
foetal respiratory distress, pre-term delivery, small-for-gestational-age birth, and higher 
infant mortality in the first year of life, has been found (Burns, Conroy, Moore, Hutchinson 
& Haber, 2011). However, few longer-term effects have been found, except for alcohol use 
in pregnancy, and other causes of adverse pregnancy outcomes are likely to also exist within 
substance-using populations.
Adding to the complexity are issues related to parenting and child maltreatment once the baby 
is born. Although not all AOD users abuse or neglect their children, a large body of research 
has found that parental AOD misuse is associated with high rates of child maltreatment and 
involvement with the child protection system (Dawe, Frye, Best et al., 2006; Grella, Hser & 
Huang, 2006; Scannapieco & Connell-Carrick, 2007; Taplin & Mattick, 2013).
Recent changes to legislation across Australia have meant that state and territory statu-
tory child protection services now have involvement with pregnant women: these services 
accept reports on, and are able to work with, pregnant women, with particular attention 
paid to substance use in pregnancy and the risk this may pose to the child once born. Some 
jurisdictions are developing intensive support programs for pregnant women, to ensure early 
intervention and planning are provided, aiming to minimise the likelihood that a statutory 
child protection intervention will be necessary after the birth of the child. An increased 
emphasis has also been placed on the early identification of substance use in pregnancy, by 
screening for substance use as part of routine antenatal care. However, some commentators 
and practitioners have expressed concerns about an apparent increasing tendency to make 
pregnant women’s bodies the subject of state surveillance, potentially leading to situations 
where the rights of the foetus are deemed superior to those of the mother (Meurk et al., 2014).
Little information, however, is available on the impacts of these new policies and practices, 
or on the outcomes of identifying AOD use during pregnancy on women, their partners and 
their children. This report aims to explore these issues and their adoption into policy and 
practice in Australia. It is focused particularly on the outcomes of this screening activity 
and the current legislative, policy and practice responses to pregnant women. That is, does 
screening for AOD use lead to better outcomes for pregnant women, their partners and their 
children; and, what is the impact of the involvement by the child protection system in the 
identification of AOD use by pregnant women, particularly in relation to removals of babies?
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1 .1 Aim and research questions
The principal aim of this project was to examine the outcomes of identifying AOD use during 
pregnancy on women, their partners and their children. The specific research questions were:
• What is the research evidence on the outcomes of maternal screening for AOD use on 
pregnant mothers, their partners and their babies as well as on the impact of statutory 
notification to child protection services?
• What is the research evidence on best practice in the management of pregnant women 
using AOD in relation to child protection risks?
• What are the existing policies, in Australian states and territories, relating to the identi-
fication of maternal AOD use in pregnancy?
• How do pathways into AOD treatment services, support services and statutory child pro-
tection services operate for the parents in these jurisdictions?
M
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2 . Methods
The methods used to answer the research questions consisted of four separate components.
2 .1 Online review of jurisdictional policies and legislation
In late 2013 and early 2014, the legislation and policies in each Australian state and territory 
that covered maternal screening for AOD use in pregnant women and prenatal reporting 
to child protection services were searched online and summarised. Relevant legislation was 
obtained using the Australasian Legal Information Institute’s (AustLII) databases. Both child 
protection/welfare and health legislation and policies were included. The summaries for each 
jurisdiction were then provided to each jurisdiction for verification of their completeness and 
currency (see Appendix A for details).
2 .2 Key stakeholder interviews
Telephone or face-to-face interviews were undertaken with policy staff members who work 
in the prenatal reporting area from statutory child protection services and health depart-
ments, in each of the eight states and territories.1 In some jurisdictions, several interviews 
were conducted. In total, 24 interviews were conducted with departmental policy makers.
Nine interviews were also undertaken with a variety of other key stakeholders who were 
representatives of: a substance users group (n=1); residential drug treatment service providers 
(n=1); family support services (n=2); general practitioners (n=1); substance use in pregnancy 
services (n=3); and a pilot perinatal family conferencing service for at-risk newborns (n=1). 
Interviewees were identified in consultation with the Project Reference Group (see Appendix 
B for key stakeholder interview list).
The main issues covered in these semi-structured interviews were current practices relating 
to identifying substance use in pregnancy; the impacts and outcomes of identifying AOD 
use during pregnancy; their views of current legislation and policies nationally, and AOD 
screening practices; and any information on evaluations or exemplary programs.
1 In one jurisdiction, a health response was not obtained, and in a second jurisdiction no child 
protection/welfare response was obtained, despite multiple attempts to contact the nominated 
departmental interviewees.
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2 .3 Literature review
The literature review draws mainly on academic sources of national and international literature, 
including research articles, monographs, systematic reviews and reports from 2003 to May 
2014. Databases used in the literature review included Medline, PsychINFO, Sociological, 
Family Studies and Family & Society Abstracts, Google Scholar, Maternity & Infant Care, 
ProQuest, BMJ Best Practice, Web of Science Core Collection and Health Collection. Addi-
tionally, publications were sourced from relevant websites including the Australian Institute 
of Family Studies, the Australian Institute of Health and Welfare, the Australian Research 
Alliance for Children and Youth, Chapin Hall at the University of Chicago, the Cochrane and 
Campbell Collaboration websites, and Western Australia’s Telethon Kids Institute.
Search terms used included: prenatal; antenatal; pregnant; mother; unborn; substance/
drug; screen(ing). Some assessments were made of the quality of the evidence in this narra-
tive review, placing greater reliance on larger-scale studies and bodies of research, previous 
systematic literature reviews and meta-analyses.
Relevant and publicly available data have also been used, predominantly from the Australian 
Institute of Health and Welfare and individual jurisdictions, particularly New South Wales 
Department of Family and Community Services.
2 .4 Project Reference Group
The Project Reference Group, established to provide specialist advice on the project, comprised 
relevant experts in maternal AOD use and child protection. Members are listed in Appendix 
C. The Project Reference Group provided advice throughout the project and contributed to 
formulating policy recommendations from the work.
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2 .5 Defining the terms
2 .5 .1 Substance use, abuse, misuse, dependence and addiction
In this report, terms ‘substance use’ and ‘substance misuse’ will be used to include both 
licit and illicit substances. Substance misuse, as defined by the World Health Organization, 
is the ‘use of a substance for a purpose not consistent with legal or medical guidelines, 
as in the non-medical use of prescription medications’ (World Health Organization, 1994, 
p. 45). The term is preferred in the belief that it is less judgmental than other terms such 
as ‘addiction’ and ‘abuse’.
The terms ‘substance abuse’ (defined in Diagnostic and Statistical Manual of Mental Disor-
ders, 4th edition (DSM–IV), as ‘a maladaptive pattern of substance use leading to clinically 
significant impairment or distress, as manifested by one (or more) criteria, occurring within a 
12-month period’) and ‘substance dependence’ (defined in DSM–IV as ‘a maladaptive pattern 
of substance use, leading to clinically significant impairment or distress, as manifested by 
three (or more) criteria’) have been replaced in the 5th edition (DSM–5) by combining the 
DSM–IV categories of substance abuse and substance dependence into a single disorder. 
In order to be diagnosed with substance use disorder, the client must now meet at least 
two of the 11 criteria for the diagnosis. A minimum of 2–3 criteria is required for a mild 
substance use disorder diagnosis, while 4–5 criteria are diagnosed as moderate, and 6–7 are 
diagnosed as severe (American Psychiatric Association, 2013).
The terms ‘substance’ and ‘AOD’ (alcohol and other drugs) will be used interchangeably 
throughout the report to refer to both licit and illicit substances ingested by the mother.
2 .5 .2 Parental and maternal
The term ‘maternal’ will be used throughout this report because of the focus on substance 
use in pregnancy and on the period immediately after the birth of babies, and because of 
the lack of research on the impact of substance use by fathers in this context. The literature 
on the impact of substance use on male sperm and associated impacts on the foetus has 
predominantly focused on the impact of substance use on male fertility.
2 .5 .3 Foetus and the unborn child
Child protection legislation in Australian jurisdictions frequently use the term ‘unborn child’ 
as opposed to ‘foetus’. In this report, the term ‘foetus’ will be used, except in relation to 
jurisdictional legislation and policy where the term ‘unborn child’ is used.
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2 .6 Exploring the legal status of the ‘unborn child’ versus 
the pregnant woman
There is considerable debate around the legal status of the ‘unborn child’ and whose rights 
take precedence — those of the foetus or of the pregnant woman. A public debate recently 
took place in the Journal of the Royal Society of Medicine. On the one hand, Currey, Stoll 
and Chastonay (2013, p. 428) argued:
There is a definitional oversight in which the life of the child is inadvertently cut into two: 
the fetus or the ‘child inside’ and the ‘child outside’ the womb. This segmented definition 
should be replaced by a new inclusive way of thinking about ‘the unborn child’. The world 
has to be reminded that traditionally birth … began from the time of conception, when 
a mother bears a new life — a life at considerable risk.
On the other hand, McCormick (2014) argued:
Perhaps it was unintentional, but this editorial raises some potentially unacceptable policies 
… Elevating the value of the fetus above that of the mother has untoward consequences, 
as we on this side of the Atlantic well know. Such approaches permit, even encourage, 
abusive treatment of pregnant women and abrogation of their human rights in the name 
of protecting the ‘unborn child’.
The preamble to the United Nations Convention on the Rights of the Child (1989), to which 
Australia is a signatory, states that ‘the child, by reason of his physical and mental immaturity, 
needs special safeguards and care, including appropriate legal protection, before as well as 
after birth’. It is likely that, for emotional and moral reasons, the vast majority of society 
would agree with the proposition that mothers ought to care for and protect their unborn 
children (Do & Mapulanga-Hulston, 2013). However, it is questionable whether those same 
members of society would agree with the imposition of a broad, legally enforceable duty of 
care on expectant mothers, when armed with knowledge of the consequences that may flow 
from breach of such a duty. For example, if a duty of care were to be imposed on expect-
ant mothers, any action taken by pregnant women, irrespective of how mundane this may 
be, could be subject to judicial scrutiny, and it would be extremely difficult to identify the 
circumstances in which mothers would have breached their duty to their unborn children 
(Do & Mapulanga-Hulston, 2013).
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Meurk, Lucke and Hall (2014) have observed that there is a growing body of legal decisions 
arising from actions taken in attempts to impose medical treatment on pregnant women. 
They discuss the tendency to make pregnant women’s bodies the subject of state surveil-
lance, particularly in countries such as the United States and Finland, where women can 
be subject to compulsory commitment and/or incarceration if their AOD use is deemed 
to be potentially harmful to the foetus. This kind of regulation of women can be seen to 
grant certain legal rights to foetuses, where the rights of the foetus are deemed superior 
to those of the mother, and the state’s assumed authority to protect the foetus overrules 
the interests of the mother (Meurk et al., 2014). Criminalisation of maternal substance use 
threatens women’s autonomy, and the status of women as equal citizens who are entitled 
to protection under the law may further jeopardise infant health and wellbeing, may lead 
women to avoid antenatal care, may unfairly target already-marginalised groups, and does 
not necessarily prevent substance abuse among women (Zizzo, Di Pietro, Green et al., 2013).
In Australia, the current position is that pregnant women do not owe a duty of care to 
their unborn children (except in the limited circumstance of road accidents), meaning that 
the mothers’ rights are superior to those of their foetuses. This position does not negate 
pregnant women’s need to consider how their actions affect the development of foetuses 
(Do & Mapulanga-Hulston, 2013). What is clear is that the rights and needs of both preg-
nant women and foetuses are critically important, and ethical and legal positions need to 
be considered, in addition to their health needs.
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3 . Findings
The findings are structured by the four key research questions. Existing research evidence, 
reviews of the jurisdictional policies and practices, and key stakeholder interviews are used 
to answer each of those questions.
3 .1 Research evidence on the outcomes of maternal screening 
for AOD use on pregnant women, their partners and their 
babies, and on the impact of statutory notification to child 
protection services
The purpose of screening for substance use in pregnancy is to identify potential substance 
misuse problems that may affect women and their foetuses. Such screening enables decisions 
to be made as to whether further assessment on the frequency and quantity of substance 
use needs to be undertaken, and to determine an appropriate intervention response.
The intervention response may take the form of referral to treatment, and may involve 
reporting to child protection services, due to concerns that pregnant substance-using women 
may not be able to safely care for their newborns. These responses have emerged from 
evidence that particular substances ingested during pregnancy can have adverse impacts on 
the development of foetuses, as well as evidence of an association between poor parenting, 
child maltreatment and maternal substance misuse.
Pregnancy has been described as the opportune time to address maternal AOD use: studies 
have found that interventions provided at this time of heightened motivation to change 
have the potential for stopping or reducing AOD use not only in the woman, but also in 
the home environment (Anthony, Austin & Cormier, 2010; Suchman, Pajulo & Mayes, 2013).
The following sections explore the issue of maternal screening for substance use in preg-
nancy, how screening is undertaken, and briefly examine best practice in identification and 
screening protocols in pregnancy, underpinned by discussion of the impacts of AOD use in 
pregnancy. The impacts of screening during pregnancy and the health and child protection 
system responses will also be examined, although research is limited on the direct outcomes 
of screening for AOD use in pregnancy.
3 .1 .1 How many women use substances in pregnancy?
Problematic substance use clearly harms the health of users (Degenhardt & Hall, 2012). 
Globally, fewer people use illicit drugs than use alcohol (roughly one-tenth), while tobacco 
use is far more widespread, and so its contribution to disease burden is greater than that 
for alcohol or illicit drugs (Degenhardt & Hall, 2012). Compared to other countries, Australia 
has a high rate of burden of disease attributable to illicit drug dependence, and among the 
highest prevalence of opioid dependence worldwide (Degenhardt, Whiteford, Ferrari et al., 
2013). In Australia, the most recent data on trends in drug use have reported that tobacco 
and alcohol use has decreased; heroin, cannabis and cocaine use has remained stable; and 
while use of methamphetamine has remained stable, recent use of the form ice/crystal has 
increased (Stafford & Burns, 2014). There are significant gender differences in prevalence 
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of substance use and dependence, with lifetime prevalence of exposure for all categories of 
substances higher for males than for females in almost all societies and cultures ( Degenhardt 
& Hall, 2012; Lev-Ran, Le Strat, Imtiaz, Rehm & Le Foll, 2013; Steingrímsson, Carlsen, 
 Sigfússon & Magnússon, 2012).
The prevalence of any substance use (including cigarettes) by pregnant women has been 
estimated at upwards of 25 per cent in the United States (Havens, Simmons, Shannon & 
Hansen, 2009). However, pregnant women use significantly fewer substances than other 
women of child-bearing age and tend to reduce use as they progress through their pregnancy. 
Havens and colleagues (2009) analysed data from pregnant (n=1800) and non-pregnant 
women (n=37 527) aged 15–44 years who participated in the 2002 or 2003 United States’ 
National Survey on Drug Use and Health, and found that the prevalence of substance use 
was significantly lower for all types of substances among pregnant women, compared to 
non-pregnant women. The most prevalent substance used by pregnant women was cigarettes 
(18.9%), followed by alcohol (10%) and cannabis (3.7%). Poly-substance use was reported 
by 6.1 per cent of pregnant women (Havens et al., 2009).
Licit drug usage, such as alcohol and tobacco use, in pregnancy has been estimated in Australia 
using the National Drug Strategy Household Survey. In the latest survey, an estimated 11.7 
per cent of women reported smoking during pregnancy, with pregnant women under 35 
years more likely to smoke (Australian Institute of Health and Welfare, 2011). The majority 
of pregnant women either reduced their alcohol consumption while pregnant (48.7%) or 
abstained (48.9%). The proportion of pregnant women abstaining during pregnancy increased 
in 2010 (statistically significantly from 40 per cent in 2007 to 48.9 per cent in 2010), as did 
the proportion of breastfeeding women abstaining. However, around half of all pregnant 
women reported some alcohol use during pregnancy (Australian Institute of Health and 
Welfare, 2011). A re-analysis of the 2005 National Drug Strategy Household Survey data 
found that while alcohol use in pregnancy was reported by around one-third, the majority 
reported low-level/occasional use of alcohol. However, significant numbers were exposed to 
three or more drinks on one occasion or to most days in utero (Hutchinson, Moore, Breen, 
Burns & Mattick, 2013).
United Kingdom studies have estimated the prevalence of illicit substance use in pregnant 
women between 0.75 per cent and 0.11 per cent (Goel, Beasley, Rajkumar & Banerjee, 2011). 
Estimates from the United States are higher, and it has been reported that more than 4.4 
per cent of pregnant women misuse one or more illicit drugs during pregnancy (Wendell, 
2013), with recent increases in estimates. Between 1999 and 2008, prevalence in America 
increased for narcotic- and hallucinogen-affected live births and neonatal drug withdrawal 
syndrome, but decreased for alcohol- and cocaine-affected live births. Maternal substance 
abuse at delivery showed similar trends, but prevalence of alcohol abuse remained relatively 
stable (Pan & Yi, 2013).
In Australia, Abdel-Latif and colleagues (2013) used hospital records and AOD service usage 
records to identify a total of 879 illicit-drug-using mothers from 62 682 pregnancies. This 
equates to 1.4 per cent (95% CI 1.3–1.5) of the total births in public hospitals in New South 
Wales and the Australian Capital Territory in 2004 affected by maternal drug dependency, a 
figure comparable to their previous estimates that 1.3 per cent of all pregnancies are affected 
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by perinatal drug use. Earlier estimates by Burns, Mattick and Cooke (2006), analysing 
416 834 live births in New South Wales over a five-year period (1998–2002), found that 1974 
pregnancies (0.47%) had an opioid ICD–10AM diagnosis recorded, 552 a stimulant-related 
ICD–10AM (0.13%) and 2172 a cannabis ICD–10AM diagnosis (0.52%).
Estimates from the 2004 Australian National Household Drug Survey ((Australian Institute of 
Health and Welfare, 2005), which found that 2 per cent of women admitted to using illicit 
drugs (other than cannabis; 6% including cannabis) when pregnant or breastfeeding in the 
previous 12 months, were slightly higher than in other studies and may be explained by 
differences in methodology. Abdel-Latif and colleagues (2013) also found regional differences 
in illicit drug use patterns: compared to urban mothers (n=764), significantly fewer mothers 
from rural areas (n=115) admitted to illicit drug use in pregnancy. In terms of specific drug 
types used in pregnancy, Abdel-Latif and colleagues (2013) found that cannabis (66%), 
opiates (including 39.7% methadone) (46.8%), amphetamines (23%) and polydrug (16.4%) 
exposure were the most common. The majority of these illicit-drug-using mothers (82.3%) 
also smoked tobacco, while 136 (15.5%) drank alcohol.
3 .1 .2 Screening
Screening for use of AOD in pregnancy is an important part of prevention (Seib, Daglish, 
Heath et al., 2012). Screening evaluates the possible presence of a particular problem, whereas 
assessment defines the nature of the problem, diagnosis and specific treatment recommen-
dations (Haug et al., 2014).
As an important part of prevention, screening for AOD use in pregnancy is well established 
as having implications for public health. Assessment of current use may help predict future 
use. For example, previous alcohol consumption use by pregnant women has been found to 
be the strongest predictor of prenatal alcohol use (Chang, McNamara, Orav & Wilkins-Haug, 
2006), and current smoking status has been found to identify women likely to use other 
substances during pregnancy (Saitz, Svikis, D’Onofrio, Kraemer & Perl, 2006).
The public health concept of screening has remained unchanged since the 1968 World Health 
Organization definition: ‘to discover among the apparently well who are in fact suffering 
from disease’ (Terplan, 2012). Similarly, Dawe, Dingle and Loxton (2013) say that ‘screening 
instruments are best thought of as a way of “flagging” that there are other important problems 
that may need either or both (1) further assessment, and/or (2) inclusion in a treatment plan’. 
The World Health Organization principles of population screening can be summarised as 
having: validated screening tests; availability of treatment; client and societal acceptability; 
and a balance of benefits to harms at a population level (Terplan, 2012).
Typically, screening includes self-reporting of substance use, review of substance use history 
and medical records, observation and drug testing. Screening instruments should be brief, 
easily administered, and scored and developed for use across a range of settings (Dawe et al., 
2013). Other strategies are more invasive and have some limitations. For example, blood tests 
are likely to identify only long-term use through damage to the liver, while urine toxicologies 
detect only recent use and cannot detect frequency or amount of AOD usage (Anthony et 
al., 2010). These tests will be discussed in subsequent sections.
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3 .1 .3 Purpose of screening
The purpose of screening for substance use in pregnancy is to identify potential substance 
misuse problems that may affect pregnant women and their foetuses. Such screening enables 
decisions to be made as to whether further assessment on the frequency and quantity of 
substance use needs to be undertaken, and to determine appropriate intervention responses.
Intervention responses may take the form of referral to treatment and involve reporting to 
child protection services because of concerns that pregnant substance-using women may 
not be able to safely care for their newborns.
In this section, the issues related to the impact of substances ingested by pregnant women, 
on both the women and the developing foetuses, will be explored, which is predominantly 
a health response, with subsequent sections focusing on the issues related to the substance-
using parents’ care of babies once born, which is predominantly a child protection response. 
Of course, child protection services are also concerned with the healthy development of the 
foetus, and the health sector has a role in ensuring adequate parenting for new infants as 
they grow.
3 .1 .4 Identifying potential substance misuse problems affecting 
a woman and her foetus
A major purpose of screening is to minimise harm and improve outcomes for both mothers 
and children (Jones & Kaltenbach, 2013). Screening may identify the type and amount of 
substances ingested during pregnancy in conjunction with a psychosocial history, and provide 
assessment and treatment to reduce morbidity and mortality (Jones & Kaltenbach, 2013). 
Screening assesses what substances have been ingested, which may transfer from a pregnant 
woman to her foetus through the placenta, and in what amount, stage and circumstances.
a. Direct impacts of substance use on a woman and her foetus
There is evidence that substance use during pregnancy can affect the developing foetus. 
Drug-exposed pregnant women may experience a range of obstetric complications, including 
gestational diabetes, placental insufficiency, post-partum haemorrhage, spontaneous abor-
tion, pre-term birth and lower gestational age (Anthony et al., 2010). Children with prenatal 
substance exposure are at increased risk for premature birth, low birth weight, impairment 
in state regulation and arousal modulation, and especially with opioid-exposure withdrawal 
symptoms (Abdel-Latif et al., 2013; Burns et al., 2006; Jones & Kaltenbach, 2013).
However, few longer-term effects have been found: besides maternal alcohol use, a birth 
defect syndrome has not been described for illicit substances or prescription drugs of abuse 
(Holbrook & Rayburn, 2014). Furthermore, other causes of adverse pregnancy outcomes are 
likely to also exist within substance-using populations.
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b. Factors other than alcohol and other drugs impacting on development of the foetus
Infants and children develop within the context of complex social and environmental con-
ditions which also influence functional and behavioural capacities, making it difficult to 
ascertain a drug-specific effect on developmental processes (Bandstra et al., 2010). Specific 
drug effects may be difficult to determine because women have ingested a range of sub-
stances before being aware of their pregnancies. Substance(s) effects may also be impacted 
by factors such as the rate of drug metabolism and excretion in mothers, as well as their 
general nutrition and health status (Anthony et al., 2010).
Substance use is associated with a number of other factors that can also have an impact 
on the development of the foetus. Some groups of women remain vulnerable to continued 
substance use in pregnancy, including those who are unemployed, single and experiencing 
possible current psychopathology (Havens, Simmons, Shannon & Hansen, 2009). Burns, 
Mattick and Cooke (2006) found that births among substance-using mothers were more 
likely to be among women who were younger, had a higher number of previous pregnan-
cies, were Indigenous, smoked heavily and were not privately insured. These women also 
presented later in their pregnancy to antenatal services and were more likely to arrive at 
hospital unbooked. Similarly, many of the mothers identified by Abdel-Latif and colleagues 
(2013) originated from socially disadvantaged backgrounds, which in itself is an independ-
ent risk for perinatal complications. The drug-using mothers in their study were younger 
than the average Australian mother, were more likely to be teenagers, and were more likely 
to experience domestic violence and single parenthood. Psychiatric co-morbidities affected 
almost half of the women in their cohort, also an independent risk factor for poorer perinatal 
outcomes (Abdel-Latif et al., 2013).
High prenatal stress, malnutrition and untreated maternal psychiatric disorders can them-
selves increase risk of developmental disabilities in children (Thompson, Levitt & Stanwood, 
2009). During prenatal development, the foetus is particularly vulnerable to the effects of 
a broad range of environmental exposures, with consequences that can persist into infancy, 
adolescence and adulthood. In particular, maternal distress during pregnancy, in the form of 
exposure to chronic or acute stressors, depression and/or anxiety, can influence both foetal 
and infant behavioural and physiological outcome measures. For example, antenatal depres-
sion and anxiety symptoms predict increased behavioural reactivity and cortisol in response 
to novelty in infants, higher resting cortisol throughout the day among adolescents, and a 
reduction in grey matter density in the prefrontal cortex (Monk, Spicer & Champagne, 2012). 
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3 .1 .5 Who is screened?
One of the major questions to be addressed in relation to identifying substance use in preg-
nancy is whether all pregnant women should be screened (universal screening), or only those 
who are already identified as substance users (targeted screening). Furthermore, in relation to 
screening for substance use in pregnancy, screening the substance use of fathers in  addition 
to that of mothers needs to be considered.
a. Universal versus targeted screening of pregnant women
There are debates in the literature over whether or not screening for substance use (and 
other risks) should be offered to all pregnant women (universal screening) or limited to those 
deemed at risk (targeted screening). In the context of AOD screening in pregnancy, universal 
screening means that every pregnant woman is asked about her substance use.
Universal screening is most respectful of the principle of justice and minimises the risk of 
stigmatising and stereotyping those population groups viewed to be at risk (Zizzo et al., 
2013). It is recognised that many women under-report their AOD use during pregnancy due 
to stigma and the fear of adverse consequences (Haug et al., 2014).
When screening is not universal, it has been found that certain women — typically those who 
are poor and from marginalised groups — are targeted for screening and/or disproportionately 
reported to child protection services (Haug et al., 2014). Substance use among women of 
higher socioeconomic status may not lead to the same responses as for women from more 
marginalised groups (Anthony et al., 2010). Universal screening has the potential to reduce 
stigma and the adverse consequences of targeted screening, particularly on child protection 
outcomes (Haug et al., 2014).
Universal screening is likely to identify risky substance use that might otherwise be missed. 
Women may not report behaviours related to medical risks in pregnancy because they were 
unaware of the significance of these behaviours (McNamara, Orav, Wilkins-Haug & Chang, 
2005). Similarly, health and medical professionals may have difficulty in identifying prob-
lematic substance use without the assistance of a screening tool (McNamara et al., 2005). 
Alcohol poses special challenges in that it is often treated differently by the medical profes-
sion and by child protective agencies than are illegal substances, although it may be more 
damaging (Drescher Burke, 2007).
Furthermore, substance-using pregnant women are already less likely to access antenatal 
care, which may lead to adverse health and developmental consequences for the baby and 
more complicated hospital stays (Anthony et al., 2010; Jones & Kaltenbach, 2013). Universal 
screening provides assurance that women’s needs will be identified and services provided 
(Anthony et al., 2010). Asking direct questions to pregnant women makes it more likely they 
will be provided with appropriate support (Terplan, 2012).
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Universal screening for substance use in pregnancy is currently recommended by organisa-
tions and professional groups. The American College of Obstetricians and Gynecologists 
(2008) committee opinion addresses the ethical rationale for universal screening for at-risk 
drinking and illicit drug use, and considers that there is an ethical duty to screen all pregnant 
and post-partum women for substance use. A recent Canadian review recommended that 
all pregnant women and women of child-bearing age be screened periodically for alcohol, 
tobacco and prescription and illicit drugs use (Wong, Ordean & Kahan, 2011). The recent 
World Health Organization’s Guidelines for Identification and Management of Substance 
Use and Substance Use Disorders in Pregnancy (World Health Organization, 2014) and the 
 Australian National Clinical Guidelines for the Management of Drug Use during Pregnancy, Birth 
and the Early Development Years of the Newborn (New South Wales Department of Health, 
2006) suggest that all pregnant women be asked about their alcohol and other drug use.
Routinely asking all pregnant women about substance use, including alcohol, via a checklist 
of issues to address during antenatal care, and asking within the context of health and every-
day behaviour are strategies that help to normalise screening and ensure greater consistency 
(Bradley, DeBenedetti, Volk et al., 2007).
b. Does universal screening lead to better outcomes for pregnant women and the foetus?
A universal screening approach is predicated on the supposition that more (net) harm can be 
prevented by focusing on the majority who are less seriously involved in harmful AOD use 
rather than through interventions that target smaller proportions of high-risk substance users. 
However, the extent to which this is realised is not clear. In the child protection context, it 
contributes to the presumed connection between a positive drug test and poor parenting 
(Anthony et al., 2010).
Debates over the costs and benefits of universal and targeted screening often revolve around 
its cost-effectiveness and the economic implications (Anthony et al., 2010). The costs of 
universal screening include the time it takes to complete instruments and the potential waste 
of scarce resources (Anthony et al., 2010). In addition, universal testing forces health care 
providers to assume sometimes conflicting roles of both the caregiver and the investigator 
(Drescher Burke, 2007).
Some authors argue that universal testing is too costly and unreliable to justify it, that an 
imperfect toxicology test may result in the reporting of mothers and infants with false posi-
tive tests to child protective services and result in unnecessary and intrusive social services. 
Similarly, they argue, false negatives will be overlooked, and families needing services will 
not receive them (Anthony et al., 2010; Berger & Waldfogel, 2000).
While there are some examples of good practice in different contexts nationally, Burns and 
Breen have reported that screening for substance use in pregnancy is currently not universal 
and there is little consistency in screening practices in Australia (Burns & Breen, 2013). For 
example, in a Western Australian study, researchers identified an estimated 15 per cent of 
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pregnant women who were drinking at moderate levels (defined as greater than two and 
less than five standard drinks on a typical occasion) were not being identified by health 
professionals because they were not being adequately screened during pregnancy (Colvin, 
Payne, Parsons, Kurinczuk & Bower, 2007). 
The evidence is also lacking that universal screening reduces targeting and disparities in service 
delivery. A recent review found that the available research does not support the claim that 
universal screening for AOD use in antenatal care reduces racial disparities in child protection 
reporting at delivery (Roberts & Nuru-Jeter, 2011).
There is inconclusive evidence that the identification through universal screening of women 
who are AOD users in pregnancy leads to more effective treatment and better outcomes. 
Although some substance use can be addressed through brief interventions and minimal 
services, long-term substance use disorders require specialist treatment that may not be 
available (Anthony et al., 2010). Both health and child protection staff have reported in 
previous research that there is insufficient treatment available and that this is a major bar-
rier to effective screening (Drescher Burke, 2007). A lack of funded AOD treatment places, 
particularly treatment places that appropriately address women’s specific needs and which 
cater for pregnant women and women with children, has also been identified in Australia 
(Breen, Awbery & Burns, 2014).
c. Screening partners
Little is known about the patterns of substance use of fathers of unborn children, despite 
evidence from studies of pregnant women that substance use by men may (i) reduce women’s 
ability to desist from substance use during pregnancy; (ii) increase the probability that women 
will return to use postpartum; and (iii) increase the risk of adverse child outcomes (Bailey & 
Sokol, 2008; Seib et al., 2012).
Paternal smoking has been found to be predictive of maternal smoking during pregnancy, but 
paternal alcohol use is not predictive of maternal alcohol use in pregnancy (Peadon, Payne, 
Henley et al., 2011). Bailey and Sokol (2008) set out to describe the association between 
pregnancy and patterns of binge drinking, daily smoking, and marijuana use among young 
fathers of unborn children, and pregnant women, from a community sample. They found 
that men’s rates of binge drinking and marijuana use were unaffected by the pregnancy of 
their unborn child. Pregnancy decreased the probability of substance use among women, but 
substantial proportions of women users of cigarettes and marijuana used these substances 
during pregnancy. Many of the women who desisted from substance use while pregnant 
returned to use after their child was born.
Peadon and colleagues (2011) found that while most women said that it would make no 
difference to their behaviour, approximately one-third of women stated that if their partner 
did not drink alcohol during pregnancy, they would be less likely to drink themselves. Chang 
and colleagues (2006) suggest that knowledge about healthy pregnancy behaviours may 
exert greater impact if it is shared by pregnant women and their partners.
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d. Screening infants
Maternal and neonatal characteristics including prenatal visits, neonatal behaviour, and birth 
weight identify some infants affected by maternal substance use, but do not reliably iden-
tify all exposed infants. To address the issue of under-identification of substance-exposed 
infants, the analysis of infant biomarkers has recently been considered: these tests may 
identify children at risk for deficits earlier and assist in targeting interventions (Hicks, Tough, 
Premji et al., 2009). However, it is unclear under what circumstances screening should be 
performed, how and when testing is performed and with which groups, how results should 
be used, whether informed consent from a mother is required, and whether it is ethical to 
obtain a neonatal sample without consent when it identifies maternal behaviour (i.e. de 
facto test of mother) (Hicks et al., 2009). Hicks and colleagues (2009) examined the condi-
tions under which mothers would consent to AOD screening of their infants and to identify 
predictors of consent by surveying postpartum women in three large Canadian hospitals. 
The majority of women supported universal screening for AOD exposure as part of routine 
care, and almost all would consent to the screening of their own infant. Almost all women 
agreed that screening was appropriate if effective intervention was provided for mother and 
child, but less than 20 per cent agreed if no intervention was provided (Hicks et al., 2009). 
However, a more recent study examined the willingness of mothers in a high-risk obstetrics 
unit to participate in voluntary testing of meconium screening and long-term developmental 
follow-up of positive cases through an existing public health program. The participation rate 
in this screening program was significantly lower than when testing had been conducted 
anonymously. The authors concluded that, despite the potential benefits of such screening 
programs, maternal unwillingness to consent, likely due to fear, embarrassment and guilt, 
may limit their effectiveness (Zelner, Shor, Lynn et al., 2012).
3 .1 .6 Who is undertaking the screening and what is the uptake?
Initial discussions about their pregnancy and substance use may take place with women’s 
general practitioners. Most women will attend antenatal appointments at stages through-
out their pregnancy, the first generally between 12 and 16 weeks. Antenatal visits usually 
take place in hospital or primary health care settings, with antenatal checks conducted by 
obstetricians, general practitioners and midwives.
The majority of the literature about the delivery of screening is from literature on screening 
for alcohol use in pregnancy. Health professionals have an important role to play in the 
prevention of prenatal alcohol exposure. Studies have shown that screening can be delivered 
effectively within a routine antenatal visit by prenatal staff (Kennedy, Finkelstein, Hutchins & 
Mahoney, 2004). Some research on self-administered and computer-administered instruments 
has found that they elicit more accurate responses than face-to-face interviews in both the 
general population and pregnant women specifically (Haug et al., 2014).
Health professionals in Western Australia have identified a need for educational resources 
about the effects of alcohol use in pregnancy (Elliott, Payne, Haan & Bower, 2006; Payne, 
Elliott, D’Antoine et al., 2005). A survey of health professionals in Western Australia in 2002 
showed that, of those who cared for pregnant women, only 45 per cent routinely asked 
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about their alcohol consumption, and only 25 per cent routinely provided pregnant women 
with information about the effects of alcohol on the foetus (Payne et al., 2005). Similarly, 
a more recent study found that Dutch midwives’ alcohol advice required improvement with 
regard to screening, knowledge about mechanisms and consequences of antenatal alcohol 
use, and the involvement of partners in alcohol advice during pregnancy (van der Wulp, 
Hoving & de Vries, 2013). Burns and Breen (2013) interviewed clinicians treating pregnant 
women with problematic alcohol use. The clinician interviews supported evidence from 
the literature that while the prevalence of alcohol use disorders in the population is higher 
than disorders related to illicit drugs, the reverse is noted in specialist treatment services; 
problematic alcohol use in pregnant women is rarely seen. They highlighted the fact that, 
despite work aimed at improving the detection of alcohol use, screening and referral rates 
remain low (Burns & Breen, 2013).
In response to the findings in Western Australia, the Alcohol and Pregnancy Project (2006–08) 
provided a broad spectrum of Western Australian health professionals with educational 
resources to inform them about the prevention of prenatal alcohol exposure and foetal 
alcohol spectrum disorder, the aim being to change practice and increase the proportion who 
routinely asked pregnant women about alcohol use, and who routinely provided pregnant 
women with information about the consequences of drinking alcohol during pregnancy 
(Payne, France, Henley et al., 2011). The evaluation found that the educational resources 
were effective in producing a 31 per cent increase in the proportion of health professionals 
who routinely provided pregnant women with information about the consequences of drink-
ing alcohol during pregnancy. One hundred per cent of the settings adopted the project, 
it reached 96.3 per cent of the target population, was implemented as intended, and the 
resources were maintained (Payne et al., 2011). Long-term outcomes of these changes in 
health professionals’ practice are expected to contribute to a reduction in prenatal alcohol 
exposure and in the prevalence of foetal alcohol spectrum disorder.
3 .1 .7 Identifying substance use in pregnancy
Identification of women using substances in pregnancy is essential to preventing or mini-
mising harm. Ideally, a validated screening tool is used to assess the AOD consumption of 
all pregnant women in the context of a routine prenatal assessment. Screening women of 
reproductive age before pregnancy may encourage them to change their AOD consumption 
to reduce the risk of a substance-exposed pregnancy. The evidence suggests that screening 
for AOD use in primary care has a range of benefits and can reduce harm.
A recent report from the National Drug and Alcohol Research Centre (Breen, Awbery & 
Burns, 2014), titled Supporting Pregnant Women Who Use Alcohol or Other Drugs: a review 
of the evidence, in addition to the World Health Organization’s Guidelines for Identifica-
tion and Management of Substance Use and Substance Use Disorders in Pregnancy (World 
Health Organization, 2014) and New South Wales Health’s National Clinical Guidelines for 
the Management of Drug Use during Pregnancy, Birth and the Early Development Years of 
the Newborn (New South Wales Department of Health, 2006) provide an overview of best 
practice in identifying substance use in pregnancy. A detailed discussion of screening tools 
used to identify substance use in pregnancy has not been undertaken in this report.
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3 .1 .8 Child protection response to positive screening of substance use 
in pregnant women, and the impact of a statutory notification to child 
protection services
The previous section discussed the role of screening for substance use in pregnancy as a 
way of identifying concerns about the impacts of the ingested substances on women and 
the development of their foetuses. A positive screen for substance use in pregnancy may 
also lead to a report or notification to statutory child protection services, commonly called a 
prenatal report. A prenatal report is likely to lead to a detailed and extended assessment of 
pregnant women’s current presentation and history, as to their future ability to safely parent 
once their babies are born. A pre-birth assessment of significant risk of child maltreatment 
may trigger additional treatments and supports, as well as child welfare and statutory child 
protection interventions.
This section of the report provides an overview of the existing evidence about (i) the impacts 
of substance use on the ability of the parent(s) to safely care for their newborn and on their 
parenting; (ii) prenatal reporting; (iii) pre-birth risk assessments; (iv) methods of identifying 
substance use in the child protection context; and (v) child protection responses includ-
ing removal of a baby from the parents’ care. An attempt has been made to ascertain the 
numbers of babies removed from their parents’ care at birth, or soon after birth. It must 
be noted, however, that there is little research evidence or data on the number of babies 
removed because their mothers have been assessed as unable to safely care for them at birth, 
nor on whether the involvement of child protection and other services leads to increased 
support for pregnant women. This lack of data makes it difficult to determine the impacts of 
statutory notifications, or child protection involvement more generally, on pregnant women, 
their partners and their babies.
a. Evidence on child maltreatment and parental substance use
Parental substance use may be investigated by the child protection system to assess the 
risks of child abuse and neglect. Although substance use and treatment are higher among 
males than females (Australian Institute of Health and Welfare, 2013), much of the research 
around parental substance use and its impacts on children has focused on mothers, partly 
because of the concerns related to prenatal substance use, but also because women are more 
likely than fathers to be the primary carers of their dependent children (Stewart, Gossop & 
Trakada, 2007).
A significant body of research has found that parental substance misuse is associated with 
child maltreatment, and that parental substance use is a common characteristic of families 
involved with the child protection system. Families in which AOD use is present are more 
likely to come to the attention of child protection services, be re-reported, have their children 
removed from their care, and have them remain in out-of-home care for long periods of 
time (Barth, Gibbons & Guo, 2006; Gregoire & Schultz, 2001; Smith & Testa, 2002; Street, 
Whitlingum, Gibson, Cairns & Ellis, 2008). Parental substance misuse is common in child 
protection practice and plays an important role in determining child removal (De Bortoli, 
Coles & Dolan, 2013).
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Limited research has examined the impact of different types of illicit substances on parenting 
and children. As Dawe and colleagues comment, the direct effects of the substance being 
used are likely to influence the quality of parenting provided for the child. Opioids, for 
example, may be more likely to be associated with child neglect, while substances such as 
amphetamines and cocaine, which are associated with serious disturbances of mental state, 
including sub-clinical symptoms of psychosis and hostility, may be more likely to result in 
physical abuse (Dawe et al., 2006). Heavy drinking can be associated with supervisory neglect 
in parenting practices, such as leaving a child where he or she may not be safe (Freisthler, 
Johnson-Motoyama & Kepple, 2014).
There is a lack of clear evidence as to the impacts of substance use alone on parenting, 
and the extent to which substance use places children at risk of maltreatment is not well 
understood (De Bortoli et al., 2013; Taplin & Mattick, 2014). Studies have attempted to 
determine whether parents with more extensive substance-use histories are more likely to be 
involved with child protection services due to child abuse or neglect than those with a less 
extensive substance-use history. Studies have generally found that when other factors are 
taken into consideration, the extent of the substance use is less important than other co-
occurring factors (Gilchrist & Taylor, 2009; Grella et al., 2006; Taplin & Mattick, 2013). Among 
mothers in treatment for substance use problems, those involved with the child protection 
system are more likely to have mental health problems, particularly depressive symptoms, 
be younger mothers, have more children, have greater economic problems, have a history 
of homelessness, sex work or incarceration, live with a substance user and have fewer social 
supports (Gilchrist & Taylor, 2009; Grant, Huggins, Graham et al., 2011; Grella et al., 2006; 
Grella, Needell, Shi & Hser, 2009; Laslett, Room & Dietze, 2014; Nair, Black, Schuler et al., 
1997; Taplin & Mattick, 2013). Furthermore, the greater the number of adversities, the less 
likely they are to be caring for their children (Gilchrist & Taylor, 2009; Grella et al., 2006).
Substance-using parents have greater levels of life stressors, often including trauma and 
abuse histories of their own, which may manifest in unresponsive and punitive parenting 
styles (Suchman et al., 2013). It has been suggested that the association between substance 
use and child maltreatment can be largely explained by the high levels of psychopathology 
in substance-using populations, and that parental substance misuse may in fact be a marker 
for mental health problems, which has a stronger association with child maltreatment (Dawe 
et al., 2006).
Research in this area is complicated by the definitions of child abuse. Although there is vari-
ability as to what constitutes child abuse internationally, differences in legislation across 
Australia defining a ‘child in need of protection’ provide similar thresholds for substantiated 
abuse or neglect requiring intervention (Holzer & Bromfield, 2010). In most research, reports/
notifications, substantiations and entry into out-of-home care are used as proxy measures 
of child abuse rather than outcomes involving child harm or parenting quality. Official child 
protection outcomes are favoured because they are clearly documented despite being associ-
ated with limitations and biases (De Bortoli, Coles & Dolan, 2014).
Id
en
tif
yi
ng
 a
lc
oh
ol
 a
nd
 o
th
er
 d
ru
g 
us
e 
du
rin
g 
pr
eg
na
nc
y
20
The majority of the research on parental substance and child protection involvement uses 
either administrative data or data collected as part of a larger study to document the extent 
of child protection involvement among substance-using parents in treatment, generally 
reporting the number of children removed from their care as the only child protection 
outcome. Studies using administrative data to estimate the extent of substance use among 
those already involved with the child protection system have found that substance use 
is a commonly identified risk factor: for example, using administrative records, parental 
substance misuse has been identified in approximately 70 per cent of all children entering 
care in two Australian studies, one of which was a national study (Delfabbro, Fernandez, 
McCormick & Kettler, 2013; Jeffreys, Hirte, Rogers & Wilson, 2008). However, prevalence 
estimates are highly variable and range from as low as 11 per cent to as high as 79 per 
cent (Young, Boles & Otero, 2007). Part of this variability can be explained by differences 
in samples and in the definition, assessment and recording of substance use. One study, for 
example, reviewed 639 child protection files where the child was removed and found there 
was evidence of parental substance use in 79 per cent of cases. However, only 16 per cent 
of these were clinically diagnosed and in only 33 per cent of cases did caregiver substance 
abuse contribute directly to the child’s removal from the home (Besinger, Garland, Litrownik 
& Landsverk, 1999; Taplin & Mattick, 2014).
b. How many substance-using women are caring for children?
Limited data are available on the extent to which substance-misusing adults are parents, 
or are caring for their children or other children, or on the nature of their substance use, 
particularly in terms of children’s exposure to substance use and the direct effects on the 
parenting they receive.
Dawe and colleagues (2006) analysed data from the 2004 National Drug Strategy Household 
Survey and estimated that, based on the number of children aged 12 years or less living in 
Australia, 13.2 per cent or 451 621 children were at risk of exposure to binge drinking in 
the household by at least one adult; 2.3 per cent or 78 691 lived in a household contain-
ing at least one daily cannabis user; and 0.8 per cent or 27 370 lived in a household with 
an adult who uses methamphetamine at least monthly and reports doing so in their home. 
Estimates of other substance use among parents living with children were too small to be 
made with confidence.
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c. Prenatal reporting
Health professionals working in antenatal services see pregnant women when they present to 
these services and are in the best position to screen women for substance use in pregnancy. 
Health professionals, as well as being concerned about the healthy development of the foetus 
and the mother’s health, have a role in raising concerns about the ability of mothers and 
their partners to parent their babies once born, and the subsequent safety of the babies.
Largely due to concerns about the impact of substance use on parenting and the associated 
risks of child maltreatment, and to some extent influenced by the increased focus on alcohol 
use and its impacts on the developing foetus, Australian jurisdictions have in recent years 
introduced into their child protection legislation the prenatal reporting of ‘at-risk’ mothers. 
The aim of this legislation in most cases is to provide a mechanism whereby certain profes-
sionals can report their concerns to child protection services and to guide the provision of 
family supports to minimise future child protection involvement.
Differences and similarities exist in the legislation, policies and practices in relation to prenatal 
reporting across Australia. The common elements which aim to provide a legislative basis 
for earlier intervention with pregnant women include: (i) identifying risk in the perinatal 
period; (ii) commencing the process of addressing protective concerns by engaging ‘at-risk’ 
mothers prior to birth; and (iii) reducing crisis-driven interventions. The legislation, policies 
and practices will be discussed in greater detail in Section 3.3.
d. Pre-birth risk assessments
Obstetric services in most countries play a critical role in the identification of at-risk infants 
and in initial decision making to activate the formal service system, either through notifica-
tion to statutory child protection or through referral to health or child and family welfare 
services. The professional groups most involved with decisions during this assessment time, 
and in pre-birth child protection interventions, are child protection or welfare officers, social 
workers and midwives. It is important to note that there are significant professional and ethi-
cal tensions with the different approaches to care by different professions. A much-reported 
tension is between the risk management approach within a child protection framework where 
the focus is on the safety of the child, and the health system focus on the health of the 
mother and development of the foetus. One of the difficulties of pre-birth screening and 
risk assessments is that the interventions have been contextualised within frameworks that 
have evolved to protect children rather than the foetus (Hodson & Deery, 2014).
However, assessments and interventions often tend to focus too narrowly on either substance 
abuse or child protection issues. As a result, there may be significant gaps in service systems 
in terms of both the knowledge and skills to identify the broad range of client problems and 
to provide the comprehensive services to address them (Marsh, Smith & Bruni, 2011). Not all 
infants exposed to substance use in pregnancy will become involved with child protection 
services. For some women, pregnancy may be a ‘window of opportunity’ where behavioural 
changes are motivated by health concerns for the foetus, or out of fear of child removal 
(Anthony et al., 2010; Burns et al., 2006; Forrester & Harwin, 2008).
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Professional groups, in conducting pre-birth risk assessments, need to consider a multitude 
of complex issues and work as a multi-agency team to consider the impact of these issues 
on babies’ health and wellbeing (Hodson & Deery, 2014). The role played by hospital-based 
services in the identification of risk requires a focus on the collaborative activity, as well 
as on the skills and knowledge needed by health professionals and child protection offic-
ers to conduct risk assessments in tertiary contexts for substance-using pregnant women 
(Tsantefski, Parkes, Tidyman & Campion, 2013). Tsantefski and colleagues (2013) found that 
obstetric services, such as antenatal clinics, were skilled in assessing risk factors but that 
accurate risk assessment did not necessarily lead to appropriate outreach, follow-up and 
ongoing collaboration. In some cases there was continuing exposure to the risks identified 
in pregnancy, including substance use and domestic violence, and inadequate follow-up of 
infants after discharge from hospital. The management of risk includes a focus not only on 
pregnant women, their partners and foetuses, but also on their engagement with the service 
system. A good outcome of interventions for substance use in pregnancy has been described 
as: ‘continuous maternal care of the infant, drug use that was manageable or had ceased, 
and absence of domestic violence’ (Tsantefski et al., 2013: 5).
e. Assessing substance use of partners and fathers
There is limited information on the parenting status of men with substance use problems. 
We know that substance use, substance use problems, and treatment for substance use 
problems are all much more common among men than among women (Australian Institute 
of Health and Welfare, 2013). Among drug users in treatment, around half are parents, 
but fathers are much less likely than mothers to be the primary carers of their dependent 
children (Stewart et al., 2007). When fathers are primary carers, their substance use affects 
their ability to parent in the same way it affects the mothers’ ability.
Intimate partner violence may be a co-occurring issue, particularly where there is problem 
drinking (Foran & O’Leary, 2008) or opioid dependence (Moore, Easton & McMahon, 2011). 
When opioid-dependent fathers have been compared to other fathers generally, there were 
significant differences found in (i) their economic resources to support family formation; 
(ii) patterns of pair bonding; (iii) patterns of procreation; and (iv) parenting behavior (De 
Bortoli et al., 2014; McMahon, Winkel & Rounsaville, 2007).
De Bortoli and colleagues (2014) have called for further research to improve our understand-
ing of how the wider family support network alters the risk of abuse or child protection 
involvement in the context of substance use in pregnancy. Given a newborn’s heightened 
vulnerability, assessing short-term risk is crucial (De Bortoli et al., 2014).
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f. Using biomarkers to test for substance use in pregnancy
Health professionals will identify the presence of substance use in pregnant women and may 
report to child protection services. Child protection services will generally rely on informa-
tion provided to them by health services, but they may request independent verification of 
substance use by requiring drug testing of pregnant women and parents who are considered 
‘at risk’. In many instances, an infant in the United States would be reported only if the child 
or the mother tested positive at the time of birth, and not necessarily if the mother used 
substances at some time during the pregnancy unless such usage was known to services 
(Young et al., 2007).
Drug tests can be performed on samples of the blood, breath (currently alcohol only), urine, 
saliva (more precisely, oral fluid), hair and sweat. The methods differ in their windows for 
detection of drug ingestion. Hair and sweat testing are generally used to detect use over a 
period of weeks or months. Urine tests detect use during previous days or weeks, depending 
on the type of substance, while oral fluid testing detects use within a shorter period of hours 
or days (Australian National Council on Drugs, 2013).
In 2006, a review of the literature on the costs and utility of parental drug testing in the 
child protection context was undertaken (Wood, Mattick, Burns & Shakeshaft, 2006) and 
made a number of recommendations about best practice: 
• Drug testing is limited in its ability to determine dependence and/or impairment in relation 
to parenting ability; however, drug testing may have some utility in leading to treatment 
and/or confirmation of self-reports of use.
• Urine or hair testing are the recommended methods of drug testing in the context of 
child protection. The use of frequent urine testing, which is best conducted on a random 
basis, is a preferred method, but is expensive. Less expensive is hair testing, as hair can 
be easily harvested and analysed in Australia for a long observation window.
• The use of frequent (weekly or more often) regular, monitored urine testing is one best-
practice model with good reliability and validity. Hair testing has significant benefits that 
should be weighed up in terms of convenience and the desired window of observation. Both 
are best-practice and reliable methods for assessing the extent of ongoing illicit drug use.
• Given the evidence (albeit limited) on the role of drug testing assisting in management of 
parents with problematic drug use patterns and children at risk, hair testing seems to be 
a viable and useful tool for management of these cases, although hair testing is currently 
not common practice in drug treatment agencies and is mainly used in the workplace 
and for court purposes.
• It has been suggested that the therapeutic relationship between caseworker and client 
may be jeopardised if the caseworker is also the person responsible for collecting the 
specimen for drug detection. For this reason, it seems preferable that a third party be 
responsible for collection.
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Drug test results provide biological information at a particular point in time, but without 
contextual information on the substances detected, or on other issues that may be relevant. 
The potential for over- or under-detection of substance use or assessment of risk based solely 
on drug tests is evident (Testa & Smith, 2009). The use of biomarkers such as blood tests 
and urine toxicologies cannot be a substitute for good clinical rapport and management. In 
the area of pregnancy, the consequences of screening are far-reaching, with the possibility 
of removal of one’s child a real possibility (Darke & Burns, 2012).
Little information is reported on the extent to which drug testing is used by the child protec-
tion system, although one New South Wales study (Taplin & Mattick, 2014) reported that 
34.5 per cent of mothers in opioid pharmacological treatment had been required post-birth 
to provide urine samples for drug testing by child protection services, usually at a pathology 
laboratory and up to three times per week.
g. How many women who use substances during pregnancy are reported to child 
protection services?
In recent years in Australia there have been large numbers of families involved with the child 
protection system. In 2012–13, there were 272 980 notifications made to child protection 
services about 184 216 Australian children (35.5 per 1000 children), with abuse or neglect 
substantiated for 40 751 children (7.8 per 1000 children) (Australian Institute of Health and 
Welfare, 2014).
In relation to prenatal reports, the Australian Institute of Health and Welfare publishes data 
from six jurisdictions on the number of ‘unborn children’ for whom child protection reports 
are substantiated, although substantiating a child protection report seems problematic until 
the child is born. Table 1 shows that 1427 ‘unborn children’ had substantiated reports of 
abuse in six jurisdictions, plus another 4356 children under 12 months of age nationally, 
constituting more than 14.25 per cent of all children with substantiated abuse (Australian 
Institute of Health and Welfare, 2014). There were 294 320 children under 12 months of 
age in 2012 (Australian Bureau of Statistics, 2013).
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Table 1: National data on notifications re ‘unborn children’ and children <12 months, 2012–13
Jurisdiction ‘Unborn child’
Children 
<12 months
Total children 
(0–17yrs)
NSW 846 1513 16 236
VIC 8 1305 10 048
QLD 443 642 7149
WA 85 214 2686
SA - 364 1836
TAS 44 77 918
ACT 1 71 494
NT - 170 1204
Total 1427 4356 40 571
Source: Australian Institute of Health and Welfare, Child Protection Australia 2012–13, Table A8.
These data have a number of limitations, however. Firstly, it is unclear how abuse is sub-
stantiated in relation to an ‘unborn child’; and secondly, the reasons for these substantiated 
reports are not publicly available.
No data are reported by the Australian Institute of Health and Welfare on the number of 
notifications or reports by the age of the child, which means no national information on 
the number of child protection reports is available. New South Wales provides greater detail 
via their Annual Statistical Reports and includes information on the number of ‘unborn 
children’ reports. Table 2 shows the number of ‘unborn children’ concern reports and the 
reports where a risk of significant harm (ROSH) has been identified (around two-thirds of 
children and young person (CYP) concern reports) over the past three years. There has been 
some increase in the number of concern reports.
Id
en
tif
yi
ng
 a
lc
oh
ol
 a
nd
 o
th
er
 d
ru
g 
us
e 
du
rin
g 
pr
eg
na
nc
y
26
Table 2: New South Wales data on ‘unborn child’ reports, 2010–13
Year
‘Unborn 
children’ in 
CYP concern 
reports
‘Unborn 
children’ in 
ROSH reports
‘Unborn children’ 
in ROSH reports as 
% of all ‘unborn 
children’ in CYP 
concern reports
‘Unborn 
children’ 
as % of all 
ROSH reports
2010–11 3268 2240 68.5 3.7
2011–12 3304 2171 65.7 3.5
2012–13 3636 2389 65.7 3.7
Source: http://www.community.nsw.gov.au/docs_menu/about_us/docs_data.html: Table A4vi
There were 98 508 births in New South Wales in 2012. This means that 33.2 pregnant 
women/births per 1000 (or 3.3%) were the subject of CYP concern reports, and 22.7 per 
1000 (or 2.3%) were the subject of ROSH reports (Australian Bureau of Statistics, 2013). The 
only other publicly available data on prenatal reports and interventions were available from 
Western Australia where, in 2012–13, 266 babies were involved in pre-birth meetings, with 
69 babies requiring a subsequent protection application.
Limited research has explored the extent of reporting of substance use in pregnancy. One 
Australian study (Abdel-Latif et al., 2013) identified 879 (1.4%) drug-using mothers from 
62 682 births. Child-at-risk issues were raised in 354 (40.3%) of the infants of drug-using 
mothers, with 149 (17.0%) infants already having other siblings living elsewhere, not with 
the mother. Another study by Wu, LaGasse, Wouldes et al. (2013) compared patterns of 
antenatal care among mothers who used methamphetamine during pregnancy and non-
using mothers in the United States and New Zealand, and evaluated associations among 
maternal drug use, child protective services (CPS) referral, and inadequate antenatal care in 
both countries. Methamphetamine use during pregnancy was associated with lower socio-
economic status, single marital status, and CPS referral in both New Zealand and the United 
States. CPS referral for drug use comprised 40 per cent of all referrals in the United States, 
but only 15 per cent of referrals in New Zealand.
Street and colleagues undertook a prospective cohort study in the United Kingdom compar-
ing child protection outcomes over the first five years of life in a group of children born to 
drug-using mothers recruited during pregnancy (cases) and a group of children matched for 
gestational age, chronological age, maternal neighbourhood and place of delivery whose 
mothers made no such declaration of problematic drug use (controls). Half of the children 
born to the drug-using mothers who received perinatal input were subject to child protection 
interventions by age five years, a threefold increase over controls from similar socioeconomic 
circumstances. They observed that risk was almost certainly higher for those drug-using 
women who do not seek help during pregnancy (Street et al., 2008).
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h. How many women who use substances during pregnancy have their infants removed 
from their care?
The most intrusive of the interventions by the child protection system is the removal of a 
child from the care of its parents.
In Australia, 40 549 children were in out-of-home care in 2012–13, an increase in both the 
number and rate of children in care in recent years; 34.3 per cent of all children in care in 
2012–13 were Indigenous. In 2012–13, 11 341 children were admitted to out-of-home care 
(mostly infants and younger children) and 9360 were discharged (mostly older children and 
young people). The only Australian data available on entries into out-of-home care by age 
report on infants under 12 months of age, so the number of removals soon after birth are 
not able to be determined.
Table 3 shows that 17.4 per cent of all children admitted to out-of-home care in 2012–13 
were under 12 months of age, a rate of 6.5 children per 1000 on average. Jurisdictions varied 
to some extent in the rate at which infants were removed and admitted into care, with the 
rate in the Northern Territory around twice that of other jurisdictions.
Table 3: Number and rate of infants admitted to out-of-home care (OOHC), 2012–13
Jurisdiction
Children <12 months 
admitted to OOHC*
Population of children 
aged <12 months 
in December 2012 
(ABS, 2013)
Rate admitted 
to OOHC per 
1000 popn
NSW 618 95 370 6.5
VIC 446 75 865 5.9
QLD 452 62 266 7.3
WA 202 33 626 6.0
SA 126 20 220 6.2
TAS 48 6173 7.8
ACT 30 5343 5.6
NT 49 3922 12.5
Total 1971 (17 .4%) 302 785 6 .5
Source: Australian Institute of Health and Welfare, Child Protection Australia 2012–13, Tables A26, A46
*Note: 488 children <12 months (24.8% of admissions) were discharged from out-of-home care in 
2012–13; of those admitted to out-of-home care in 2012–13, some will be discharged at older ages 
or in subsequent years.
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Limited data are available on the number of women using substances during pregnancy who 
have their infants removed from their care at, or soon after, their birth. Table 4 shows that, 
in 2012–13, 505 infants nationally were admitted to out-of-home care within one week of 
their birth, and 851 within one month of their birth.
Table 4: Number of infants admitted to out-of-home care 
within one week and one month of birth, 2012–13
Jurisdiction
Children <=7 days 
admitted to OOHC*
Children <=31 days 
admitted to OOHC*
NSW 182 327
VIC 60 132
QLD 151 221
WA a, b 68 87
SA 23 46
TAS 11 18
ACT 5 8
NT 5 12
Total 505 851
*Data provided by Australian Institute of Health and Welfare
a In Western Australia infants are placed into care for a variety of reasons, not just because of 
parental alcohol and other drug use. Therefore, the numbers in the table are not an accurate 
reflection of how many children were placed into care because of parental alcohol and drug use.
b The Department works with parents and significant family members to return children to the care 
of their family, where possible. Therefore, the numbers of children do not accurately reflect the 
number of infants who remained in care for a long period or until 18 years.
*Notes:
1. This table counts children who were admitted to out-of-home care in less than or equal to 7 days 
after birth and less than or equal to 31 days after birth, during the year ended 30 June 2013.
2. Each child should be counted only once in each of the specified counting periods. However, a 
child may be counted in more than one counting period: for example, a child who was admitted 
to care in less than or equal to 7 days after birth, would be counted in both the ‘<=7 days’ 
period and the ‘<=31 days’ period for that year.
3. Age of child refers to age at time of first admission.
4. Children admitted to out-of-home care on their day of birth are counted as being one day old. 
This may have a subsequent impact on the count of children included in the <=7 days or <=31 
days categories.
5. Children for whom date of birth was unknown have been excluded from this table.
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Most of the available data does not report the reasons for removal, so the contribution of 
substance use in pregnancy is not able to be determined from these data. Even if substance 
use is identified as a reason for reporting or removal of a child, we know that the use of 
administrative data to estimate the extent of substance use among women involved with 
the child protection system leads to highly variable prevalence estimates ranging from 11 
per cent to 79 per cent (Young et al., 2007). Part of this variability can be explained by 
differences in those included and in the definition, assessment and recording of substance 
use (Taplin & Mattick, 2014).
Two recent Australian studies explored the child protection involvement of substance-using 
mothers in treatment. Taylor and colleagues found that, of 139 women engaged with a 
perinatal drug health service in Sydney, approximately one-third (35.3%) reported past child 
protection involvement with other children, and over half (58.9%) had at least one previous 
child in kinship or foster care (Taylor, Hutchinson, Rapee et al., 2012); 19 neonates (13.7%) 
were assumed into care at or before discharge. Taplin and Mattick (2014) interviewed 171 
mothers in opioid pharmacological treatment. Most of the mothers (63.7%; n=109) said 
that one or more of their children had been reported to child protection services within the 
past 16 years, with the most common reason being for substance use (including alcohol) 
(65.1%). Fifty-six women (32.7%) had at least one child in out-of-home care (n=99) at the 
time of interview, nearly half of whom (n=42) had been removed immediately or within 
weeks of their birth. Among the younger children, higher proportions had been removed at 
birth than among the older age groups, suggesting that increasing proportions of babies are 
being removed at birth in New South Wales. Another Australian study by Abdel-Latif and 
colleagues (2013) identified 879 (1.4%) drug-using mothers from 62 682 births. A total of 
66 (7.6%) of these infants of drug-using mothers were placed in out-of-home care.
In France, Simmat-Durand and colleagues followed up 167 children born alive from 1999 
to 2008 whose mothers used at least two substances at the beginning of their pregnancies. 
At the follow-up in 2010, 25 children had been immediately separated or removed from 
their mothers at discharge from the maternity hospital, while 41 children had been separated 
altogether (Simmat-Durand, Genest & Lejeune, 2014).
From these few studies, it appears that around 10 per cent (range 7.6–15.0%) of the babies of 
mothers who use substances in pregnancy have their babies removed from their care around 
the time of birth, and that having had previous babies removed at birth increases this risk.
Id
en
tif
yi
ng
 a
lc
oh
ol
 a
nd
 o
th
er
 d
ru
g 
us
e 
du
rin
g 
pr
eg
na
nc
y
30
i. Is there further child protection involvement after the removal of a baby?
Recent research has focused more closely on recurrence in the child protection system, par-
ticularly when infants have been removed at birth.
A recent paper presents the initial findings of a feasibility study that has captured the scale 
and pattern of recurrent care proceedings. Broadhurst and colleagues (2014) have arrived 
at a first estimate of prevalence, confirming that recurrence is a sizeable problem for the 
English system. Based on cases that completed during the observational window 2007–13 
(calendar years), 7143 birth mothers appeared in 15 645 recurrent care applications concern-
ing 22 790 infants and children. Initial observations are that the spacing between recurrent 
care proceedings is very short. Where episodes of care proceedings follow in swift succession, 
most likely prompted by the birth of another infant, this affords mothers little opportunity 
to effect change. The authors suggest that, unless the ‘status quo’ is tackled, it is difficult 
to envisage how vulnerable birth mothers can exit this cycle (Broadhurst, Harwin, Shaw & 
Alrouh, 2014).
Grant and colleagues (2011) found only four published studies that examined recurrent 
childbearing among substance-abusing mothers. In all these studies they found high rates 
of subsequent substance-exposed infants. Ryan and colleagues, for example, reported that 
94 per cent of the 151 subsequent substance-exposed infants born during their study period 
were the offspring of women who had had a prior substance-exposed infant (Ryan, Choi, 
Hong, Hernandez & Larrison, 2008). Smith and Testa (2002) found that families involved 
with the child welfare system due to prenatal substance abuse were more likely to have 
subsequent allegations compared to families involved in the system due to other child mal-
treatment allegations, a finding largely attributable to mothers who had subsequent births 
with accompanying substance-exposed infant allegations. These researchers even suggested 
that a substance-exposed infant allegation may have predicted subsequent prenatal drug 
use (Smith & Testa, 2002). Taplin and Mattick (2014), in their study of mothers on the New 
South Wales opioid treatment program, found that once one baby had been removed at birth, 
the woman’s subsequent children were also removed at birth. These high rates of recurrence 
point to the need to intervene with the mothers in such a way that the rates are reduced.
3 .1 .9 Key findings from this section
• Parental substance use can affect children developmentally from the point of conception, 
after birth and across the lifespan. Pregnancy has been described as the opportune time 
to address maternal AOD use, but represents a brief window within which to address ‘the 
multiple intersecting and complex issues that led to substance use initiation and continu-
ation’ (Jones & Kaltenbach, 2013).
• The purpose of screening for substance use in pregnancy is to identify potential substance 
misuse problems that may affect pregnant women and their foetuses. This then enables 
decisions to be made as to whether further assessment on the frequency and quantity of 
substance use needs to be undertaken, and to determine appropriate intervention responses.
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• These intervention responses may take the form of referral to treatment and involve 
reporting to child protection services, due to concerns that the pregnant substance-using 
women may not be able to safely care for their newborns.
• Infants and children develop within the context of complex social and environmental 
conditions that also influence functional and behavioural capacities, making it difficult 
to ascertain a drug-specific effect on developmental processes (Bandstra et al., 2010).
• Parental substance misuse can be associated with child maltreatment and is a common 
characteristic of families involved with the child protection system.
• Mothers with an AOD problem who are involved with the child protection system are 
more likely to have mental health problems, be younger, have more children, have greater 
economic problems, have a history of homelessness, sex work or incarceration, live with 
a substance user and have fewer social supports. The greater the number of adversities, 
the less likely they are to be caring for their children.
• Although the evidence is limited, universal screening for AOD use in pregnancy (including 
tobacco) is recommended: it reduces the targeted screening of marginalised groups, stigma 
and the under-identification of AOD use in pregnancy. Screening should be undertaken 
by health professionals in a non-judgmental manner at antenatal visits.
• Australian jurisdictions have in recent years introduced into their child protection legislation 
the prenatal reporting of ‘at-risk’ mothers, the aim of which is to provide a mechanism 
for reports of concerns to child protection services and to guide the provision of family 
supports to minimise future child protection involvement.
• A reported professional and ethical tension in risk assessment is between the risk manage-
ment approach within a child protection framework where the focus is on the safety of 
the child, and the health system whose focus is on the health of the mother and the 
development of the foetus.
• Available data on prenatal reporting are limited. In 2012–13, 1427 ‘unborn children’ had 
substantiated reports of abuse in six Australian jurisdictions, plus another 4356 children 
under 12 months of age nationally (Australian Institute of Health and Welfare, 2014). 
Only New South Wales publishes more detailed data. In New South Wales, 2389 ‘unborn 
children’ were assessed at risk of significant harm in 2012–13. Definitional differences 
and the use of ‘reports’, ‘substantiations’ and ‘entry into out-of-home care’ as proxy 
measures of child abuse and neglect, rather than outcomes involving child harm or par-
enting quality, are an issue.
• It is estimated that around 10 per cent (range 7.6–15.0%) of the babies of mothers who 
use substances in pregnancy are removed from their care around the time of birth (see 
Section 3.1.8h).
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3 .2 Research evidence on best practice in the management of 
pregnant women using AOD in relation to child protection risks
3 .2 .1 AOD treatment responses to the identification of substance use in 
pregnant women
Detailed discussion of specific treatments provided for substance use and dependence (such 
as pharmacotherapies and counselling) is not within the scope of this report. However, a brief 
overview of the treatment types found to be the most effective with pregnant substance-
using women is provided. Also discussed are the process and service system contexts of AOD 
treatments; namely, how treatment may be delivered to improve outcomes for pregnant 
substance-using women, as identified in the literature.
Although there is limited evidence about the outcomes of screening in terms of increased 
support for pregnant women and increased safety for their foetuses once born, screening 
can lead to an increasing range of responses, from brief interventions to linking women to 
AOD treatment, generally provided by the health system. The following section will outline 
the major responses.
a. Brief interventions
Following on from a screening outcome that shows risky substance use, a brief intervention 
involves the engagement of a client in a short conversation, providing feedback and advice, 
usually undertaken by a health professional in a hospital or community health setting.
There is good research evidence for brief interventions as an effective approach to reducing 
alcohol use. The positive effects of brief interventions have been well documented in the 
literature. In a systematic review of 22 randomised control trials examining the effects of 
brief alcohol interventions, subjects offered brief interventions significantly reduced their 
alcohol consumption in comparison to other groups (Kaner, Dickinson, Beyer et al., 2007). 
The evidence is not as strong in relation to brief alcohol interventions with pregnant women. 
However, brief interventions have been found to be a promising strategy for reducing alcohol-
exposed pregnancies (Chang et al., 2006; Floyd, Sobell, Velasquez et al., 2007; O’Donnell, 
Anderson, Newbury-Birch et al., 2013; Seib et al., 2012). A minimum, one-session interven-
tion involving personalised assessment, feedback, motivational interviewing and contracep-
tive advice could be beneficial in reducing the risk of an alcohol-exposed pregnancy, while 
a longer intervention is likely to have a more robust effect (Ingersoll, Ceperich, Hettema, 
Farrell-Carnahan & Penberthy, 2013).
There is less research into the effects of brief intervention for drugs other than alcohol, 
both for the general population and for pregnant women (Breen et al., 2014). For pregnant 
women with AOD dependence or disorders, the most appropriate interventions include 
specialised treatment services with a comprehensive bio-psychosocial approach. An exception 
is tobacco. There is strong evidence for the effectiveness of smoking cessation programs for 
pregnant women and these can be delivered in routine antenatal care (Flenady, Macphail, 
New, Devenish-Meares & Smith, 2008). Brief interventions providing integrated motivational 
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interviewing content and contraceptive advice have been found to be effective in reducing 
the risk of alcohol-exposed pregnancies in non-pregnant women, in randomised controlled 
trials in the United States and South Africa (Floyd et al., 2007; Ingersoll et al., 2013; Rendall-
Mkosi, Morojele, London et al., 2013). Further research is needed on the design of these 
interventions, the skills needed, the length and frequency of the intervention, the mode of 
delivery and the long-term outcomes (Breen et al., 2014).
b. Motivational interviewing
Motivational interviewing is a style of brief intervention that focuses on a person’s readiness 
to change their behaviour. It uses an empathetic, collaborative and reflective counselling 
approach with the intention of motivating change and addressing any resistance or ambiva-
lence that someone may be feeling about changing their behaviour (Jones & Kaltenbach, 
2013). Motivational interviewing aims to clarify the person’s motivation for change in their 
own language and to develop goals, and has been found to be effective in reducing prob-
lematic alcohol consumption in women (Jones & Kaltenbach, 2013).
Pregnancy may provide the ideal opportunity and motivation for behaviour change around 
substance use and can be assisted via motivational interviewing accompanied by the appro-
priate treatment and support (Lui, Terplan & Smith, 2008). Project CHOICES is a model of 
motivational interviewing for AOD use integrated with contraceptive advice. Developed in 
the United States, the Project CHOICES model provides four brief motivational counselling 
sessions and a contraceptive appointment to non-pregnant women of reproductive age. The 
model has been tested in randomised controlled trials and shown to be effective in reducing 
the risk of an alcohol-exposed pregnancy (Floyd et al., 2007; Ingersoll et al., 2013).
c. Treatment for substance use problems
Pregnant women who are assessed as being dependent on substances are likely to be referred 
to treatment, which may take the form of pharmacological treatment (when the woman is 
dependent on opioids), residential treatment or counselling.
In any discussion of best practice treatment approaches to pregnant substance-using women 
and their families, it is important to note that treating women during pregnancy represents 
a short period within which to address ‘the multiple intersecting and complex issues that 
led to substance use initiation and continuation’ (Jones & Kaltenbach, 2013). The perinatal 
period has been referred to as a ‘window of opportunity’ in which women re-evaluate their 
domestic situations, particularly where there is violence, with motivation to possible absti-
nence from substance use or at least to minimise substance use (Tsantefski et al., 2013).
Substance-dependent mothers face unique challenges in caring for their infants while man-
aging drug use or pharmacotherapy (Tsantefski et al., 2013). Most substance-use treatment 
services are focused on treating the individual substance user, with less regard for the children 
and family. Efforts to change this focus are being implemented in Australia, such as the 
work being undertaken by the National Centre for Education and Training on Addiction. One 
United States study highlighted the balance between the need to provide low income and 
AOD-dependent women with the health care and safety that they themselves require, while 
understanding that they are expected to also provide for their babies (Flavin & Paltrow, 2010).
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Treatment programs for substance-using pregnant women need to address survival needs 
such as housing, food and financial problems, as well as physical health (both obstetrical and 
general health), psychological health, social functioning, relationships and social supports 
(Jones & Kaltenbach, 2013). There is also a greater awareness that services and programs 
should be informed by recognition that most substance-using women in treatment have 
a history of trauma (Jones & Kaltenbach, 2013). Treatment should be multidisciplinary, 
comprehensive and collaborative in scope, use coordinated and evidence-based strategies 
that incorporate support, and comprehensive health and social services that are responsive 
to women’s needs (Marsh et al., 2011). Some authors recommend that treatment comprise a 
comprehensive network of accessible, non-judgmental, non-punitive, culturally- and gender-
specific services that includes provision for the care of the mother–baby dyad as well as 
partners and other children (Velez & Jansson, 2013). Other authors emphasise the need for 
all contacts within the treatment setting to be therapeutic; that is, reinforcing, optimistic, 
supportive and respectful (Jones & Kaltenbach, 2013).
In a Public Policy Statement on Women, Alcohol, Other Drugs and Pregnancy, the American 
Society of Addiction Medicine (ASAM) (American Society of Addiction Medicine, 2011) rec-
ommended that high-quality, affordable and culturally competent substance-use treatment 
services should be readily available to pregnant and parenting women and their families. 
Pregnant women and their partners should be offered the highest priority for admission to 
available treatment slots. The treatment components of the ASAM recommendations include:
• opioid agonist therapy for women dependent on illicit opioids
• family-centred treatment, including education and treatment of domestic partners
• evaluation and case management for substance-exposed children
• childcare and transportation
• adequate and appropriate facilities for the outpatient and continuing care phases of treatment
• perinatal care that is non-judgmental and sensitive to special needs
• facilitation of maintaining the family unit and mother–child unit, with consideration of 
alternative arrangements as needed
• child protection services as alternative placement when there is active substance-use 
disorder and absence of others able to fulfil the parental role
• collaborative, interdisciplinary relationships and consultation among primary care, obstetric, 
family medicine, and midwife practices with addiction treatment providers
• preservation of the physician–client relationship in regard to confidentiality and report-
ing laws
• screening, evaluation, treatment planning, and case management for co-occurring mental 
illness and personal history of prenatal alcohol exposure, foetal alcohol spectrum disorder, 
or foetal alcohol syndrome
• reproductive and contraceptive counselling, including the effects of alcohol, nicotine, and 
other drugs on pregnancy and foetal health.
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d. Does treating the mother’s substance use improve child outcomes?
Although substance misuse is one of the primary reasons that parents become involved 
with the child protection system, there is surprisingly little empirical research that examines 
the relationship between substance abuse treatment and child protection outcomes (Green, 
Rockhill & Furrer, 2007; Grella et al., 2009). Studies have most often focused on the role of 
treatment completion, which judges report using as a key factor in reunification decisions; 
custody status and overall family functioning have rarely been included within evaluations of 
substance abuse treatment outcomes (Grella et al., 2009; Karoll & Poertner, 2002). As Barnard 
and McKeganey comment, children have only rarely been the direct focus of interventions, 
with the assumption that they will derive indirect benefit from the support offered to their 
parents (Barnard & McKeganey, 2004).
Where the outcomes for children have been considered, findings are mixed (Grella et al., 
2009). On the one hand, Green, Rockhill and Furrer, in a longitudinal study of 1911 women 
who had children placed in care, found that when women entered treatment more quickly, 
spent more time in treatment, or completed at least one treatment episode, their children 
spent fewer days in foster care and were more likely to be reunified with their parents (Green 
et al., 2007). Smith found that, in a sample of 159 substance-abusing families with at least 
one child in substitute care, about 50 per cent of parents completed at least one episode 
of substance abuse treatment, and that treatment completion was a strong predictor of the 
likelihood of reunification, even after controlling for parents’ self-reported drug use and 
quality of parenting practices, among longer-term child welfare cases (Smith, 2003).
On the other hand, Gregoire and Schultz (2001) showed that there was a relatively low rate 
of treatment completion (less than one-quarter) among parents referred to substance abuse 
treatment from child welfare, and that treatment non-completion was strongly associated 
with continued substance abuse and eventual loss of parental rights. While parents who 
completed treatment were more likely to be reported by their caseworkers as ‘clean and 
sober’, they were no more likely to have custody of their children or to retain their legal 
parental rights (Gregoire & Schultz, 2001). In another study using case records, compliance 
with court-ordered substance abuse treatment was found to not affect either the likeli-
hood of subsequent reports of child abuse or the duration of child welfare services received 
(Rittner & Dozier, 2000).
Barth, Gibbons and Guo undertook a secondary analysis of data from the National Survey 
of Child and Adolescent Wellbeing, a longitudinal study intended to answer a range of 
questions about the outcomes for abused and neglected children and their involvement 
in the child welfare system. From their nationally representative sample of 5501 children 
whose families were investigated by child protection services for child maltreatment in the 
year 2000, cases with any indication of carer substance misuse (n=1101) were selected. They 
found that families that enter substance abuse treatment have higher re-report rates; this 
may be because the families are more troubled, but also because they experience greater 
agency surveillance during the service period, thus increasing the likelihood of a subsequent 
report (Barth et al., 2006).
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3 .2 .2 Interventions aimed at improving the substance-using mother’s 
ability to safely care for her child
From previous reviews of the literature in this area, one of the strongest messages is the 
need for a coordinated service response in addressing parental substance misuse in a child 
protection context. There is some evidence that combining family-based interventions with 
drug treatment services has positive effects on children of substance users when it builds 
family routines and promotes strong bonds to non-drug-using family members. Other studies 
have found that re-abuse and re-entry to care for children are less likely the more time, 
assistance and supports that families receive (Taplin & Mattick, 2011).
a. Shared and collaborative decision making
Case planning, case management and family group conferencing are all strategies aimed at 
bringing services together with families, to discuss decisions and strategies with the aim of 
working collaboratively to reduce risks to children.
Case plans and safety plans
The development of a case plan that incorporates a safety plan is the first stage in any com-
prehensive intervention with substance-using pregnant women (Jones & Kaltenbach, 2013). 
Jones and Kaltenbach suggest that there are some key elements that need to be incorporated 
for their successful engagement with service interventions. These include: (i) woman-led 
and -owned case plans; (ii) priority given to addressing basic survival needs; (iii) involve-
ment in decisions about any treatment intervention, such as opioid agonist medication or 
medication-assisted withdrawal (benzodiazepines); (iv) assessment of mood disorders after 
a period of stabilisation of drug use; (v) monitoring of the case plan; and (vi) recognition of 
the capacity of women to address goals and to break down goals into those that are realistic 
and can be managed (Jones & Kaltenbach, 2013).
In the context of child protection outcomes for substance-using pregnant women, case plans 
and safety plans can influence their early engagement with specialists, as well as with the 
broader service system. One study involving a specialist AOD service in Australia found that 
early engagement of pregnant women in case planning could lead to the avoidance of a crisis 
response, coordinated planning before birth for the care of the infant, and timely referral and 
links to services. Many of the women interviewed in this study reported a fragmented and 
uncoordinated response to substance use treatment and in the early period after discharge 
from hospital (Tsantefski, Humphreys & Jackson, 2011).
In Australia, case planning meetings are generally held for all neonates considered to be at risk 
prior to discharge from hospital. However, a small-scale qualitative study of a major provider 
of obstetric services to substance-dependent women in Victoria (the Women’s Alcohol and 
Drug Service and the Royal Women’s Hospital) found that the implementation of case plans 
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required resources that were not available. Mothers highlighted the lack of detoxification 
and rehabilitation programs or continuity of support for the family unit following infant 
discharge from hospital. In the context of child protection, it is noteworthy that, in the 
absence of appropriate services, surveillance leading to removal is more likely than family 
support (Tsantefski et al., 2011).
Case management
Case management in the context of substance-using pregnant women has been described 
as a comprehensive, coordinated continuum of services to optimise recovery of the aspects 
of women’s lives that have been affected by substance use, which advocates on behalf of 
the women and enhances the women’s advocacy skills. It involves the solving of practical 
problems with the active participation of women, and aims to overcome barriers to services 
and coordinate services across systems.
The literature supports case management as an integral part of a comprehensive treat-
ment plan for substance use disorders in pregnant women (Jones & Kaltenbach, 2013). It 
has produced positive outcomes for vulnerable substance abusers facing multiple barriers, 
including pregnant women and mothers of young children, building on the knowledge that 
women have historically not responded well to traditional substance abuse treatment models 
that focus on abstinence alone, without incorporating services for problems in other areas 
(Dauber, Neighbors, Dasaro, Riordan & Morgenstern, 2012).
Case management is broad in concept and practice but specific elements have been identi-
fied in the literature as key principles toward a best practice model of care for pregnant 
women. These elements include: (i) establishment of rapport at intake; (ii) reaching out to 
pregnant women to maintain engagement, including home visiting; (iii) undertaking an 
assessment of women’s needs, which can also enhance the trust and relationship between 
service provider and client; (iv) linking women to appropriate services; and (v) advocacy on 
their behalf (Jones & Kaltenbach, 2013).
A recent United States study, with a sample of 302 substance-dependent mothers recruited 
from welfare offices and their 888 children, examined the impact of ‘intensive case manage-
ment’ (ICM) on child protection system involvement. The findings showed an initial reduction 
in child protection reports but no clear benefits of ICM over usual care. In addition, a lower 
proportion of children were removed from participants in the ICM condition compared to 
usual care, but this effect decreased over time. Overall, however, they found minimal benefits 
from case management in terms of child protection outcomes but it was effective in the 
areas of treatment, engagement and abstinence (Dauber et al., 2012).
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Family group conferencing
Family group conferencing (FGC) is a family-led decision-making process that provides 
parents, extended family members, children/young people, child protection workers and 
service providers with an opportunity to come together for the purpose of discussing and 
developing strategies that will protect the safety and wellbeing of the children/young people. 
Conferences are typically facilitated by a neutral third party (facilitators) who ensures that all 
participants have an opportunity to speak, are listened to and remain focused on the needs 
of the children. In addition to empowering families to develop strategies, FGC also aims to 
improve relationships between child protection agency professionals and family members, to 
provide a culturally appropriate means of resolving child protection concerns, and to rebuild 
family ties, especially in families that may have stopped communicating or drifted apart 
(Boxall, Morgan & Terer, 2012; Chandler & Giovannucci, 2009).
Family group conferencing has been mandatory practice in New Zealand since 1989, when it 
was introduced to better address the practice issues experienced by Indigenous people that 
did not reflect the importance of their kinship networks (Connolly & Smith, 2010). In other 
countries, including Australia, the use of FGC is largely at the discretion of child protection 
workers. Australian child protection laws come under the jurisdiction of individual states 
and territories; all except one jurisdiction have implemented or conducted trials of FGC with 
significant variation in implementation (Tsantefski et al., 2011).
Research into the effectiveness of FGC has been generally positive. Previous evaluations of 
FGC programs operating in Australia and overseas have found: (i) the majority of families 
have been able to develop appropriate family plans that address the identified child welfare 
concerns and meet the requirements of the child protection agency; (ii) families are more 
likely to engage in services identified through conferences; (iii) children/young people have 
increased contact with their extended family; and (iv) families report an improved working 
relationship with the child protection agency (Boxall et al., 2012).
Further, while the cost-saving benefits of FGC are less clear, there is some evidence that 
FGC programs either generate some cost-saving benefits or are no more expensive than 
traditional care and protection processes (Boxall et al., 2012). Despite evidence that there 
are some benefits from FGC, there has generally been a low uptake of the model in Australia 
(Harris, 2008).
The literature has noted the tensions that emerge when two very different discourses attempt 
to integrate the ‘democratic’, participatory discourse of FGC versus the legalistic, bureaucratised 
discourse of conventional child welfare practice (Ney, Stoltz & Maloney, 2013). Delivering FGC 
needs an awareness of how power operates in this context and the potential for discourses that 
are incompatible with FGC objectives and values (Ney et al., 2013). Challenging and changing 
existing power relations and structures can be difficult to achieve (Tsantefski et al., 2011).
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Family group conferencing with pregnant ‘at-risk’ women and their partners
There is limited research focusing specifically on the effectiveness of FGC with ‘at-risk’ pregnant 
substance-using women. In Western Australia, an evaluation was undertaken of interagency 
early intervention in the form of pre-birth planning using the New Zealand model of FGC 
in conjunction with the Signs of Safety Assessment and Planning Framework. The Signs of 
Safety Framework is used to assess safety in partnership with family members to address child 
abuse and neglect concerns (Turnell & Edwards, 1999). The Western Australian evaluation 
involved a sample of 31 mothers who participated in pre-birth planning using FGC and the 
Signs of Safety Framework (Hunter, 2009). The evaluation found that both mothers and 
professionals considered the pre-birth planning meetings underpinned by FGC principles to 
be a more effective and consistent process overall, the framework improved communication 
and planning during the trial, and there was better engagement with families. The authors 
also reported that it was not always possible to engage with the mother early enough to 
allow adequate time for the pre-birth planning process, and there was a need to increase 
the cultural responsiveness of the model to ensure that the Aboriginal kinship networks were 
incorporated (Hunter, 2009). It has been suggested that the discretionary use of FGC severely 
limited the engagement of the extended family at a time not only of heightened infant 
risk, but also of increased maternal and parental motivation for change, and limited the 
valuable opportunity for early intervention and prevention afforded by pre-birth notification 
(Tsantefski et al., 2011).
b. Co-location of services — integrated antenatal and substance abuse treatment programs
In addition to the strategies discussed above, services may be brought together or physically 
co-located to ensure more collaborative working arrangements aimed at reducing the risk 
to the child. These are commonly integrated treatment programs.
Integrated programs — that is, programs that integrate onsite pregnancy, parenting or child-
related services with substance use treatment — have been developed to address the barriers 
to accessing care, and the unique needs of pregnant women who misuse substances (Niccols, 
Milligan, Sword et al., 2012). Within these models, the needs of women in relation to their 
substance use, wellbeing, mental and physical health (including antenatal care), and the 
needs of their children (including parenting interventions) are addressed by the provision of 
specific services. Integrated programs may differ in the number of services offered and the 
degree to which they are integrated from a process perspective, including the ways in which 
agencies work together, service linkage, cooperation, coordination and partnership (Milligan, 
Niccols, Sword et al., 2011). Substance-using women require integration of obstetric and 
specialist treatment services including education in caring for newborns, particularly with 
neonatal abstinence syndrome (Jones & Kaltenbach, 2013).
A review of the literature on integrated substance abuse and child welfare services for women 
found that improvements in service utilisation and outcomes were made when substance 
abuse and child welfare services were integrated, with women remaining in treatment longer 
and being more likely to reduce substance use and reunify with their children (Marsh et al., 
2011). Grella and colleagues found that mothers who were treated in programs providing a 
‘high’ level of family-related or education/employment services were approximately twice as 
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likely to reunify with their children as those who were treated in programs with ‘low’ levels 
of these services (Grella et al., 2009). In their study of 160 mothers who had delivered a 
substance-exposed infant, Huang and Ryan reported that mothers who received residential 
treatment combined with other community-based transitional programs (including outpatient, 
intensive outpatient, recovery homes, and methadone maintenance) were significantly more 
likely to achieve reunification compared to mothers who received only inpatient residential 
treatment (Huang & Ryan, 2011). The client–provider relationship has also been found to 
be an important element and reasonably consistent predictor of retention in treatment, but 
an inconsistent predictor of post-treatment substance use (Marsh et al., 2011).
One of the early integrated programs was Early Start, introduced in 1990 in northern 
California as an obstetric clinic-based perinatal substance-abuse intervention program. This 
program provided pregnant women with screening and early identification of substance use 
problems, early intervention, counselling and case management by a clinical therapist with 
expertise in substance abuse — the Early Start specialist. The Early Start program diagnosed 
and scheduled those identified as having substance use problems for Early Start appointments 
linked with their perinatal appointments. The program’s unique feature was that the Early 
Start specialist was co-located in the prenatal clinic, as an integral part of the perinatal care. 
Co-location promotes easy access to services and client compliance (Armstrong, Gonzales 
Osejo, Lieberman et al., 2003).
Milligan and colleagues undertook a meta-analysis of studies evaluating the impact of inte-
grated programs on birth outcomes. They found that, compared to women with substance 
abuse issues not in treatment, women in integrated programs had infants with significantly 
higher birth weights, larger head circumferences, fewer birth complications, positive toxicology 
screens, and low birth weight classifications. Women in integrated programs also attended 
significantly more prenatal visits and had significantly fewer pre-term births than women in 
non-integrated programs (Milligan et al., 2011). Furthermore, in a systematic review examining 
the effectiveness of integrated programs for mothers with substance abuse issues, Niccols 
and colleagues found that the limited available evidence supports integrated programs as 
being associated with improvements in parenting skills (Niccols et al., 2012).
In summary, meta-analyses of integrated programs show their positive impact on maternal 
mental health and birth outcomes and, in qualitative studies, women stated that integrated 
programs helped them to gain insight into intergenerational influences on parenting, to 
strengthen emotional bonds with children, and to use positive discipline techniques. However, 
the findings related to improvement of parenting skills, which has been shown to reduce the 
risk of child maltreatment, are fewer. Even though the advantage of integrated programs over 
addiction treatment-as-usual may be small, it could have a potentially large impact on the 
associated financial and human burden in this vulnerable population (Niccols et al., 2012).
Findings
41
c. Home visiting
Home visiting programs are an early intervention strategy providing a range of structured 
services to young children and their family in their home environment, usually by a professional 
service provider. Home visiting programs encompass a wide variety of strategies and service 
elements. However, they all emphasise the importance of parental behaviour in influencing 
the lives of children and the importance of the home environment as an opportune place for 
providing services. The observation of family dynamics and environment enhances a better 
understanding of families’ needs and opportunities for service interventions. Interventions 
may include case management, referrals to existing community services, parenting and child 
education, and the provision of social supports to women and their families, prenatally and 
postnatally. Home visiting programs are most effective with lower socioeconomic groups, 
when nurses and/or other professionals deliver services to families instead of paraprofessionals, 
when services are comprehensive in focus, the program model is adhered to and families’ 
multiple needs are targeted (Olds, Kitzman et al., 2004; 2007; 2014).
Participation in home visiting programs for ‘at-risk’ families has been shown to be effective 
for improving children’s cognitive and behavioural outcomes (e.g. Peacock, Konrad, Watson 
et al., 2013). However, few home visiting programs have been able to significantly improve 
pregnancy outcomes and reductions in child maltreatment have been found for some models, 
but not for others.
Western Australian researchers recruited 152 illicit-drug-using mothers at 35–40 weeks 
gestation from Perth’s King Edward Memorial Hospital and randomised them after delivery 
to a home visiting group or to a control group. The home visiting group received eight home 
visits, parenting support, and breastfeeding and child development education, while the 
control group had telephone contact at two months and at six months and no additional 
support. In both groups substance use reduced in pregnancy but increased by six months 
post-partum (Bartu, Sharp, Ludlow & Doherty, 2006).
A recent systematic review published by the Cochrane Collaboration focused on whether there 
was potential for improving outcomes for pregnant and post-partum women with an AOD 
problem via home visits (Turnbull & Osborn, 2012). The authors found that, although indi-
vidual studies reported a significant reduction in involvement with child protection services, 
there was insufficient evidence to recommend the routine use of home visits for pregnant or 
post-partum women with an AOD problem (Turnbull & Osborn, 2012). Similar findings have 
been reported by Tsantefski and colleagues, who found evidence that home visits after births 
increased the engagement of women in drug treatment services, but there were insufficient 
data to indicate if this improved the health of the baby or mother (Tsantefski et al., 2013).
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d. Additional or ancillary services to address the needs of substance-using 
pregnant women
Parenting interventions
Experience in early relationships with parents is known to be crucial for the child’s brain 
development as well as for cognitive, emotional and social development (Cicchetti & Toth, 
2009). Substance-use dependence reduces the rewarding value of caregiving and renders 
parents particularly vulnerable to stress, especially in the perinatal period. The outcomes 
may be a lack of response to infant cues (leading to neglect) or responding inappropriately 
to infant cues, which may lead to abuse or a combination of these responses. Many pro-
grams for substance-using pregnant women and new mothers use strategies that provide 
support and education based on the need to address the demands of parenting, as well as 
the problems of the substance use itself (Suchman et al., 2013). Without improvement in a 
substance-using mother’s capacity to recognise and respond sensitively to a child’s emotional 
cues, other interventions may do little to strengthen the mother–child relationship (Pajulo 
& Kalland, 2013; Suchman, DeCoste, Castiglioni et al., 2010).
However, attendance alone is not sufficient to improve parenting capacity. ‘Simply arguing 
that a parent has attended an “evidence based” parenting intervention does not equate 
to an improvement in the capacity to provide a responsive and nurturing environment for 
children’ (Dawe & Harnett, 2007, p. 388).
A small number of parenting programs have been developed for substance-using parents, 
some of which engage women prenatally.
e. Contingency management
Contingency management is an empirically supported intervention for substance dependence 
(Petry, Alessi & Rash, 2013). Contingency management has the ‘greatest depth and breadth of 
empirical data’ to support its use in changing substance use behaviours of pregnant women 
(Jones & Kaltenbach, 2013). Contingency management treatments are based on learning 
and conditioning theories that aim to alter the environment by arranging ways that make 
substance use less attractive (Jones & Kaltenbach, 2013). The theoretical basis for interven-
tions and treatments needs to be operationalised through comprehensive programs that 
treat substance use disorders in pregnant women incorporating strengths-based, supportive, 
professionally respectful and affirming interventions. There is also evidence regarding the 
efficacy of treatments for substance use disorders during pregnancy showing that a combi-
nation of treatments are most successful (Jones & Kaltenbach, 2013).
Haug and colleagues (2014) recently reviewed the literature on the use of contingency 
manage ment with pregnant women. They reported that, in general, contingency manage-
ment approaches have shown effectiveness for improving retention and drug abstinence 
among substance abusers in treatment, thereby allowing clients to benefit from other com-
ponents of clinical services. Contingency management is of particular relevance during a 
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time-limited window of opportunity such as pregnancy, in which longer treatment duration 
results in better maternal and infant outcomes. Contingency management interventions 
have consistently been shown to improve retention in drug abuse treatment and access to 
prenatal services for pregnant women, but with less promising effects on substance use. 
The cost of contingency management programs makes clinical application challenging in 
community-based treatment clinics. Moreover, stigma and related negative public percep-
tions of paying women to abstain from substance use during pregnancy are often difficult 
to overcome (Haug et al., 2014).
f. Residential treatment programs for substance-using mothers
Pregnant women are often granted priority admission into residential treatment and imme-
diate access when a bed is available. Residential treatment programs have been developed 
specifically for substance-using pregnant and parenting women, focusing on simultaneously 
treating the substance use and supporting the mother–baby relationship. Collaboration 
between treatment providers and onsite nursing resources are important components of 
the residential treatment of pregnant women. Residential and inpatient treatment offers a 
safe environment for stabilisation, structure and intense support for recovery. Additionally, 
important and intensive early work to support the mother–child relationship within a safe 
residential treatment context is valuable from the babies’ developmental viewpoint and for the 
mothers’ future solutions and collaborative capacity (Pajulo, Pyykkönen, Kalland et al., 2012).
Pregnant women who live in drug-using environments may especially benefit from residential 
versus outpatient treatment (Haug et al., 2014). However, women who have other child and 
family responsibilities may prefer community-based programs rather than residential programs.
Research suggests that women become more engaged, obtain greater benefit from treat-
ment, and have higher retention when they are permitted to bring their children into the 
residential treatment setting (Haug et al., 2014). Women in residential treatment with their 
children have better outcomes across multiple areas of psychosocial functioning (i.e. drug 
abstinence, employment, child custody, and involvement with continuing care and support 
groups) at six months after discharge than women who do not bring their children to treat-
ment. Moreover, improved behavioural and emotional functioning at 6 and 12 months after 
residential treatment was found among children who attended residential treatment with 
their mothers (Haug et al., 2014).
Women-only residential treatment services are associated with increased length of stay 
compared with mixed-gender substance abuse treatment programs, and treatment focused 
on gender-specific needs results in longer stays and improved continuity of care (Ashley et 
al., 2003; Haug et al., 2014).
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Women-only treatments
Drug treatment programs are often based on models that lack cultural sensitivity to minorities 
or women. For example, some people may find aspects of the initial involvement in these 
programs — such as self-disclosure, trust in virtual strangers, being urged to ‘surrender’ or 
admit they are ‘powerless’ — to be alien and culturally inappropriate (Wechsberg, Luseno, 
Karg et al., 2008). Copeland’s study of women who had ceased substance use without formal 
treatment found that the principal barriers to entering formal treatment services among 
this group included social stigma and labelling, lack of awareness of the range of treatment 
options, concerns about childcare, the perceived economic and time costs of residential 
treatment, concerns about the confrontation models used by some treatment services, and 
stereotypical views of clients of treatment services (Copeland, 1997).
Ashley and colleagues define substance abuse treatment programming for women as the 
delivery of services that (i) reduce women’s barriers to entering substance abuse treatment; 
and (ii) address the treatment needs specific to women. These investigators emphasise how 
services are delivered, in addition to the specific type or quantity of services (Ashley et al., 
2003). Specifically, this consists of a nurturing and supportive group therapy environment, 
focus on self-worth, and a comfortable setting for women to discuss sensitive and painful 
issues (Haug et al., 2014; Marsh et al., 2011).
Comprehensive programs involving children that include specialised health and mental health 
services, and which offer practical help, have been shown to improve child welfare outcomes 
for AOD-using mothers involved with the child welfare system (Marsh et al., 2011).
3 .2 .3 Key findings from this section
• One of the strongest messages is the need for a coordinated service response in addres-
sing parental substance misuse in a child protection context. There is some evidence that 
combining family-based interventions with drug treatment services has positive effects 
on children of substance users.
• There is some evidence that if pregnant women’s partners are encouraged by antenatal 
services to reduce their substance use, women are also more likely to reduce their substance 
use. Other family members may also be an important source of support.
• Following on from a screening outcome that shows risky or dependent substance use, a 
brief intervention, referral to pharmacological treatment (where women are dependent 
on opioids), residential treatment or counselling is recommended.
• The service response should be multidisciplinary, comprehensive and collaborative in scope, 
use coordinated and evidence-based strategies that incorporate support, and compre-
hensive health and social services that are responsive to women’s and children’s needs.
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• There is little evidence on the extent to which pregnant women gain access to appropriate 
services in a timely manner.
• Treatment compliance increases the likelihood of reunification.
• Case planning, case management and family group conferencing are all strategies aimed 
at bringing services together with the family, to discuss decisions and strategies with the 
aim of working collaboratively to reduce risks to the child.
• The literature supports case management as an integral part of a comprehensive treatment 
plan for substance use disorders in pregnant women.
• Research into the effectiveness of family group conferencing has been positive, but there is 
limited research focusing specifically on its effectiveness with pregnant AOD-using women.
• Integrated programs, programs that integrate onsite pregnancy, parenting or child-related 
services with substance use treatment, address the barriers to accessing care and the 
unique needs of pregnant women who misuse substances. Meta-analyses of integrated 
programs show their positive impact on maternal mental health and birth outcomes, but 
limited improvements in parenting skills.
• A recent systematic review found that, although individual studies reported a significant 
reduction in involvement with child protection services, there was insufficient evidence 
to recommend the routine use of home visits for pregnant or post-partum women with 
an AOD problem (Turnbull & Osborn, 2012).
• Contingency management approaches have shown effectiveness for improving retention 
and drug abstinence among substance abusers in treatment, thereby allowing patients 
to benefit from other components of clinical services.
• Residential treatment programs for substance-using pregnant and parenting women focus 
on simultaneously treating the substance use and supporting the mother–baby relation-
ship. Research suggests that women become more engaged, obtain greater benefit from 
treatment, and have higher retention when they are permitted to bring their children into 
the residential treatment setting (Haug et al., 2014).
• Women-only residential treatment services are associated with increased length of stay 
compared with mixed-gender substance abuse treatment programs, and treatment focused 
on gender-specific needs results in longer stays and improved continuity of care (Ashley 
et al., 2003; Haug et al., 2014).
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3 .3 Policies in Australian jurisdictions relating to the 
identification of maternal AOD use in pregnancy
This section identifies the current legislative and policy context in Australia with regard to the 
identification of maternal AOD use in pregnancy. It draws on consultations undertaken with 
key stakeholders as well as relevant material accessed online to identify the similarities and 
differences, along with the common approaches in legislation and policy across jurisdictions.
Current Australian policy and practice can be characterised as taking a clinical approach to 
managing substance use during pregnancy, which emphasises the health of the newborn 
rather than the enforcement of laws in relation to drug use (De Bortoli et al., 2014). This 
position can be contrasted with that in the United States where a zero-tolerance approach 
regards drug use as requiring a strong law enforcement apparatus and a drug policy that tends 
to punish the user. As part of this approach, all newborns exposed to illicit drugs through 
positive testing must be reported to child protection services, with responses ranging from 
service referral to punitive outcomes. In the United Kingdom, the approach to managing 
substance use during pregnancy appears to be similar to that adopted in Australia (De Bortoli 
et al., 2014).
In 2005, South Australia was the only Australian jurisdiction that accepted notifications 
for unborn children, while other jurisdictions either recorded or investigated a notification 
(Western Australia, Queensland, New South Wales) or were considering legislation on prenatal 
reporting (Tasmania, Victoria, Australian Capital Territory) (Bromfield & Higgins, 2005). All 
jurisdictions progressively introduced legislation on prenatal reporting over the next few 
years. Prenatal reporting was introduced into legislation in the United Kingdom (2004) and 
the United States (2000) earlier than in Australia. The drivers for changes in child protection 
legislation in Australia were mainly in the aftermath of inquiries into child abuse following 
tragedies (e.g. Queensland Crime and Misconduct Commission, 2004), concerns in the United 
States about exposure to substance use in pregnancy and the presumption that such children 
have been abused or neglected and the mother’s parental rights need to be terminated, and 
the United Nations Convention on the Rights of the Child (1989) which states that ‘the 
child, by reason of his physical and mental immaturity, needs special safeguards and care, 
including appropriate legal protection, before as well as after birth’.
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3 .3 .1 Australian legislation — overview of similarities and differences
A mapping of legislation across Australian jurisdictions with a focus on unborn reporting 
provisions and supporting policies found that differences have evolved in their statutory 
provisions and in their responses following an unborn child notification (see Appendix A for 
specific detail and legislation).
All jurisdictions, with the exception of the Northern Territory and South Australia, have 
legislation for reporting the unborn child to statutory authorities. Although South Australia 
and the Northern Territory have no specific provisions for unborn child reporting in their 
legislation, these jurisdictions have developed policies and practice guidelines for the man-
agement of reports including ‘high-risk infant alerts’ in conjunction with state and territory 
health and statutory child protection services (see Appendix A).
Tasmania has included prenatal reporting (Children, Young Persons and Their Families Amend-
ment Act 2009, section 14) in the reporting requirements to child protection services for 
mandated reporters. The list of prescribed mandated reporters included in Tasmania’s child 
protection legislation, the Children, Young Persons and Their Families Act 1997, is extensive. 
It includes professionals such as medical practitioners and dentists similar to other Australian 
child protection legislation, but is more extensive in scope with the inclusion of employees 
and volunteers of all government-funded agencies that provide services to children.
All jurisdictions specify that a notification may be made to statutory child protection services 
prenatally without the consent of the parent. However, all other child protection interventions 
prenatally are voluntary; that is, requiring the consent of the pregnant woman. Another key 
feature of unborn reporting legislation is the intended aim of the reporting, which is stated 
to be generally non-punitive but rather aimed at providing opportunities for supportive 
interventions for better outcomes for children and pregnant women.
There are, however, differences in legislation across the jurisdictions, on the nature and 
thresholds for risk in the context of unborn reporting. For example, Queensland looks at harm 
initially, rather than causes of harm, and considers that it is the impact of a risk factor such 
as AOD use in pregnancy, not the presence or absence of AOD use, which would generate 
a report/notification.
Most jurisdictions have developed routine screening and assessment processes for bio-
psychosocial risks prenatally including for AOD use. This area of interest will be the subject 
of discussion later in this report. The known in-utero effects of AOD use in pregnancy have 
been and are currently gaining momentum, through increased awareness of foetal alcohol 
spectrum disorder for example, as significant drivers for health policies relating to screening 
and assessment for AOD use in the antenatal health policy. It is unclear, however, whether 
unborn reporting legislation and policies per se in the context of risk are influencing the 
development of structured screening and assessment protocols for antenatal care in maternity 
hospitals and in primary care. Nevertheless, screening and assessment of AOD use in pregnancy 
and most child protection policies that have identified AOD use in pregnancy as a high-risk 
factor for interventions are inextricably linked. Pre-birth notifications are common across 
jurisdictions and are reported to be increasing (see Section 3.1.8g).
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a. Major features of each jurisdiction’s legislation re prenatal reporting
A summary of the major features of each jurisdiction’s legislation and policies is outlined 
below along with any planned changes.
In New South Wales, current legislation as outlined in the Children and Young Persons (Care 
and Protection) Act 1998 provides for the making of a prenatal report where the child may be 
‘at risk of significant harm’ when born. Of relevance to this discussion is a recent proposed 
amendment to the Act, the Child Protection Legislation Amendment Bill 2013 (expected 
proclamation date in October 2014), influenced by an increased emphasis on adoption. Under 
section 38A(1), Parent responsibility contracts (PRC), the scope of PRCs has been extended 
to include, under (b):
an agreement between the Director-General and either or both expectant parents whose 
unborn child is the subject of a pre-natal report under section 25 that contains provi-
sions aimed at improving the parenting skills of the prospective parent and reducing the 
likelihood that the child will be at risk of significant harm after birth.
In addition, the legislated timeframes for decisions on returning children to their parents 
have become six months if a child is less than two years old, or within 12 months for a child 
over the age of two years. The implications in relation to PRCs where a prenatal report has 
been made in relation to parental substance use are that they will be required to attend and 
comply with treatment. Under the new legislation, it is likely that cases would go to court 
earlier than would previously have been the case. Some stakeholders consider that the new 
legislation may increase the number of removals at birth because of early court involvement.
The Northern Territory currently does not have legislation for reporting the unborn to 
statutory authorities. However, in 2010 a major review of the Care and Protection of  Children 
Act 2007 made recommendations that the Act be extended to enable the acceptance of a 
notification for an unborn child and to make provision for the care of the child once born 
(Northern Territory Government, 2010). In the recommendations for legislative review, there 
was support for the introduction of mandatory reporting for the protection of unborn 
children when the foetus is at risk of AOD use. This was seen as a logical step once unborn 
notifications provisions were provided in the Act. However, it was noted in the review that 
there may be unintended consequences for legislation of unborn reporting — as there is, 
for example, no known safe level of alcohol consumption during pregnancy, which may 
lead to a difficult and inappropriate plethora of notifications with the potential to further 
marginalise already-disadvantaged groups in the community. The legislative changes have 
not to date been introduced.
South Australia has no specific legislative provisions for reporting unborn children, but has 
developed policy and practice guidelines.
In the Australian Capital Territory, section 362 of the Children and Young People Act 2008 
provides for the prenatal reporting of an unborn child deemed ‘in need of care and protection’ 
following birth, based on a belief on reasonable grounds of anticipated abuse or neglect. 
The focus is currently on providing the optimal response to an unborn child report in terms 
of support, and whether child protection statutory responses are necessarily the best first 
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intervention. Information-sharing entities may report an unborn child and, as noted above, 
may do it without consent if it is deemed to be appropriate. A voluntary assessment may 
be undertaken and a referral made to a community service or provided with advice. If the 
pregnant woman does not consent under section 362(6) of the Act, the legislation allows 
the giving of prenatal information to the information-sharing entities; for example, to ACT 
Health if it suspects that the child may be in need of protection after birth.
In Queensland, section 21A of the Child Protection Act 1999 provides for unborn children 
notifications and investigation if a reporter reasonably suspects the child may be in need 
of protection after their birth. There is also provision for the offer of help and support to 
pregnant women. The Act specifically states that the purpose of section 21A is ‘to reduce 
the likelihood that the child will need protection after he or she is born (as opposed to 
interfering with the pregnant woman’s rights or liberties)’. The recent Carmody Inquiry has 
been instrumental in instigating reforms of the child protection system (Queensland Child 
Protection Commission of Inquiry, 2013). The major development that has been noted from 
the Queensland reform is the greater consistency and uniformity of policies and guidelines 
around reporting of significant harm thresholds. The Inquiry report outlines provisions for 
unborn reporting in the circumstances that should result in prenatal reporting to child 
protection and support systems having an impact on good outcomes (Queensland Child 
Protection Commission of Inquiry, 2013).
In Tasmania, prenatal reporting requirements are outlined under section 13 of the Children, 
Young Persons and Their Families Act 1997. The current provisions came about under amend-
ment of this Act in 2009, with the Children, Young Persons and Their Families Amendment 
Act 2009, whereby reporting of pregnant women became mandatory. This amendment has 
extended the statutory authority for unborn child reporting, and makes Tasmania the only 
state in Australia with mandatory provisions for unborn child reporting. Under section 14, 
any prescribed person must inform statutory child protection authorities of their belief, 
suspicion or knowledge that a child once born is reasonably likely to suffer abuse or neglect, 
or require medical treatment.
In Victoria, under section 29 of the Children, Youth and Families Act 2005 a person may make 
a report, before the birth of a child, if they have a significant concern for the wellbeing of 
the child after their birth, and under section 32, referrals can be made to community-based 
child and family services about an unborn child. The aim is to support the pregnant woman 
and to collaborate to reduce risk to the unborn child.
In Western Australia, under section 33A of the Children and Community Services Act 2004, 
the chief executive officer of the relevant government department may make enquiries in 
order to determine actions to safeguard or promote the child’s wellbeing after the child is 
born, then must provide or arrange for the provision of social services, ensure that a meeting 
is arranged with service providers for case planning, or arrange an investigation to assess the 
likelihood that the child will be in need of protection after the child is born.
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b. Risk assessment policies and guidelines
As discussed above, all jurisdictions have developed at least some level of policy, guidelines 
and procedures for reporting of unborn children, including the receiving and processing of 
unborn child reports; AOD screening and assessments, including the use of drug screens in 
child protection assessments; high-risk infant alerts and protocols between hospitals, AOD 
services and child protection services. All jurisdictions except one have developed protocols 
and pathways that distinguish, through risk assessment, the level of risk of AOD use and the 
nature of the risk factors that provide the appropriate pathway for the pregnant woman. 
Case management practice guidelines for prenatal reporting, such as in New South Wales 
Health’s Child Wellbeing and Child Protection Policies and Procedures (2013), Tasmania’s 
Department of Health and Human Services’ guidelines on Unborn Children — Reporting 
Concerns about Safety and Wellbeing (2013) and Victoria’s Department of Human Services’ 
Reports Regarding Unborn Children (2013), provide a list of levels of risk factors that include 
substance use as a specific risk factor in assessment for child protection involvement.
In all jurisdictions, no specific thresholds of frequency or type of substance used in pregnancy 
exist for making an unborn child report or for child protection involvement. All jurisdictions 
have reported that most child protection interventions are instigated when there are multiple 
risk factors. Examples of risk factors that are commonly included in child protection guide-
lines, such as in Victoria’s Department of Human Services protocols, as reason(s) for unborn 
child reporting across Australia include: (i) another child in the family previously suffering 
abuse, neglect or death while in the care of the parent; (ii) a sibling previously being removed 
from the care of either parent; (iii) where AOD use is likely to have a significant impact on 
the child’s safety and stability after birth; (iv) where mental health problems are likely to 
have an impact on the child; (v) where domestic violence is present; and the likelihood that 
parental capacity is of concern because of (vi) the youth of the mother, or (vii) the presence 
of an intellectual disability. Additionally, a trigger may arise where the mother is the subject 
of a protection intervention or a protection order.
The issue of whether AOD use in pregnancy is a significant risk factor is not contested in the 
policies and practice across jurisdictions in child protection and health sectors. For exam-
ple, resources that aim to support practitioners’ work around the perinatal period include 
the following statement: ‘the use of drugs by a parent or carer does not necessarily mean 
a child is at risk. Parenting capacities can vary as widely in substance-using parents as in 
non-using parents. Often substance-using parents express a desire to change to meet their 
children’s needs and many can and do’ (New South Wales Community Services’ Parental 
Drug Testing Policy, 2009).
Nevertheless, although AOD use is stated as a separate risk factor in risk assessment protocols, 
all jurisdictions noted that AOD use in pregnancy alone is rarely a reason for the involve-
ment of child protection services, but that the complexity and multiplicity of factors such 
as mental health concerns and domestic violence remain the priority for decisions on child 
protection statutory involvement. However, risk assessments include other factors, such as 
previous involvement with the child protection system.
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3 .3 .2 Health screening policies and guidelines
This section provides an overview of the current screening policies and guidelines. Some 
examples of current policies, guidelines and screening practices are presented to address the 
major areas as noted in the introduction to this report. It is, however, not the purpose of 
this section to provide information and comparisons of screening processes per se, but to 
set a context for jurisdictional developments in this area with a focus on child protection. 
This section also identifies the views from participants about the pros and cons of universal 
health AOD screening for pregnant women and considers the emergent practice issues and 
responses from jurisdictions.
The identification and screening for AOD use in pregnancy across Australian jurisdictions 
are common for pregnant women in a variety of settings, but especially in antenatal set-
tings in large maternity hospitals. There are key differences in the policies and practice of 
identification and screening protocols for AOD use in pregnancy across health and child 
protection settings. However, there is general agreement that identification and screening 
are advantageous to the foetus, the pregnant woman and her family; that the earlier the 
identification (including preconception) of AOD use the better the outcomes; and that the 
unintended consequences are generally related to the possibility of disengagement from the 
antenatal services and the risk of removals of babies at birth because of AOD use.
a. Common health service approaches across jurisdictions
Nationally agreed guidelines, such as the National Clinical Guidelines for the Management 
of Alcohol and Drug Use during Pregnancy, Birth and the Early Development Years of the 
Newborn (2006) (under review), are intended to support a range of healthcare workers who 
care for and treat pregnant women with AOD use issues, their infants and their families. 
The guidelines provide a framework for the practice of identification and screening for AOD 
use in pregnancy, as well as for the management and treatment of women prenatally and 
postnatally, and their babies. This overarching framework has recommended screening but 
has not specified any particular structured or validated screening process requirements.
Policies and practice protocols have also been developed by all jurisdictions, which have 
consequently put into practice various ways of identification and screening for AOD use. 
One consistent theme in this context across the jurisdictions is the desirability for effective, 
consistent and structured brief interventions following an AOD screen that are acceptable 
to pregnant women.
All jurisdictions currently include some form of questioning about AOD use, and particu-
larly about alcohol and tobacco. There was general agreement that the identification and 
screening for AOD use in pregnancy are worthwhile and should be universal for a number 
of reasons. The first is aimed at outcomes for a healthy pregnancy through the early identi-
fication of physical and psychosocial risk factors, such as medical conditions, mental health 
issues, especially depression and anxiety, domestic violence and financial disadvantage. The 
second, linked to the first objective, is aimed at ensuring a safe environment in utero and 
once born. In this context, identification and screening of risk factors such as AOD use in 
pregnancy are important.
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All jurisdictions were supportive of the earliest possible screening of AOD use together with 
the repertoire of other risk factors, in order to engage appropriate services such as family 
support, parenting skills support and multidisciplinary case planning as required. This is an 
emerging priority across the jurisdictions.
b. Developments in screening practices
Some responses to the complexity surrounding prenatal substance use is evident in policy 
and practice developments across the jurisdictions, such as the utilisation of specific screening 
tools, policies for intersectoral collaboration (e.g. in Western Australia), shared responsibility 
for decision making, such as in the Australian Capital Territory, and training for professionals. 
These responses will be explored further through examples of policies and practice across 
the jurisdictions.
Screening tools
The most recent national initiative has developed protocols and resources for the identifica-
tion and screening of alcohol in pregnancy with specific screening tools and requirements 
recommended in health settings. This initiative is an outcome of the ‘Women Want to 
Know’ project that is consistent with the National Health and Medical Research Council’s 
Australian Guidelines to Reduce Health Risks from Drinking Alcohol (National Health and 
Medical Research Council, 2009). The protocols and resources for health professionals were 
developed by the Foundation for Alcohol Research and Education. The resources include the 
alcohol screening tool AUDIT–C. In addition, online e-learning resources have been developed 
through the Royal Australian College of General Practitioners, the Royal Australian and New 
Zealand College of Obstetricians and Gynaecologists, and the Australian College of Midwives.
Some examples of tools used to screen a range of substances across the jurisdictions include 
the Australian Capital Territory’s implementation of a validated screening tool for AOD use: 
ACT eASSIST. The screening tool is an electronic Alcohol, Smoking and Substance Involve-
ment Screening Test developed by the Drug and Alcohol Service in South Australia and is an 
electronic version of the World Health Organization’s ASSIST. The eASSIST tool is intended 
to screen for all levels of risky substance use, including tobacco, alcohol, cannabis, cocaine, 
amphetamine-type stimulants, sedatives, hallucinogens, inhalants, opioids and ‘other drugs’. 
A risk score is obtained for each substance and falls into a ‘low’, ‘moderate’ or ‘high’ risk 
category, which then determines the type of intervention offered. The Australian Capital 
Territory version was developed in 2014 by the Alcohol Tobacco and Other Drug Associa-
tion ACT and the Drug and Alcohol Service in South Australia and includes ACT-specific 
referrals and information.
In collaboration with the World Health Organization, South Australia Health uses the ASSIST 
tool for the assessment of AOD use and has developed an abbreviated version of it. This tool 
is currently being circulated for comment to hospitals. The ASSIST tool includes elements 
from the AUDIT–C. Positive acceptance of this tool has been reported by clinicians, who found 
that there was less pressure on the midwife if a standardised tool was used for assessment. 
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It is a priority across the jurisdictions to maintain the engagement of women in antenatal 
care, and it is hoped that the use of a validated tool may help with engagement by assisting 
midwives to feel more comfortable asking pregnant women about substance use.
Alternatively, Western Australia has introduced the AUDIT–C tool, which is administered up 
to three times during pregnancy, and includes guidelines that are used as an appendix to 
the Perinatal Hand Held Record (which is personally held by the woman). The use of the 
Hand Held Record has meant that women at the secondary and tertiary levels of care have 
earlier, and improved, access to tertiary services. If a woman scores high on the AUDIT–C, 
urinalysis and blood tests may be conducted voluntarily by the Health Department (urine in 
the first trimester and blood consequently). Information on its impacts is not yet available, 
as it was only introduced in 2013. However, it is reportedly very well received across health 
settings including in primary care. In practice, Western Australia has introduced universal 
screening that includes AOD use; stakeholders argue that this has greatly raised the aware-
ness of clinicians (including general practitioners in shared care arrangements) of the issues 
surrounding AOD use in pregnancy and appropriate interventions. It is noted that Western 
Australia considers that the validated AUDIT–C is far better than having informal questions 
to assess substance use in pregnancy.
In other jurisdictions, a variety of screening tools are used to screen for AOD use in pregnancy.
Screening for specific substances
Alcohol
New thresholds recommending zero alcohol consumption in pregnancy were recently intro-
duced in response to the lack of evidence on the safe levels of alcohol consumption in 
pregnancy (National Health and Medical Research Council, 2009). One example of a policy 
position on alcohol is the Tasmanian Alcohol Action Framework 2010–2015, which includes 
strategies for reducing alcohol use in pregnancy, based on the National Health and Medi-
cal Research Council advice guidelines on zero alcohol in pregnancy (National Health and 
Medical Research Council, 2009).
Consultations revealed that a major issue that has arisen across the jurisdictions is the poten-
tial for ‘mixed messages’ about alcohol use in pregnancy. An identified issue was that there 
are gaps in consistent information about the types and amounts of alcoholic drinks that are 
particularly harmful and equally about intermittent binge drinking.
There has been a great deal more information about the effects of alcohol in pregnancy in 
the media over the last few years, including public health campaigns and messages about in 
utero effects, that are also reinforced by messages from general practitioners and antenatal 
clinics. Stakeholders reported that a change has been noted in the understanding of alcohol 
and smoking effects in the community. Some jurisdictions have noted that alcohol use by 
pregnant women presenting to hospital settings is lower than expected, given the pervasive-
ness of social drinking, binge drinking and hazardous drinking generally in the population 
of women of child-bearing age. From our consultations the most commonly reported reason 
for low reporting of alcohol use among pregnant women is the associated stigma and guilt, 
which lead to concealment of their alcohol use in pregnancy.
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Emergence of foetal alcohol spectrum disorder
The recent increased awareness of the effect of alcohol on the developing foetus and of 
foetal alcohol spectrum disorder has had an impact on jurisdictional policies. The Australian 
Parliament’s inquiry into foetal alcohol spectrum disorder may have contributed to increased 
awareness of alcohol use in pregnancy (Australia. House of Representatives Standing Com-
mittee on Social Policy and Legal Affairs, 2012).
Many jurisdictions have responded to these issues via policy and practice changes as well as 
by developing specific training. In the Northern Territory there is currently a review into foetal 
alcohol spectrum disorder. The Western Australian Department of Health has developed a 
practice module containing a rationale for screening and the early detection of foetal alcohol 
spectrum disorder (Western Australia Department of Health, 2013). This module provides 
recommendations that include universal antenatal screening for alcohol consumption at 
first antenatal visit and at each trimester followed by brief interventions where indicated; 
the use of a standardised self-report questionnaire, the AUDIT–C, administered by a health 
professional; and the routine reporting of data on alcohol use during pregnancy for the 
maternity and child health information division with annual reporting in the Western Australian 
Government’s perinatal statistics report (Western Australia Department of Health, 2013).
Generally, jurisdictions reported that although foetal alcohol spectrum disorder research 
and public health interest are accelerating and well developed, there is no screening tool 
for the diagnosis of foetal alcohol spectrum disorder, either in pregnancy or at birth, and 
no incidence data are available. All jurisdictions have noted that in their experience there 
is a low incidence and prevalence of foetal alcohol spectrum disorder in their clientele. It 
was also noted that, in the child protection sector, foetal alcohol spectrum disorder was not 
generally well understood.
Jurisdictions noted that, in practice, pregnancy can be a positive catalyst for change. How-
ever, it was also noted that clinicians who are not specialist AOD workers can tend to over-
identify with pregnant women’s feelings of guilt about substance use, and in particular 
with alcohol use. In relation to alcohol use, it was frequently noted that pregnant women 
wanted to know as much as possible about its impact on the foetus and the developing 
child. The information provided to the pregnant woman, however, was deemed inconsistent 
and sometimes inadequate.
Smoking
Screening for tobacco use in pregnancy is well developed across primary care and hospital 
antenatal settings in Australia. Public health campaigns and the less stigmatised nature of 
talking to pregnant women about smoking (compared to alcohol) have helped in providing 
effective universal screening for tobacco use in pregnancy. In some jurisdictions, brief inter-
ventions are undertaken when smoking is identified. Although smoking may be associated 
with the use of other substances such as alcohol, it is not in itself identified as a ‘significant 
risk of harm’ issue in the context of child protection.
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Other substances
Another issue for policy makers and practitioners is that of changing AOD-use patterns in 
Australia. Most jurisdictions have noted that there has been a shift in the types of substances 
being used by pregnant women, which reflects the overall usage patterns and accessibility of 
particular drugs. Some have observed a shift toward the increased use of amphetamines and 
prescribed opiates, with benzodiazepines and polydrug use being common among pregnant 
women seen in specialist services. Concerns were raised by some tertiary hospitals about 
benzodiazepines such as Xanax and its effects on babies, particularly when there is polydrug 
use. The issue of over-prescription and ‘shopping’ for these drugs (benzodiazepines and anti-
depressants) was raised by a number of jurisdictions. Some concerns were expressed about the 
changes in types of substances women were presenting with, and their effects on women’s 
mental health (such as borderline personality disorders and post-traumatic stress disorders) 
and social problems, including domestic violence and homelessness. With amphetamines, in 
particular, there is also an increasing potential for complex psychiatric problems.
c. Views about universal screening
Most jurisdictions viewed universal screening not only as administering questions on AOD 
use to all pregnant women (which is currently the practice across all jurisdictions), but also 
as requiring additional elements: structured, standardised protocols, driven by more specific 
policies and procedural guidelines. Additionally, a need was identified for accessible pathol-
ogy services for urinalysis testing (when required) as well as appropriate interventions and 
services following positive screens.
A number of jurisdictions reported that the implementation of a comprehensive universal 
screening policy would come at a high cost in terms of resources, yet it was seen as potentially 
advantageous in supporting practitioners in providing interventions. Some pressures noted 
by stakeholders include the capacity to fit additional screening processes into an already-
busy antenatal visit; and in relation to drug testing, the capacity of pathology services to be 
able to cope with the extra demand on their services. Antenatal visits were reported to be of 
around 15 minutes in duration on average, with the exception of the initial visit, which is 
usually 90 minutes. It was reported that midwives can be affected by time restraints in their 
antenatal appointments and, as a consequence, some women’s AOD use may not be identified.
There was support by stakeholders for more structured, validated and consistent approaches 
to screening for AOD use, together with the provision of brief interventions. Interest was 
shown for screening that has high sensitivity and specificity for the vast majority of pregnant 
women who use alcohol at low to medium levels. There was a consensus that interventions 
should provide benefits with appropriate information on harms and risks in a non-judgmental, 
supportive and timely way. Another recurring theme was the importance of pregnancy as a 
time for change and a motivator for the woman to focus on her unborn child, and provide 
the earliest opportunities for making changes to behaviours. There was general agreement, 
however, that policies and practice in this context need to be realistic, not expect major 
changes, and be responsive to the multiplicity and complexity of factors that impinge upon 
pregnant women.
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3 .3 .3 Practice issues
a. Risk to relationships
There were a number of shared issues that emerged across jurisdictions, which were identified 
as affecting the identification of substance use in pregnancy. Although there was general 
agreement about the need to screen for substance use in pregnancy, a recurring theme of the 
consultations was the difficulty that some health practitioners, such as general practitioners 
and midwives, experienced in having conversations about AOD use with pregnant women. 
Many voiced concerns about the risk of compromising their practitioner–client relationship 
throughout pregnancy as a result of such conversations. Often the difficult questions tended 
to be avoided to help maintain relationships with pregnant women. A lack of consistency of 
skill level across the health and child protection workforce was also identified as an issue.
A professional tension was identified between maintaining a positive relationship between 
women and their practitioners throughout the pregnancy and postnatally (predominantly 
health practitioners, such as midwives), and in having to make decisions relating to the 
safety and wellbeing of the child once born (the statutory risk held by child protection 
authorities), although there is some overlap between the balancing of these risks. The lit-
erature also suggests that there is a need to identify risk at various stages throughout the 
pregnancy, as it appears that such assessments (for example, domestic violence, substance 
use) are not necessarily repeated later in the pregnancy. Again, a tension exists between the 
need to identify and respond to risk factors and maintaining the engagement of the woman 
throughout pregnancy.
b. Increased anxiety for pregnant women
Stakeholder interviews identified that one of the unintended consequences of AOD screening 
in pregnancy is the fear and anxiety that screening can generate in pregnant women as a 
consequence of discussing AOD use with them, particularly in relation to alcohol. Midwives 
reported that they were not keen to discuss alcohol use and foetal alcohol spectrum disorder 
generally, and that they used their common sense in assessments, particularly in discussing 
foetal alcohol spectrum disorder with women who may become stressed and over-anxious 
about their minimal use of alcohol during pregnancy and its potential effects.
Conveying to a woman the risks associated with substance use was recognised as difficult, 
especially when referral pathways and supports may not be available. This lack of services 
and supports was recognised as a critical issue in clinical settings. Some stakeholders ques-
tioned the value in screening for substance use and other risk factors when interventions 
may not be accessible or are non-existent, and that it may simply result in increased stress 
and anxiety. Raising anxiety and distress in a pregnant woman may affect her experience 
of pregnancy or exacerbate an existing mental health problem. These stakeholders were 
strongly of the view that the identification and screening of AOD or any other risk factors 
in pregnancy should cause no additional harm.
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c. Need for holistic assessment — screening for risk and assessing for need
One of the strongest messages from the literature is the need for a coordinated service 
response in addressing parental substance misuse in a child protection context. Interviewed 
stakeholders acknowledged that AOD problems are highly prevalent among vulnerable groups 
who often experience multiple disadvantages, requiring a holistic assessment of need that 
reflects the known impacts of AOD and other risk factors and cross-sectoral responses. 
Stakeholders were concerned about the group of pregnant women with multiple risk factors, 
experiencing serious domestic violence, mental health problems, intellectual disability and 
AOD use. They were seen as the most vulnerable and most likely to have impaired parenting 
capacity, to be unable to safely care for their baby, and to come to the attention of child 
protection authorities.
A view voiced by stakeholders interviewed across jurisdictions was that AOD issues often 
fade into the background as these disadvantaged women and families have higher, more 
urgent needs, such as homelessness, domestic violence and serious nutritional issues, which 
may take priority. These cumulative disadvantages and risk factors are too complex and 
intertwined to separate for targeted screening and interventions for AOD alone, and require 
strong, intersectoral collaborative approaches.
Collaborative working is also reflected in jurisdictional policy and practice activity in the 
development of cross-sectoral memorandums of understanding. For example, in Western 
Australia, policy and practice have been developed specifically relating to effective partner-
ships for early interventions following the reporting of an unborn child (see Appendix A). In 
Tasmania, advances have been made through public health policies, including Working in 
Health Promoting Ways: a strategic framework 2009–2012 (Tasmania Department of Health 
and Human Services, 2010), which focuses on the importance of a collaborative approach 
to public health issues such as AOD use in pregnancy. Intersectoral and collaborative ways 
of working are evident in the practice models and pathways discussed in the pathways 
 section below.
d. Training
Training to increase staff confidence in screening, to become familiar with new screening 
tools and to update knowledge of the effects of particular substances has been used by 
jurisdictions to respond to some of the above issues. Continuity of training, increasing the 
skills base and education of the workforce are seen as key strategies in being able to identify 
and promote a broader understanding of how to address AOD use and other issues, resulting 
in increased support for pregnant women.
As an example, Alcohol Tobacco and Other Drug Association ACT, supported by the Aus-
tralian Capital Territory Government, has provided workshop and training opportunities to 
support health and community services workers to build their capacity to better identify and 
respond to AOD issues. The drivers for this initiative included workers’ lack of confidence 
in raising AOD issues with clients, and a lack of knowledge about referrals and follow-up 
with specialist services. In Tasmania, a Foetal Alcohol Spectrum Disorder Placement Sup-
port Training Program has been established: the goal of this project was to develop a foetal 
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alcohol spectrum disorder training program to build the capacity of service providers in the 
child protection sector to provide support to those who care for individuals living with and 
affected by foetal alcohol spectrum disorder. This pilot project has also raised awareness 
of the in utero effects of alcohol in pregnancy (Russell, Eaton & Petersen-Williams, 2013).
3 .3 .4 Key findings from this section
• Current Australian policy and practice can be characterised as taking a clinical approach 
to managing AOD use during pregnancy, which emphasises the health of newborns rather 
than the enforcement of laws in relation to drug use.
• Six jurisdictions have legislation for reporting an unborn child to statutory authorities. 
Those with no specific provisions in their legislation have developed policies and practice 
guidelines. Only Tasmania has mandated prenatal reporting.
• Most jurisdictions have developed routine screening and assessment processes for bio-
psychosocial risks prenatally including for AOD use. Antenatal services are generally the 
first contact.
• All jurisdictions reported that most child protection interventions are initiated when there 
are multiple risk factors, and that substance use in isolation is not necessarily a trigger 
for child protection involvement.
• Recent initiatives have had a strong focus on reducing the use of alcohol in pregnancy 
following the adoption of new guidelines by the National Health and Medical Research 
Council’s Australian Guidelines to Reduce Health Risks from Drinking Alcohol (2009).
• Some lack of understanding and consistency in relation to the identification and advice 
around alcohol use in pregnancy was reported in the consultations, plus reports of staff’s 
limited understanding of diagnosis and prevalence of foetal alcohol spectrum disorder.
• The AOD screening tools known as ASSIST and AUDIT–C are used and recommended by 
several jurisdictions.
• A recurring theme of the consultations was the difficulty that some health practitioners 
experienced in having conversations about AOD use with pregnant women. Many voiced 
concerns about the risk of compromising their practitioner–client relationship and increas-
ing stress and anxiety.
• A lack of consistency of skill level across the health and child protection workforce was 
also identified as an issue by those interviewed, with suggestions for training.
• A lack of referral pathways into treatment and support services was identified through 
the consultations.
• The need for a coordinated service response in addressing parental substance misuse in a 
child protection context, having holistic assessments and services to address multiple dis-
advantages, and the need to work collaboratively were all emphasised in the consultations.
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3 .4 Pathways into AOD treatment services, support services 
and statutory child protection services for parents and their 
unborn children
This section provides an overview of the common pathways for pregnant women into treat-
ment and support. It begins with a discussion of the common existing antenatal pathways 
and specialist AOD responses before examining the existing interaction between pregnant 
substance-using women and statutory child protection services.
3 .4 .1 Professional guidelines for the management of AOD use
The Royal Australian and New Zealand College of Obstetricians and Gynecologists in its 
College Statement, Substance Use in Pregnancy (2013), states that AOD use in pregnancy is a 
common and important issue in maternity care; patterns of substance use before pregnancy 
are important considerations, as such use commonly carries into pregnancy. The policy 
advises that the key considerations following a positive antenatal screen for substance use 
should be a broad psychosocial assessment to understand the reasons for AOD use, and 
to help to address the substance use, providing sensitive counselling and referral to AOD 
multidisciplinary service programs and/or mental health services. The College has developed 
specialised training modules that may be undertaken by practitioners, such as information 
about AOD use, treatment of withdrawal and the involvement of partners and other family 
members. Additionally, information is outlined on the circumstances when a pre-birth child 
protection notification may be appropriate.
The Australian College of Midwives has also developed specialised modules outlined in the 
National Midwifery Guidelines for Consultation and Referral (2013). A key focus for midwives 
is on the continuity of care that is provided to pregnant women and the importance of build-
ing a strong and supportive relationship with pregnant woman throughout their pregnancy. 
Stakeholder consultations strongly supported this focus of the Australian  College of Midwives. 
Stakeholders emphasised that antenatal screening by midwives supports women’s potential 
to change in pregnancy and any concerns they may have for their babies. In the Australian 
Capital Territory, the midwife asks: ‘Aren’t you worried about the baby?’ and responds to 
each woman’s circumstances.
The Royal Australian College of General Practitioners produces a wide range of clinical 
guidelines for the screening and management of AOD use in pregnancy and specifically for 
comorbidity — AOD use and mental health issues. Most recently, the College, along with 
other groups, has been involved in the publication of guidelines and resources in conjunction 
with the Foundation for Alcohol Research and Education’s ‘Women Want to Know’ public 
health campaign (2014).
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3 .4 .2 Common practice for identification and referral
This section documents the common pathways, policy and practice for responding to preg-
nant women who use AOD, as reported in the interviews with stakeholders. The discussion 
includes mainstream antenatal care (midwives and obstetricians) and primary health care 
provided by general practitioners. Women with substance use problems are generally referred 
to specialised AOD services, discussed below.
a. Mainstream health service pathways
As discussed, pregnant women with substance use issues are generally identified at the time 
of booking in at the first antenatal visit, at which time their medical history, alcohol, smoking 
and illicit drug use are assessed, along with other health and psychosocial issues. In most 
jurisdictions there are clear guidelines around the provision of information and brief interven-
tions on alcohol, tobacco and other drugs. However, not all jurisdictions have standardised 
responses and this is an area that has been identified as requiring further development.
Self-reported smoking in pregnancy at the first antenatal visit is often followed by informa-
tion and referral for nicotine replacement therapy. With regard to alcohol, if the woman’s 
consumption of alcohol was greater than the National Health and Medical Research Council’s 
guidelines, it is likely that a brief intervention would be conducted, particularly with women 
who are consuming at low to medium levels. However, referral pathways for women who 
self-report AOD use, especially alcohol use, at low to medium levels are limited; a positive 
screening presents a potential dilemma.
If a woman has been identified via the antenatal substance use screening and there are con-
cerns, a referral could be made to a specialist drug-use-in-pregnancy service. Most jurisdic-
tions have commented that there is significant under-reporting of AOD use and other social 
issues (e.g. domestic or family violence). Midwives and others interviewed made the point 
that women need to feel safe and supported in this sensitive area of disclosure.
b. When referrals are made to specialist AOD services
Most jurisdictions have a triage system from the first antenatal visit assessment. In most 
pathways, practice reflects the policies of early identification, engagement and collaborative 
safety planning to reduce both medical and social risks.
In the majority of jurisdictions, policies identify the point at which substance use in preg-
nancy warrants a referral for specialist interventions in either AOD-in-pregnancy services or 
specialist social work services in hospital settings such as Royal Prince Alfred and Westmead 
hospitals in Sydney or King Edward Memorial Hospital for Women in Perth. In South Aus-
tralia, for example, stakeholders reported that a referral would occur if there is self-reported 
(i) daily cannabis use greater than four cones per day; (ii) opioid dependency or current 
opioid treatment; (iii) any other illicit drug within the past three months; and/or (iv) alcohol 
consumption greater than two standard drinks per day. Any of these responses may result 
in a referral to the Drug and Alcohol Service South Australia.
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In New South Wales, midwives reportedly refer to a specialist service, such as the Drug Use 
in Pregnancy Service at Westmead Hospital in Sydney, if a pregnant woman self-reports any 
alcohol use, such as 1–2 drinks per day, smoking and/or use of other drugs. Women may also 
be referred when there is identified anxiety about pre-conception alcohol use. However, it 
was noted that the majority of women who are referred to a specialist assessment following 
identification of AOD use are women on an opioid treatment program.
Some referrals to specialist AOD-in-pregnancy services in hospital settings are generated 
from emergency departments. However, most women are identified through the antenatal 
visit’s screening and assessment processes. General practitioners may also refer to specialist 
services if AOD use in pregnancy is a concern.
Once referred, a pregnant woman’s substance use is further assessed by the tertiary AOD-
in-pregnancy service.
Significant concerns were expressed about substance-using pregnant women presenting late to 
antenatal services. Some women have been noted to arrive at the hospital in labour having had 
no antenatal care. The issue of late presentation or presentation in labour has been noted by all 
jurisdictions as an outcome of the stigma, fear of child protection involvement, lack of access 
to primary health care, and chaotic lifestyles that are often associated with AOD dependence.
3 .4 .3 Case planning — a health service response
In many jurisdictions, once concerns about AOD use in a woman’s pregnancy have been 
identified and she has been referred to specialist AOD services, a case plan is developed by 
the health services and other services are initiated in an effort to reduce further risk to the 
foetus. A caseworker may be appointed from the specialist AOD team or, if the woman does 
not already have one, from the opiate treatment program. Multidisciplinary specialist AOD 
teams may include: specialist AOD workers (often nurses); an AOD caseworker; a social worker; 
midwifery/birth unit personnel; a mental health professional; an obstetrician; nursery staff; 
and specialist neonatologists. In most tertiary hospital maternity settings (e.g. Westmead 
Hospital), management plans are developed through the multidisciplinary team at around 
24–36 weeks gestation for the AOD-using pregnant woman. The plan is initiated at around 
20 weeks or earlier in other jurisdictions, such as at King Edward Memorial Hospital in Perth.
3 .4 .4 Specialist AOD-in-pregnancy services
Many tertiary maternity hospitals provide specialist AOD services for pregnant women. The 
key issue in this context is early engagement of pregnant women in services that respond to 
the often multiple needs they may experience in pregnancy. Integrated treatment programs, 
such as substance use in pregnancy services, have been found to improve outcomes for the 
child, improve service utilisation, and decrease the risk of mothers’ substance use (Marsh et 
al., 2012). Stakeholders pointed to some evidence of the success of specialist AOD pregnancy 
services. For example, the Substance Use in Pregnancy and Parenting Support Service, operated 
by Barnardos in the Illawarra region of New South Wales, noted that their antenatal visit 
attendance rates are equal to other mainstream clinics, indicating that they have managed 
to reduce the rate of late presentations to antenatal care among substance-using women.
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Below is an example of a specialist substance use in pregnancy service that reflects an inte-
grated model of practice.2
An example of a specialist substance-use-in-pregnancy service
The Western Australian Newborn & Drug and Alcohol Service (WANDAS) is a specialist 
AOD-in-pregnancy clinic situated at King Edward Memorial Hospital for Women in Perth. 
This tertiary hospital has a specialist multidisciplinary team that provides comprehensive 
and intensive support to AOD-using pregnant women.
Midwives are heavily involved with WANDAS, together with hospital social workers, child 
protection staff, clinical psychologists and medical obstetric services. Women are screened 
and referred to the service, and other issues such as housing are also addressed. This 
involves a pre-management plan. Where a care plan is established, women are seen early 
in their pregnancy via primary or secondary service referrals. Referrals are often from 
a general practitioner, an outreach service or from other services, such as a hostel for 
homeless women. It is an advantage that referrals are not required to access the specialist 
service. However, women are required to be connected with a general practitioner. Services 
incorporate social work, psychiatric and parent education services with midwives often 
conducting parent education.
In Western Australia, 31 000 women out of the total births of 32 000 women who present 
to antenatal clinics per annum have screening as part of their care. WANDAS’ clients are 
seen for longer than are other pregnant women, and up to 250 clients per year are seen 
within the specialist service. Women see a social worker and a midwife at every visit. An 
obstetrician may see them around 4–5 times during their pregnancy, and a feature of the 
service is prenatal ‘continuity of care’ by the midwife.
WANDAS does not recommend complete abstinence during pregnancy, as it is believed 
that it is unrealistic within this short period. The recommendation is that these women 
are given the highest levels of support to stop AOD use if they can. Most specialist AOD 
services in hospital settings around Australia are linked to opioid treatment programs. 
Video links are sometimes used to communicate remotely to the central specialist services.
3 .4 .5 Prenatal reporting — child protection involvement
As described in previous sections, all Australian jurisdictions have developed at least some 
level of policies, guidelines and procedures for reporting of unborn children, including the 
receiving and processing of unborn reports; AOD screening and assessments, including the 
use of drug screens in child protection assessments; high-risk infant alerts and protocols 
between hospitals, AOD services and child protection services. Although unborn reporting 
policy varies across jurisdictions leading, not surprisingly, to considerable differences in the 
responses from child protection authorities to the reporting/notifications, all jurisdictions 
aim to intervene early and offer voluntary support to the pregnant woman and her family.
2 Women who are not significant users or dependent users can also be seen by the Western Australian 
Newborn & Drug and Alcohol Service, with less intense provision of services for this group.
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a. Prenatal reporting responses — providing voluntary family support
In the previous sections, the legislative basis for prenatal reporting and child protection 
involvement when substance use has been identified in pregnancy is outlined. It is, however, 
useful to provide some examples of prenatal reporting policy and practice responses across 
the jurisdictions.
Current child protection practice in the Northern Territory considers that, where a report 
identifies that an unborn child would be at risk of harm or in need of protection at birth, 
a family support case is created. Support is provided to the pregnant woman to reduce 
potential risks and to allow planning to take place with other agencies for appropriate care 
and protection once the child is born. However, a child protection report can be created 
only when the child is born.
In Queensland, the Department of Health’s Protecting Children and Young People Policy 
states that all reports relating to an unborn child are to be discussed with the health service’s 
child protection adviser or liaison officer prior to a report being made to the Queensland 
Government’s Child Safety Services centres. This includes the initiation by Child Safety Services 
of unborn child ‘high-risk alerts’, which may occur where there are significant protective 
concerns about the unborn child and the parents have refused to participate or be engaged 
in an assessment of their circumstances.
Victoria’s Department of Human Services has developed comprehensive policy guidelines and 
protocols for child protection that have a significant focus on collaboration across sectors, 
particularly the AOD and other health services and child protection services (Victoria Depart-
ment of Human Services, 2002). The Children, Youth and Families Act 2005 establishes two 
pathways in Victoria for people to report or refer an unborn child where they have ‘significant 
concern for the wellbeing of the child after his or her birth’.
In Tasmania, amendments in 2009 for new provisions to the Children, Young Persons and 
Their Families Act 1997 provided the Department of Health and Human Services with the 
ability to receive information concerning unborn children and to enable effective planning 
prior to the birth of a child who could be at risk. Reports are made through Gateway Services 
or Child Protection Services (see Appendix A). Tasmania is the only jurisdiction that requires 
mandated reporters to report an unborn child at risk. The pathway following a prenatal 
report in Tasmania, for example, is the offering of an assessment and family support services 
to the mother and other family members, Intensive Family Support Services, AOD, mental 
health or disability services. In effect, this pathway reinforces service supports as an initial 
response to prevent child protection service responses being the first line of intervention.
All jurisdictions identify specific risk factors in their risk assessment frameworks that may 
lead to a notification of an unborn child, including significant AOD abuse by the caregivers 
(mother and/or other). Stakeholders noted that there are limited data on the numbers of 
unborn child reports across the jurisdictions, and no available data on the specific factors 
(including AOD use) that may have led directly to an unborn report and/or substantiation. 
Therefore, it may be difficult to identify any specific factor that led to an unborn report or 
substantiation. Furthermore, a number of jurisdictions have noted that this is an area where 
specific data would be highly beneficial to further understanding of the impacts of legislation 
(and policies) on identification of AOD use in pregnancy and reporting of unborn children.
Id
en
tif
yi
ng
 a
lc
oh
ol
 a
nd
 o
th
er
 d
ru
g 
us
e 
du
rin
g 
pr
eg
na
nc
y
64
b. Drug use testing (urinalysis) to monitor AOD use
Antenatal drug screening via urinalysis is undertaken by the health sector, which necessitates 
a certain amount of collaborative activity and information sharing required between health 
and child protection sectors. Child protection policies and protocols that guide the use of 
urinalysis (including prenatal screening) include the description and purpose of screening 
by urinalysis, the circumstances in which requests occur, and the utilisation of the results 
in case planning and risk and needs assessments. In Victoria, child protection guidelines 
stipulate the use of urinalysis in conjunction with an AOD assessment in order to regularly 
monitor and assess the parents’ level and type of substance use and their commitment and 
capacity to change.
Prenatal urinalysis screening is done with the consent of the pregnant women and in the 
context of potential support and monitoring. Once the baby is born, voluntary engagement 
is still the desirable course with regard to drug testing. However, if it is considered neces-
sary by child protection authorities, the case would be taken to court and an order sought 
requiring drug screening via urinalysis. In Victoria, for example, the court would specify the 
type and the frequency with which urinalysis is required.
Urinalysis and other drug tests are a consequence of antenatal screening that has identified 
the use of substances in pregnancy. Urinalysis testing in jurisdictions such as Victoria and the 
Australian Capital Territory requires specialist AOD services to be available to child protection 
services to interpret the results. Most jurisdictions provide telephone consultancy services 
that assist practitioners in other sectors with AOD use information and interpretation of test 
results and specialist referral pathways. The New South Wales Drug Testing Policy prescribes 
consultation with the Clinical Issues Unit if there is AOD use involvement in pregnancy.
The purpose of drug testing is to confirm abstinence or to gather information on AOD use, 
which may be used as evidence in court. It is, however, currently difficult to establish the level 
of evidence of AOD use around cumulative harm that courts accept following birth, and this 
has been a point for education and training of magistrates through child protection services 
about child development and the impact of trauma and AOD on the foetus and the baby. 
Some jurisdictions noted that if court orders require complete abstinence following birth, 
one single positive result through drug testing can initiate a child protection response. Many 
jurisdictions commented that a more ideal situation would be to take a holistic approach.
Two key issues were raised in response to the use of urinalysis results to inform decisions 
about child protection involvement. Firstly, the interpretation of AOD use screening by child 
protection services has been identified as an issue, particularly the difficulty in interpreting 
meaningful results from pathology laboratories, which depend on dose, timeframes and the 
type of substance used. The second is the impact of false negatives and false positives in 
the results. Policy and stakeholders reported that, as a result, urinalysis results are rarely used 
as the sole factor in deciding a child protection response, both prenatally and postnatally.
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c. Example of a pathway for prenatal reporting
Below is an example of a pathway for the intake and assessment phase for a prenatal report 
from Victoria’s Department of Human Services: Protecting Victoria’s Children: Child Protec-
tion Practice Manual (p. 3).
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Figure 1: Intake and assessment phase in a Victorian prenatal report
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d. Engagement with services and information sharing prenatally
It is important to note that, while a child is in utero, no jurisdictional legislation or policies 
provide for statutory powers to investigate harm or risk of harm, including the ordering 
of drug testing, until the child is born. With the important exception of sharing informa-
tion about mothers and unborn children across information-sharing entities such as child 
protection, welfare and health services, all interventions including drug testing require the 
consent of the mother until the child is born. However, policies and guidelines across the 
jurisdictions enable the mobilisation of support and treatment services for pregnant women 
and their families, including child protection support and assistance that are not specifically 
statutory protective interventions.
Stakeholders in all jurisdictions reported that the mother’s and/or family members’ deci-
sion to actively participate in the support services offered (or not) is a key factor in the risk 
assessment undertaken upon the birth of the child, and this determines any subsequent 
child protection interventions.
e. Planning and decision making for early support
Also noted across most jurisdictions is the importance of early identification and the involve-
ment of child protection services if potential harm during pregnancy could result in a report. 
It was generally agreed that the earlier that child protection services became involved in this 
context the better that outcomes could be achieved, as there would be more time to support 
women to enable them to address the risk factors. However, in a number of jurisdictions, 
the child protection authority does not always start its involvement early in the pregnancy. 
Stakeholders commented that their involvement at a later stage is more likely to result in 
crisis-driven interventions and decision making. It was noted that the major outcome of 
identifying and screening for AOD use in pregnancy should be the early engagement of 
supportive services.
Within at least two jurisdictions, prenatal case conferencing was used as a strategy to plan 
and implement support for pregnant women. One example of a tertiary maternity hospital 
in Sydney using this approach aimed to hold three case conferences during pregnancy. The 
aim is to have pregnant women work with health and child protection services and return 
home with their babies, with community-based support services already in place.
Throughout the jurisdictions, the need was noted for the child protection and health sectors 
to collaborate through regular meetings and support. Collaborative working was enhanced 
by implementing strategies such as liaison officers working together across sectors, co-
location of health and child protection personnel, joint policies, and having a memorandum 
of understanding between agencies. For example, involvement by maternity hospital social 
work departments was identified as an important factor in reaching and engaging substance-
using pregnant women in services.
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The early engagement of substance-using pregnant women with antenatal and support 
services, including child protection involvement, is seen as a critical factor for better out-
comes for unborn children, their mothers and families. Early engagement and support for 
substance-using pregnant women do not always occur, however. A factor that was reported 
as reducing the likelihood of early intervention in pregnancy was the overwhelming and 
competing priorities within the child protection system concerning children who have already 
been harmed or are at risk of harm. In addition, the multidimensional and complex nature 
of pregnant substance-using women was seen to reduce the likelihood of early intervention. 
Some stakeholders reported that in this group of women the complexity of medical risks 
can often overwhelm other risks, and the medical risks take priority. Also mentioned in the 
consultations as a barrier to early engagement in services was the high level of unrealistic 
engagement and/or expectation of change from pregnant women and their families within 
a short timeframe.
Stakeholders mentioned the need for information on the number of mothers who take up 
the offers of prenatal support and on the outcomes of early prenatal reporting.
f. Examples of early engagement programs
Differences exist across jurisdictions as to the ideal time for making a prenatal report and 
triggering a child protection intervention: report times range from 12 weeks gestation (in a 
New South Wales pilot program discussed below) to around 20 weeks in most jurisdictions.
Western Australian outreach program for Indigenous substance-using pregnant women
An outreach program for Indigenous substance-using pregnant women operating from Perth 
aimed to engage women early, and was reported as being effective for the early and main-
tained engagement of Indigenous women in antenatal care and for having good neonatal 
outcomes. Outcomes from this outreach program that were reported through the consultations 
include: linking women to antenatal services continuously through the pregnancy; reducing 
the tension around assessment; improving access to support services; meeting women in 
their own space; pre- and post-natal conversations about baby care and personal care; and 
the capacity to link with local medical services, such as diabetes services. This program’s 
funding has not been continued, however, and the outreach strategy is now confined to 
pregnant incarcerated women. Some information regarding the approach to engaging vul-
nerable populations of pregnant women is contained in the Western Australian Department 
of Health’s Strategic Plan for the Aboriginal Maternity Services Support Unit (2010–13).
Early engagement pilot program in New South Wales
A second example describes a collaborative project conducted between the Metro Central 
Office of New South Wales Community Services and the Sydney Local Health District using 
family conferencing to promote early engagement and interagency planning with pregnant 
women and families at risk of their newborns entering out-of-home care at birth (Hurley 
& George, 2013). This pilot program, now implemented as a permanent program, received 
several unborn child referrals per week regarding pregnant women with multiple risk factors.
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As part of this program, a case conference is initially held with the family when the woman 
is 12–15 weeks pregnant, the first of three meetings. Case plans are developed for support 
and goals are set as to what needs to change. A review is held at the second meeting to see 
how the woman is progressing with meeting her goals. The final meeting is held 2–3 weeks 
before birth and the mother is informed of the decision made by the child protection service 
— whether she will take her baby home or if there will be an ‘assumption of care’ (Family 
and Community Services New South Wales). Women may be referred to a program such as 
Brighter Futures, an early intervention program with significant child protection involvement, 
which provides close monitoring and support to mothers and families, especially during the 
first three months post-birth.
A major dilemma in child protection has been whether to inform pregnant women when a 
decision has been made to remove their babies at birth, prior to their giving birth. This has 
been in the context of the possibility that women may abscond. The experience of the Central 
Sydney program has been that women do not abscond or disengage from the program and 
that it was rare (possibly only in the case of serious mental health issues) for women not to 
be told about child protection decisions for removal.
In a small-scale evaluation of the program, it was found that 75 per cent of the families 
accessing the program had substance use issues, and many were on opioid treatment programs. 
Domestic violence was also a reason for reporting. Twenty-four women were referred to the 
pilot: ten women were referred between 12–20 weeks gestation; five between 21–28 weeks; 
and nine between 29–36 weeks (Hurley & George, 2013). Of the 24 who had given birth by 
the end of the evaluation, 16 infants were reported to be in the care of their mothers, nine 
were assumed (removed) into care, and a further three infants have since been removed. 
Service providers reported that the pilot achieved a 50 per cent reduction in the removal of 
babies from women who had been reported prenatally.
The level of engagement of the pregnant women with this program appeared to be a factor 
in making decisions about whether to remove the baby at birth, or for the baby to go home 
with the mother. Anecdotally, it has been noted that if the situation was identified as unsafe 
for the baby, it was likely that the mother would have disengaged from the program by 
the third meeting during her pregnancy. The strengths of the Sydney pilot were that: early 
engagement could lead to health and child protection services collaboration with parents 
around case planning; it avoided crisis responses at birth; and it could reduce the trauma 
to mothers and families, as well as to health and child protection personnel. The program 
aimed to coordinate planning for the care of the infant during pregnancy. In summary, early 
engagement appeared to reduce the risks and reduce the number of infants assumed into care.
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g. Planning, case management and collaboration across sectors
In most jurisdictions there is a level of pre-birth planning that may cover the spectrum from 
informal case meetings, shared information and provision of support, to providing formal 
protocols that include case conferencing, family group conferencing, and family decision 
making (see Appendix A).
Most jurisdictional policies and practices in relation to AOD-using pregnant women have a 
position on case and safety plans. There are many different examples noted across jurisdic-
tions of policies identifying pathways following identification of AOD use, which include 
case management and linkages to specialist and community services. However, it was often 
reported that there are gaps and a paucity of community-based supports for substance-
using women, with at times less than exemplary case management, mainly due to limited 
resources. Many women have no case plan and no way of asking for support, notwithstand-
ing the policy and guideline positions of all jurisdictions, whose aim is to be supportive of 
substance-using mothers. At times, case reviews are reportedly not conducted, although they 
were seen as an integral part of case management, especially for the most vulnerable groups.
Collaboration across health and child protection sectors
As discussed, jurisdictional policy and practice point to the need for health and child pro-
tection sectors to work better together to support pregnant women, to increase positive 
outcomes for mothers and babies after birth, and to contribute to the decrease in removals 
of babies at birth.
Most jurisdictions have some form of joint decision-making processes, and some jurisdictions 
such as Western Australia have developed a bilateral policy for interagency collaborative pro-
cesses when unborn or newborn babies are identified as being at risk of abuse or neglect. In 
Western Australia, the bilateral schedule is between the Department for Child Protection and 
Family Support and the Department of Health. It aims to facilitate interagency collaborative 
processes across the sectors in this context, and is part of a memorandum of understanding 
developed in 2013 between the sectors. The processes include pre-birth interagency meet-
ings and ‘interagency protection and care planning meetings’, to develop safety plans with 
the purpose of progressing the post-birth decision made regarding care and management of 
newborns and mothers within the hospital setting, in a manner that causes the least distress 
for newborn babies, their mothers and other clients and staff.
Strong collaboration across the sectors is also a major strategy of the Western Australian 
Signs of Safety framework. This framework seeks to engage women prenatally to reduce the 
number of child removals at birth, with a shared message and goal that if they wish to take 
their babies home, they are supported through shared case and safety planning processes. 
In this approach there are opportunities to engage family members who may also need to 
support mothers to care for their babies at home (Western Australia Department of Child 
Protection, 2011). An evaluation of the first year of using Signs of Safety meetings in pre-birth 
planning with pregnant mothers facing high-risk situations showed a 30 per cent reduction 
in child removals for this cohort and a significantly improved working relationship between 
the Department of Child Protection and Western Australia’s primary maternity hospital, the 
King Edward Memorial Hospital for Women in Perth (Turnell, 2013).
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The South Australian new practice casework model, based on the Solution-Focused Casework 
approach, ensures a stronger collaborative approach across sectors (the Solution-Focused 
Casework approach originated in the AOD sector and was used for relapse interventions). The 
model promotes a sense of continuity in the client, which will help maintain positive behaviours.
One further area for collaboration across sectors, discussed in the consultations, is the joint 
commitment to cross-disciplinary training, education and support of staff across the sectors. 
In Victoria there has been an emphasis, for example, on training around attachment theory 
and the neurosciences and the impact of neglect of children, which is essentially a focus on 
parenting roles and capacity. The ability to stay connected with the baby is the focus, equally 
for fathers and partners, and the impact of domestic violence on the mother–child dyad.
h. Child protection responses — removal of babies
For women reported to child protection services during pregnancy, stakeholders reported that 
removals at birth were more likely to occur when there was not enough change demonstrated 
by the mother before the birth. However, it was also acknowledged that the gestation period 
may not provide enough time to show change if there was a significant history of AOD use 
or domestic violence.
Some stakeholders were of the view that earlier involvement of child protection services 
prenatally, and increasing mothers’ engagement with services, were resulting in fewer babies 
being removed by their service.
Health professionals are generally strong advocates for pregnant women, while having a strong 
commitment to the safety of infants. It is acknowledged that there is a threshold for risk and 
harm, and that the legislation is there to protect children. However, there is still ambivalence 
voiced by some stakeholders, who are concerned about the particularly distressing effect on 
mothers and families of the removal of a baby at birth. Several stakeholders reported that 
when removal does occur, the impact on the mother and also on the midwives is enormous. 
There have been reported situations where it has been necessary to provide security in the 
hospital because of the reaction by the partner to the removal of the baby.
As most jurisdictions agree, providing sustained early intervention services prenatally has 
the best chance of decreasing removals at birth. It was also pointed out that if support and 
case planning are prematurely terminated, outcomes will be poor and there is an increased 
possibility that the baby will be taken into care at a later date. There are some reports of 
removals increasing by six months post-birth, supporting the need for longer-term support.
A number of jurisdictions noted that the likelihood of removal is higher if another child has 
already been removed from the family.
Key points that have been noted to contribute to the decrease in removals at birth are better 
collaboration and relationships with the health sector, and a reduction in the tensions and 
conflicts that can arise between stakeholders who may hold different views, such as different 
foci on family deficits versus protective factors. The New South Wales Central Sydney pilot, 
for example, demonstrated reduced conflict overall, earlier assessments and a greater clarity 
around the reasons for child removal.
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3 .4 .6 Key service and program models
This section identifies some of the key service and program models, such as intensive sup-
port programs, residential programs and other forms of family support. Examples of existing 
programs are discussed, as well as common issues that emerge in providing support and 
treatment to substance-using pregnant women.
A strong theme that emerged from the consultations was the fear that substance-using 
pregnant women, particularly those with complex issues, have of child protection involve-
ment. This fear was identified as a critical barrier to women accessing support and treatment, 
and affects the level of disclosure of substance use, which relies on the development of a 
trusting and supportive relationship with clinicians (e.g. midwives) and specialist AOD staff 
who play a major role in identification and screening of AOD use in pregnancy through the 
antenatal period.
A specific role of non-government AOD specialist services, such as Odyssey House in Victoria, 
was seen to be in assisting pregnant women to understand the child protection system, to 
help overcome their fear of child protection involvement and, in some cases, the possible 
consequences of the removal of their baby at birth. In this approach there is an emphasis on 
advocacy and working closely with women to help them regard child protection services as 
a source of assistance (including the development of parenting skills, practical support and 
accessing treatment) and to reframe their involvement in order to achieve better outcomes 
for themselves and their babies. However, this advocacy can be more difficult in situations 
when there has been previous involvement with the child protection system.
During consultations, stakeholders at Odyssey House in Victoria identified elements they 
considered to be best practice programs in AOD use in pregnancy in the context of child protec-
tion, which included: (i) offering a women’s discussion group on mother–infant attachment; 
(ii) supporting the intensity and longevity of service engagement; (iii) focusing on building 
trust in the client; (iv) supporting the client to engage with other sectors and agencies; 
(v) providing training and education particularly about the science of brain plasticity and 
emotions; (vi) providing mindfulness training to help the mother connect with her baby; 
(vii) helping women to recognise when they are emotionally disconnected; (viii) teaching 
women to minimise the use of threats; and (ix) meeting a woman’s practical needs, such as 
providing a cot or a baby bath.
As discussed, strong intersectoral partnerships and responsive programs are essential to pro-
vide the intensive sustained support that is required, beginning in pregnancy, and for some 
families, until the child is five years old. However, some jurisdictions have noted that it is 
difficult to find support services for substance-using pregnant women, particularly where 
there are no local specialised programs. When this is the case, pregnant substance-using 
women are encouraged to access mainstream supportive interventions programs, such as 
the Northern Territory’s Strong Women: Strong Babies.
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a. Specialist intensive support programs
One of the aims of intensive programs for AOD use in pregnancy is to ensure that collabora-
tive and holistic services are provided, aimed at maintaining the mother–baby dyad, and for 
the baby to go home with the mother. The provision of intensive sustained interventions 
with high-risk pregnancies, which include AOD use as a major risk factor, has been identified 
as a necessary part of tertiary AOD maternity pathways. The Substance Use in Pregnancy 
and Parenting Support Service in the Illawarra region of New South Wales, noted earlier, is 
an example of integrated perinatal care that begins at 20 weeks with collaboration across 
health and child protection sectors, and may include other support services such as parent 
groups, playgroups and education about foetal alcohol spectrum disorder. Staff working in 
teams are seen to play a strong advocacy role, with the focus on the mother–baby dyad but 
also including partners and families in their service provision.
b. Residential programs
As discussed, residential treatment programs have been developed specifically for substance-
using pregnant and parenting women. There is a simultaneous focus on treating the sub-
stance use and supporting the mother–baby relationship. Although pregnant women are 
often granted priority admission into existing residential treatment and immediate access 
when a bed is available, a lack of residential facilities for AOD-using pregnant women and 
families has been noted as a significant gap across jurisdictions. Where these programs exist, 
there were reported to be delays in access due to high demand. Additionally, there was a 
stated need for more local residential programs to maintain a family within their local area.
The report of the inquiry into protecting vulnerable children in Victoria (Cummins, Scott 
& Scales, 2012) made key recommendations to improve responses to meet the needs of 
vulnerable children. As a consequence, a four-bed residential mother–baby unit for high-
need intensive interventions, through the Uniting Care ReGen agency, has been funded and 
is currently being developed, and due to open in 2015. This initiative is a response to the 
identified gap for programs that enable babies to stay with their mothers, while the mothers 
undergo detoxification/withdrawal from substance misuse. This unit will support women 
with babies under 12 months as well as pregnant women. Stakeholders identified that in 
some jurisdictions, such as in South Australia, there are no specific residential programs for 
pregnant AOD-using women. In that state, however, a 30-bed hospital-based inpatient unit 
will admit women at up to 28 weeks in their pregnancy with referral to an obstetric setting 
when required.
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3 .4 .7 Need for ongoing support
There was agreement that AOD-exposed families who experience multiple issues (e.g. violence, 
mental health issues, disability) need a wraparound service from birth until the child is aged 
five years, thereby covering the transition to school and increasing the chances of improved 
outcomes for the children. Programs such as these are improved by having continuity of 
care, which at present is not always available.
A major issue arising from the consultations is that AOD-using women require ongoing sup-
port following the birth of their babies. Antenatal services and specialist services, such as the 
Western Australian Newborn & Drug and Alcohol Service and the Substance Use in Pregnancy 
and Parenting Support Service in New South Wales, aim to link and maintain women to 
services and programs within the community on a longer-term basis. The Victorian program 
Kids in Focus, a specialist child parenting and family support service for highly vulnerable 
families where parental AOD use is an issue, aims for sustainable supports and networking 
for their clients from pregnancy and birth to 13 years of age.
Across jurisdictions most family support programs were reported to begin postnatally. However, 
some programs provide antenatal interventions particularly when there are other children 
involved who are of concern to child protection services. The Western Australian Best Begin-
nings program is an example of an intensive home visiting program for vulnerable families 
which engages with the mother and family from three months prior to the birth, until the 
child is aged two years, although few visits are provided during pregnancy. Best Beginnings 
involves collaboration between the health and child protection sectors and trained health 
nurses who have a small caseload but who also have a role as consultants.
3 .4 .8 New models for intervention and support
Victoria has recently commenced a three-year pilot of a Family Drug Treatment Court, the 
first in Australia (De Bortoli et al., 2013). The aim of the Victorian pilot is to provide support 
and services to substance-using parents, prevent child maltreatment, and promote family 
reunification. The Family Drug Treatment Court pilot, modelled on those in the United States 
and the United Kingdom, is intended to ensure timely judicial decisions through coordinated 
services, provision of substance use treatment, and increased judicial oversight. This approach 
depends on court-based collaboration among child welfare agencies, substance use treat-
ment providers, the legal system, and other community agencies (Boles, Young, Moore & 
DiPirro-Beard, 2007). Pilots of pre-birth assessments of pregnant women whose expected 
babies are likely to be made subject to care proceedings have recently begun in the United 
Kingdom. Pre-birth involvement recognises the benefits of early intervention with pregnant 
women who have substance misuse problems in order to lengthen the time available to effect 
change before their babies’ birth. These pre-birth assessments raise their own unique legal 
issues and assessment complexities and it can be difficult to engage the women after their 
babies have been born, if the Family Drug Treatment Court has recommended the baby’s 
removal in order to ensure the child’s safety (Harwin, Ryan, Tunnard et al., 2011).
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The Cradle to Kinder program in Victoria operates for a family with children up to four years 
of age and begins prenatally. Referrals can be made through Child FIRST (Child and Family 
Information, Referral and Support Teams) across the state. The program is a collaborative 
family support program incorporating case conferencing and partnerships with families to 
develop plans for improved outcomes. Cradle to Kinder is a recently implemented program 
which is yet to be evaluated. The initial phase of the project (February to June 2013) has 
focused on the development of the evaluation.
a. Co-location and liaison models of intervention — promising practice
A strategy for building greater collaboration and coordination across sectors is improved and 
shared training. In South Australia, a trial aimed to co-locate the Drug and Alcohol Service 
SA and Families SA to work alongside family preservation and reunification staff. The objec-
tives were to increase the level of knowledge and skills of workers across sectors, to better 
address AOD issues, and to improve client access to AOD services. Stakeholders commented 
that AOD clinicians provided an educative role for child protection staff through jointly 
working on cases and provided training on ASSIST (the AOD screening tool). Stakeholders 
also reported positive outcomes of the project as AOD clinicians were being used effectively 
to link families who were the subject of unborn child notifications and plans, and clinicians 
succeeded in diverting the parents from the child protection system.
3 .4 .9 Key findings from this section
• Identification of any substance use issues at the antenatal visit results in referral to a 
specialist drug-use-in-pregnancy service where further assessments are then undertaken.
• No jurisdiction’s legislation or policies provide for statutory powers to investigate harm or 
risk of harm until the child is born. With the important exception of sharing information 
about mothers and unborn children across information-sharing entities (such as child 
protection, welfare and health services), all interventions including drug testing require 
the consent of the mother until the child is born. However, policies and guidelines enable 
the mobilisation of support and treatment services that are not statutory protective 
interventions.
• Prenatal urinalysis screening is undertaken with the consent of the pregnant women 
and in the context of potential support and monitoring. Policy makers and stakeholders 
reported that urinalysis results are rarely used as the sole factor in deciding upon a child 
protection response, both prenatally and postnatally.
• Concerns were expressed about AOD-using pregnant women presenting late to antenatal 
services, seen as a product of the stigma, fear of child protection involvement, lack of 
access to primary health care, and chaotic lifestyles.
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• The early engagement of substance-using pregnant women with antenatal and support 
services is seen as a critical factor for better outcomes for unborn children, their mothers 
and families. Early child protection involvement allows more time to support women to 
address their risk factors.
• Actively participating in the support services offered (or not) and demonstrating change 
are key factors in any subsequent child protection interventions at birth.
• Stakeholders expressed concern about the particularly distressing effect on mothers and 
families of the removal of a baby at birth.
• Stakeholders were concerned that if support is prematurely terminated, outcomes will be 
poor and there is an increased possibility that the baby will be taken into care at a later 
date. There were some reports of removals of babies increasing by the time six months 
post-birth was reached, supporting the need for longer-term support.
• Case management, although supported across jurisdictions, was not always undertaken. 
Within at least two jurisdictions, prenatal case conferencing was used as a strategy to 
plan and implement support for pregnant women.
• The need for cross-disciplinary training, education and support of staff, and better col-
laboration and relationships across sectors and services were identified.
• A lack of comprehensive accessible services, for pregnant substance-using women, par-
ticularly residential services, was also identified as an issue.
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4 . Implications for 
policy and practice
The aim of this project was to examine the outcomes of identifying AOD use during preg-
nancy on women, their partners and their children through existing evidence and current 
jurisdictional policy and practice. Concerns about the extent (that we know of) that AOD 
plays in reducing the safety and wellbeing of children and the impact of AOD on the devel-
oping foetus have led to the increased screening of women for problematic AOD use and 
the developing of new responses by child protection authorities. The report has focused 
particularly on the outcomes of this screening activity and the current legislative, policy 
and practice responses to pregnant women identified as using substances. Unfortunately 
we are unable to make any extensive comment on how partners and their wider family are 
responded to in this context as there is limited attention paid to them, the main focus being 
on pregnant women.
Most jurisdictions screen for a range of issues including AOD use in pregnant women; and 
most jurisdictions have pathways for responding to women, including some specialist ser-
vices. All jurisdictions specify that a prenatal notification may be made to statutory child 
protection services without the consent of the parent where there are concerns for the foetus. 
However, all other child protection interventions delivered prenatally are voluntary, requiring 
the consent of the pregnant woman. Another key feature of prenatal reporting legislation 
is the intended aim of the reporting, which is stated to be generally non-punitive and is 
aimed at providing opportunities for supportive interventions aimed at improving outcomes 
for children and mothers.
In general, what has been highlighted across jurisdictions is the difficult balance between 
risk and protective factors on the one hand, which may be tipped towards the removal of 
a baby at birth or later; and maintaining the dyad relationship, which evidence suggests is 
critical to the health, wellbeing and development of the infant.
The following section outlines the key implications arising from the report, which include a 
consideration of the implications of screening for AOD use, and what is required to increase 
the engagement of, and better support for, at-risk pregnant women in this context, to prevent 
involvement with the child protection system.
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4 .1 Screening for risk but assessing for need
All jurisdictions ask pregnant women about their levels of AOD use but some jurisdictions 
have more formal screening processes than others. In some jurisdictions there is considerable 
effort being expended on identifying AOD use, but with little consistency or commitment to 
providing a response. Some ambivalence around the need to intervene in relation to low-level 
alcohol use was expressed in particular. Smoking was recognised as a problem in pregnancy, 
as was the use of other drugs such as benzodiazepines, although there seem to be limited 
responses to these issues. Although generally supportive, stakeholders pondered the focus 
on a universal screening approach because of the level of resources required to implement 
such a strategy and the limited capacity to provide differentiated responses.
The reviewed literature and examples from practice indicate that a more holistic and ongoing 
assessment process is required to be most effective in engaging women with complex needs, 
and to better identify particular issues such as mental health, homelessness and violence. 
There is only limited evidence that women receive the services they need and that increased 
identification through screening may contribute to the targeting and further stigmatising 
of marginalised women, such as those already known to services. Although the literature 
suggests that there is a need to identify risk at various stages throughout the pregnancy, 
it appears that such assessments (for example, domestic violence, substance use) are not 
necessarily repeated later in the pregnancy.
Simply put, screening for AOD risk on its own appears to be of limited benefit. It requires 
two further elements: greater attention to building and maintaining partnerships with key 
services (discussed further below); and the increased availability of specialist treatment 
services for women. Some jurisdictions noted that it is difficult to find support services for 
substance-using pregnant women, particularly where there are no local specialised programs 
available, including in larger cities.
4 .2 Integrated systems of support
Child protection involvement appears to be working more effectively where child protection 
workers are active participants in a more integrated and collaborative working arrangement 
with health authorities.
Jurisdictional policy and practice, along with the research evidence, point to the need for 
health and child protection sectors to work together better, to support pregnant women, 
to improve outcomes for mothers and babies after birth, and to contribute to reducing the 
number of removals of babies at birth. Women with issues such as AOD misuse, domestic 
and family violence, and mental health issues are also more likely to face other difficulties, 
such as homelessness and severe financial disadvantage. This complexity and multifaceted 
disadvantage require strong intersectoral partnerships and responsive programs to provide the 
intensive sustained support that is required, beginning in pregnancy. As the level of family 
vulnerability and complexity of issues increase, so too does the need for services to work 
more closely together (Winkworth & White, 2011).
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There is evidence from the international literature that when substance abuse and child 
welfare services worked together, there was better engagement of women with services, 
women attended more prenatal visits and experienced fewer birth complications, which led 
to improved outcomes for babies (Marsh et al., 2011; Milligan et al., 2011). A review of the 
effectiveness of family interventions where parents were already involved in AOD treatment 
concluded that, along with developing a trusting working alliance with the parent, successful 
outcomes were dependent on agencies working together with child protection services and 
a wide range of other services to resolve multiple problems. Working together in this way 
can help ‘build trust’ and provide ‘a clear rationale’ for intervention (Dawe, Harnett & Frye, 
2008, p. 11). It is a case of working together to redirect negative pathways for children when 
risk factors are high and protective factors need to be strengthened (Winkworth, McArthur, 
Layton & Thomson, 2010). Indeed, preliminary evaluation findings from some local models 
being developed appear to be replicating some of these international findings (e.g. New 
South Wales inner city pilot).
4 .3 Engaging women, engaging early and staying engaged
The literature and the consultations raised concerns about possible negative outcomes that 
can occur as a result of prenatal reporting to child protection. Negative outcomes for women 
may range from disengagement from or avoidance of health services, later presentations at 
antenatal care, and increased marginalisation, through to an increased involvement with the 
child protection system. There was a strong sense from the consultations that AOD-using 
mothers are difficult to engage because of fear of child protection involvement. All jurisdictions 
made the point that interventions can be provided prenatally only with the consent of the 
mother, so child protection services take a back seat until the baby is born. Late presenta-
tions at antenatal services, as well as carrying significant obstetric risks, mean that there is a 
very short window in which pregnant substance-using women can demonstrate the change 
that child protection services require to assess them as able to safely care for their newborns.
Participants also identified a professional tension in maintaining a positive relationship 
between women and the health practitioners (predominantly midwives) throughout the 
pregnancy and postnatally, and in child protection practitioners having to make decisions 
relating to the safety and wellbeing of children once they are born.
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It was acknowledged that most pregnant women are motivated to improve their health 
and reduce their AOD use to ensure a healthy baby, and that this could be a period when 
engagement may be more successful. This issue of engagement is evident in other areas of 
supportive service provision, where some families with multiple complex issues do not take up 
the offer of services because they have had previous negative experiences, feel ashamed about 
asking for help, have insufficient information about services to access them, or because they 
are too overwhelmed to do so. There are some emerging models, such as the pilot program 
in New South Wales, where engagement with pregnant women is occurring as early as pos-
sible and is leading to promising results in terms of outcomes for mothers and their babies.
There is some evidence that early engagement in services and strategies such as case con-
ferencing and family group conferencing are promising mechanisms to develop sustainable 
plans to support women to safely care for their newborns at home. Unless support is con-
tinued for longer periods of time there is some evidence that women may have their babies 
removed later as supports drop off. There are some good examples of antenatal services 
and specialist services within Australia that aim to link and maintain women to services and 
programs within the community on a longer-term basis.
4 .4 Lack of data on prenatal reports and removals at birth
In attempting to determine the number of pregnant women and their families who are 
identified or screened for AOD use in pregnancy and/or affected by prenatal reporting and 
removals of their babies by the child protection system at birth, it became apparent that 
limited data are available. Data reported by the Australian Institute of Health and Welfare 
include the number of infants under one year of age admitted to out-of-home care in each 
jurisdiction and limited information on substantiated abuse related to ‘unborn children’. 
Information published by New South Wales shows that a high proportion of prenatal reports 
are made (3.3 per cent of all pregnant women in New South Wales were reported to child 
protection services in 2012–13). Anecdotally, many of these women are reported and their 
babies removed because of maternal substance use issues, with an over-representation of 
illicit-drug-using women in opioid pharmacological treatment. No information is published, 
however, on the reasons for prenatal reports, the removals of infants, or on the longer-term 
outcomes. Without such data and longitudinal research on the impacts of prenatal reporting 
and removals at birth, we are unable to make assessments about the outcomes from these 
policies and practices.
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4 .5 What will be the future prenatal legislation, 
policies and practices?
Currently, Australian legislation and policies around prenatal reporting are focused on the 
early identification of risk in pregnancy and the provision of appropriate services and sup-
ports. The extent to which this is realised in practice is unclear.
There are emerging indications of a weakening of this supportive focus in some Australian 
jurisdictions and a leaning towards the more punitive responses evident in the United 
States. In some American states there is a tendency to make pregnant women’s bodies the 
subject of state surveillance, and women can be committed or incarcerated if their AOD use 
is considered potentially harmful to the foetus. In this context the rights of the foetus are 
deemed superior to those of the mother and the state’s assumed authority to protect the 
foetus overrules the interests of the mother (Meurk et al., 2014).
In recent years there have been a number of government inquiries into past welfare practices 
in Australia, including Bringing Them Home: the ‘Stolen Children’ report (1997); Lost Innocents: 
Righting the Record: report on child migration (2001); and Forgotten Australians: a report 
on Australians who experienced institutional or out-of-home care as children (2004). Most 
recently the report of a Senate committee inquiry, Commonwealth Contribution to Former 
Forced Adoption Policies and Practices (2012), whereby mothers and their now-adult adopted 
children were separated as a matter of social policy, led to recent governments apologising 
to those affected and stating that it should never happen again. Furthermore, recent studies 
have highlighted recurrent childbearing among substance-abusing mothers and the issue 
of repeat involvement with the child protection system, including the removal of multiple 
children within a short period of time (Broadhurst et al., 2014).
The focus of any policies and practices should be on ensuring that every pregnant woman 
and developing foetus are healthy, and that every child has a right to be safe and well cared 
for. However, there is also a duty to support women with substance-use and mental health 
problems, to take into account the multiple problems and disadvantages that many of these 
women experience, and to provide them with adequate services and supports to give them 
realistic opportunities to change and to parent their children.
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6 . Appendices
Appendix A: Mapping of legislation, programs and services 
by jurisdiction
This Appendix provides online mapping of child protection legislation, child protection 
and health policies and guidelines, key pathways, programs and services in the context of 
identification of AOD use in pregnancy and prenatal (unborn child) reporting of child abuse 
and neglect.
An overview for the Australian Capital Territory, New South Wales, the Northern Territory, 
Queensland, South Australia, Tasmania, Victoria and Western Australia is provided below.
(a) Child protection legislation and policies
1 . Australian Capital Territory
Key variables
Legislation / 
statutory authority
Children and Young People Act 2008 (ACT)
Care and Protection Services, Community Services Directorate
Prenatal reporting
(Does the statutory 
authority accept 
notifications for 
unborn children?)
Yes. Section 362 of the above Act provides for prenatal reporting 
of an unborn child deemed ‘in need of protection’ following birth 
and based on a belief, on reasonable grounds, of anticipated 
abuse or neglect.
Voluntary assessment; provision of a range of voluntary support 
services; referrals with consent giving prenatal information to a 
prenatal information sharing entity, e.g. health facility and vice 
versa. The purpose is to assist the pregnant woman to reduce the 
likelihood of need for care and protection intervention but also 
to protect the woman’s human rights. However, consent may be 
waived if on reasonable grounds the unborn child is deemed to be 
in need of care and protection when born.
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Key variables
Is unborn 
child reporting 
mandatory?
No. While not mandatory, the policy and guidelines support 
practitioners in the reporting of the unborn child.
Related legislation Adoption Act 1993 (ACT)
Human Rights Act 2004 (ACT)
Human Rights Commission Act 2005 (ACT)
Public Advocate Act 2005 (ACT)
Family Law Act 1975 (Cwth)
Mental Health (Treatment & Care) Act 1994 (ACT) (under review)
Policies, guidelines, 
reporting, intake 
and assessment
Keeping Children and Young People Safe: a shared community 
responsibility. Community Services, ACT Government, 2012.
Child, Youth and Family Services Program Service Delivery Framework: 
2011–2015. Community Services, ACT Government, 2012.
‘Child, Youth and Family Gateway’ (prenatal – 18 years) — 
Information, Engagement and Coordination Service; use of the 
Common Assessment Framework.
The Act makes provision for reporting an unborn child as a 
voluntary report and consent must be received from the pregnant 
woman (see above). However, if the pregnant woman does not 
consent to assistance and if the Director-General suspects on 
reasonable grounds, and considering the woman’s human rights, 
that the child once born may be in need of care and protection, 
the Director-General may give prenatal information to or ask for 
prenatal information from a relevant organisation(s).
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Key variables
Services, programs 
and pathways
Unborn child notifications are received by the Prenatal Support 
Team within the Centralised Intake Service. The Prenatal Support 
Team provides support for the family up to 28 days postnatally. 
The team is responsible for conducting appraisals/investigations 
upon birth as necessary. Prenatal liaison officers (2) liaise with 
hospitals and other health services in relation to the unborn child.
Prenatal Support Team (to 28 days postnatal): Responsible for 
deciding whether the child is safe to be discharged from hospital 
to the home or not. Provides a collaborative approach using case 
conferencing to provide a multidisciplinary coordinated service.
Care and Protection Services Family Work Team
Child, Youth and Families Services Program: A service delivery 
framework for community organisations funded to provide 
early childhood and support services to vulnerable and in-need 
children, young people and their families in the ACT.
Child and Family Centres: Four centres across the ACT provide 
support programs (including pregnancy AOD use), early 
intervention through a multidisciplinary service from pre-birth to 
8 years.
Substance Use in Pregnancy Support at the Canberra Hospital 
provides support and care for pregnant women who are on opiate 
replacement therapy and/or who use drugs or alcohol and also 
specialised care for their babies.
IMPACT program: The Integrated Multi-agencies for Parents 
and Children Together program is designed to strengthen 
service provision through integrated and collaborative practice 
and supports being offered to women who are pregnant or 
families with children less than 2 years of age, and who are 
clients of Mental Health ACT and/or are receiving opioid 
replacement therapy.
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2 . New South Wales
Key variables
Legislation / 
statutory authority
Children and Young Persons (Care and Protection) Act 1998 (NSW)
Department of Family & Community Services (FACS)
Child Protection Legislation Amendment Bill 2013 (NSW)
Prenatal reporting
(Does the statutory 
authority accept 
notifications for 
unborn children?)
Yes. Section 25 of the 1998 Act provides for reports concerning 
unborn children where the child may be ‘at risk of significant harm’ 
when born. The intention of the legislation is to allow assistance 
and support to be provided to the expectant mother to reduce 
likelihood that a child when born will need to be placed in ‘out of 
home care’. To provide early information that a child who is not yet 
born may be ‘at risk of significant harm’ subsequent to birth.
The Child Protection Legislation Amendment Bill 2013: Under 
the amendment to section 38A, Parent Responsibility Contracts 
are extended to include either or both expectant parents whose 
unborn child is the subject of a prenatal report under section 25, 
which contains provisions aimed at improving the parenting skills 
of the prospective parents and reducing the likelihood that the 
child will be at risk of significant harm after birth.
Is unborn 
child reporting 
mandatory?
No. Reports related to an unborn child are not mandatory. While 
reports are not mandatory, those with mandatory responsibilities are 
required to consider the benefits for the mother and to an unborn 
child of making a report. This is to enable Child Safety Services and 
other agencies to mobilise services for the benefit of the mother 
and the child or enable Child Safety Services to prepare appropriate 
statutory/protective intervention following the birth of the child 
(Family and Community Services Mandatory Reporting Guide).
Related legislation Children and Young Persons (Care and Protection) Amendment 
(Parent Responsibility Contracts) Act 2006 (NSW)
Child Protection (Offenders Registration) Act 2000 (NSW)
Commission for Children and Young People Act 1998 (NSW)
Ombudsman Act 1975 (Cwth)
Family Law Act 1975 (Cwth)
Children and Young Persons (Care and Protection) Amendment Bill 
2009 (information to Children’s Guardian and Director-General)
Children Legislation Amendment (Wood Inquiry Recommendations) 
Act 2009 (NSW)
Privacy and Personal Information Protection Act 1998 (NSW)
Health Records and Information Privacy Act 2002 (NSW)
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Key variables
Policies, guidelines, 
reporting, intake 
and assessment
Child Wellbeing Units (CWU) Family Referral Services
Child Wellbeing and Child Protection — NSW Interagency 
Guidelines: ‘Child Wellbeing Units’.
Intake for unborn reports: Six government agencies where 
there is a Child Wellbeing Unit practitioner’s report to CWU. 
‘Risk of significant harm’ threshold — report to the Child 
Protection Helpline.
New South Wales Mandatory Reporter Guide (2014); Mandatory 
Reporters Guidance Assessment Tool CSS.
Safe Start Strategic Policy — Families NSW: supporting families.
Structured Decision Making System used when there are concerns 
for the welfare of an unborn child once born.
Keep Them Safe is a framework that reflects the legislation to 
strengthen the role and capacity of the non-government sector in 
providing services to children. Keep Them Safe: a shared approach 
to child wellbeing (2009): whole-of-government, five-year plan 
following report of special commission of inquiry into child 
protection services in NSW (2008).
Brighter Futures Caseworker Manual (6th ed., 2010).
Aboriginal Maternal and Infant Health Strategy (AMIHS): 
antenatal and postnatal assessments and interventions direct 
pathway to Brighter Futures (2010).
Aboriginal Child Youth and Family Strategy
Wellnet information-sharing computerised system
Parental Drug Testing Policy (2009): informs the Children’s 
Court on the removal of children or restoration. The trigger is 
‘serious and persistent’ use of drugs. (Alcohol is not included in 
this policy.)
Families NSW whole-of-government (health education, 
community services, NGOs) initiative for pregnant women and 
specific strategies to address the needs of vulnerable families; 
Family Services volunteer home visiting and playgroups.
The Legislative Framework for a Partnership Approach to Child 
Protection in NSW.
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Key variables
Services, programs 
and pathways
Families NSW offers a wide range of early intervention and 
prevention programs statewide including: universal health home 
visiting (but not antenatally); Safe Start; the Positive Parenting 
Program (‘Triple P’); whole-of-government, community-based 
volunteer home visiting; playgroups; family workers.
Brighter Futures is a community-based government program for 
vulnerable families. Early intervention: pregnancy up to 8 years of 
age where there have been concerns reported to FACS. Voluntary.
Drugs in Pregnancy programs: Safe Start — psychosocial 
assessment questions through Department of Family and 
Community Services.
Child Protection Case Conferencing (CPCC) planning and 
coordination of service activity.
NSW Government expanded AMIHS to 31 teams in locations 
across the state to provide priority referral to the Department 
of Community Services’ Brighter Futures early intervention 
program. Aims to improve the health of Aboriginal women during 
pregnancy and reduce mortality rates for Aboriginal babies.
3 . Northern Territory
Key variables
Legislation / 
statutory authority
Care and Protection of Children Act 2007 (NT)
Department of Children and Families
Prenatal reporting
(Does the statutory 
authority accept 
notifications for 
unborn children?)
Legislation does not include unborn children in categories for 
notifications and statutory interventions. However, if there is a 
belief on reasonable grounds for a notification under Care and 
Protection Policies (see below), a notification about an unborn 
child can be made to care and protection.
A major review of the Care and Protection of Children Act in 2012 
made a recommendation (No. 112) that the Department extend 
the Act to enable acceptance of notifications for unborn children, 
and to make provision for the care of the child once born 
and that this change should be incorporated into the Act. NT 
Government is considering new legislation for punitive responses 
to alcohol use in pregnancy.
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Key variables
Is unborn 
child reporting 
mandatory?
The Act does not have provisions currently for notifications to be 
made about unborn children (see above).
Related legislation Information Act 2006 (NT)
Disability Services Act 2004 (ACT)
Criminal Code Act 2006 (NT)
Family Law Act 1975 (Cwth)
Stronger Futures in the Northern Territory Act 2012 (Cwth)
Adoption of Children Act (NT); Adoption of Children Regulations (NT)
Care and Protection of Children Act 2007 (NT) (provisions relating 
to child protection)
Care and Protection of Children (Mediation Conference) 
Regulations (NT)
Care and Protection of Children (Placement Arrangement) 
Regulations (NT)
Care and Protection of Children (Screening) Regulations (NT)
Guardianship of Infants Act (NT)
Policies, guidelines, 
reporting, intake 
and assessment
Centralised Intake Service, Department of Children and Families
NT Families and Communities Policy and Procedures Manual
Casework Manual (2010)
Child Safety and Wellbeing Plan 2012: key strategies and actions 
— multi-agency, whole-of-government plan.
Strong Aboriginal Families, Together (2011) — policy and guidelines.
Care and Protection Policy and Procedures Practice Manual allows 
for a referral to be accepted on an unborn child. A family support 
case can be created and support and planning services provided.
The Child Protection Operations Manual 2 (2008) states that:
Reports made before the birth of a child which identify risks 
to the child after birth should be recorded on CCIS [the 
Community Care Information System] and referred to an 
NTFC [Northern Territory Families and Children] work unit 
for follow-up, if appropriate. The purpose of recording these 
reports is to allow assistance and support to be provided to the 
family to reduce the likelihood of the child being harmed after 
birth. The work unit may need to plan child protection action 
in advance of the birth and liaise with maternity services.
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Key variables
Policies, guidelines, 
reporting, intake 
and assessment 
(continued)
General control measures relating to alcohol abuse but specifically 
directed at pregnant women are those in the Alcohol Reform 
(Prevention of Alcohol-Related Crime and Substance Misuse) Act 
2011 (NT).
The Northern Territory Ombudsman’s report A Life Long Shadow: 
report of a partial investigation of the Child Protection Authority 
(2011) recommended that:
an immediate change be made to the Operations Manual from: 
‘the work unit may need to plan child protection action in 
advance of the birth and liaise with maternity services’ to ‘the 
work unit must plan a child protection action in advance and 
must liaise with maternity services when there is a foreseeable 
risk to the wellbeing of an unborn child’. 
Additionally the report recommends that:
There needs to be co-operation between RDH [Royal Darwin 
Hospital] and CIT [the Central Intake Team] to establish a 
mechanism whereby when a baby is born there is immediate 
monitoring and support for a family whose history of caring for 
children or lifestyle factors known to the CPA [Child Protection 
Authority] indicate a risk to the wellbeing of the unborn.
Information Sharing Guidelines (2012): A Safe Territory.
AOD policy: Alcohol and Other Drugs Strategic Direction 2009–
2012 — priority action area targeting alcohol and other drugs.
Stronger Futures in Northern Territory Policy: a ten year 
commitment to Aboriginal people in the Northern Territory (2012): 
a joint Commonwealth/NT program with strategies for enhanced 
safety, health and wellbeing of children and families which 
includes the Stronger Communities for Children Program.
Indigenous Family Safety Agenda (2010): addresses program 
development for alcohol abuse; completion of project to improve 
referral & intervention processes to families affected by AOD use 
involved with the child protection system (under the National 
Framework for Protecting Australia’s Children).
Tune in to Little Ones: a resource kit to help Office of Children 
& Families staff focus on vulnerable infants (neonatal abstinence 
syndrome, AOD, foetal alcohol syndrome disorder and toxic 
stress included).
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Key variables
Services, programs 
and pathways 
Department of Children and Families: child protection is 
currently aiming to adopt the Signs of Safety Practice Framework 
developed in WA (2013).
Program and service pathways through Stronger Futures roll-out, 
e.g. antenatal care for domestic violence and alcohol abuse.
Implementation of the Structured Decision Making System 
(Safety, Family Strengths and Needs and Risk Assessment and 
Reassessment) tools across all service centres.
Community Child Safety and Wellbeing Teams: child protection 
professionals living and working in remote Aboriginal 
communities.
Community Child Safety and Wellbeing Teams: establishment of 
interagency hospital-based child safety and wellbeing units. This 
initiative was a recommendation of the report of the board of 
inquiry into the child protection system in NT (2010): Growing 
Them Strong, Together: promoting the safety and wellbeing of the 
Northern Territory’s children.
Stronger Futures in Northern Territory Policy: joint program (see 
above) with the federal government also includes funding for 
partnerships across sectors.
Introduction of an information-sharing framework under the 
legislation.
Multi-agency Assessment and Coordination Teams in Darwin 
and Alice Springs to provide interagency responses to hospital 
admissions of child and family at risk.
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4 . Queensland
Key variables
Legislation / 
statutory authority
Child Protection Act 1999 (Qld)
Department of Communities, Child Safety & Disability Services: 
Child Safety Services (CSS)
Prenatal reporting
(Does the statutory 
authority accept 
notifications for 
unborn children?)
Yes. Section 21A. There are provisions in the Act for unborn 
children notifications and investigation if a reporter becomes 
aware of risk or reasonably suspects harm. There is also provision 
for offer of help and support to the pregnant woman. The Act 
states that the purpose of the section of the Act is to reduce 
the likelihood that the child will need protection after he or 
she is born (as opposed to interfering with a woman’s rights 
or liberties).
Is unborn 
child reporting 
mandatory?
No. While reports are not mandatory, there is provision for 
mandated reporters to report their concerns to CSS about the 
potential risk of harm to a child following their birth. Section 21 
of Act enables CSS to take appropriate action when it suspects an 
unborn child may be at risk of harm after birth. CSS can initiate 
an ‘unborn child high-risk alert’.
Related legislation Commission for Children and Young People and Child Guardian Act 
2000 (Qld)
Education (General Provisions) Act 2006 (Qld)
Public Health Act 2005 (Qld)
Adoption of Children Act 1964 (Qld)
Family Law Act 1975 (Cwth)
Queensland Civil and Administrative Tribunal Act 2009 (Qld)
Hospital and Health Boards Act 2011 (Qld) (Disclosure of 
information)
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Key variables
Policies, guidelines, 
reporting, intake 
and assessment
Child Safety Practice Manual (CSS)
Notifications of unborn children at risk are made to CSS for 
investigation and referral and for support services.
Child Safety Services policy on Investigation and Assessment
Protecting Queensland Children: policy statement and guidelines 
on the management of abuse and neglect in children and young 
people 0–18 years (includes prenatal). Includes guidelines on 
needs assessment and follow-up; and parenting: for example, life 
management skills and other practical assistance for pregnant 
women who use substances.
Queensland the Smart State: putting families first (2000): 
Queensland Government.
Parental Substance Misuse and Child Protection: intervention 
strategies. Department of Child Safety (2007).
Services, programs 
and pathways 
Family CARE Home Visiting Program: an initiative with Mental 
Health and Alcohol and Drug Service and Queensland Health’s 
Domestic Violence Initiative providing home-based support for 
vulnerable families.
Parents under Pressure (PUP) program for clients of the opioid 
dependence program.
Intensive Family Support Services, e.g. New Families Program 
Brisbane including antenatal care.
Helping Out Families Initiative (roll-out 2014)
Enhanced Health Home Visiting Service
Ngarramam Intensive Home Visiting Service, Indigenous Child 
Health Team
Child Health Centre initiative aims to improve antenatal, 
perinatal and paediatric care through better service integration, 
clinical partnerships and programs such as Family CARE Home 
Visiting Program.
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5 . South Australia
Key variables
Legislation / 
statutory authority
Children’s Protection Act 1993 (SA)
Families SA, Department of Education and Child Development
Prenatal reporting
(Does the statutory 
authority accept 
notifications for 
unborn children?)
No. There are no specific provisions for reporting, assessment 
or interventions for unborn children. However, notifications to 
Families SA can be made. Changes have been made to policy and 
guidelines to support practitioners in the reporting of unborn 
children, the management of reporting and interventions.
Is unborn 
child reporting 
mandatory?
No.
Related legislation Adoption Act 1988 (SA)
Children’s Protection Regulations 2010 (SA)
Family Law Act 1975 (Cwth)
Family and Community Services Act 1972 (SA)
Policies, guidelines, 
reporting, intake 
and assessment
Families SA: Intake Child Abuse Reporting Line (CARL); 
centralised intake.
Children, Youth and Family Services policy: Infants at Risk Policy, 
Procedures and Standards (2005): outlines how the reporting of 
unborn children should be managed. All notifications are to be 
reported to Families SA Child Protection if the unborn child is 
assessed as being at risk once born.
Families SA redesign: Brighter Futures — solution-focused 
casework policy and practice.
Keeping Them Safe: SA Government’s Child Protection Reform 
Program: enhanced prevention and early intervention strategies.
Child Protection Manual (2008): Families SA.
Keeping the Child in Mind: child protection practice and 
parental mental health (2011): SA Department of Families and 
Communities — chapters on the impact of mental health disorders 
on children (inclusive of substance abuse).
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Key variables
Service, programs 
and pathways
High Risk Infant Service: identification of risk for early 
intervention.
Interagency networks are in place to identify high-risk pregnant 
women and their families and coordinate support and counselling 
services prior to the birth of the infant.
Stronger Families, Safer Children Program to support 
families in contact with child protection and care system; 
targeted early intervention; intensive placement prevention 
reunification services.
Strong Start: a program that helps first-time pregnant mothers to 
care for their babies.
Partnerships across government departments and NGOs through 
continued implementation of ‘Information sharing: guidelines for 
promoting the safety and wellbeing of children, young people and 
their families’ (ISG).
6 . Tasmania
Key variables
Legislation / 
statutory authority
Children, Young Persons and Their Families Act 1997 (Tas)
Children, Young Persons and Their Families Amendment Act 2009 (Tas)
Department of Health and Human Services
Prenatal reporting
(Does the statutory 
authority accept 
notifications for 
unborn children?)
Yes. Section 13 of the Children, Young Persons and Their Families 
Act 1997 provides for reporting on reasonable grounds of concern 
for an unborn child when an adult suspects that, once born, 
the child would be likely to suffer abuse, neglect or be in need 
of medical attention due to the mother’s (or other’s residing) 
behaviour (domestic violence/AOD). The provision for notification 
is stated for prevention purposes. Notifications are from mandated 
persons but there is no legal authority until the child is born. 
The report by the Commissioner for Children on Child Protection 
Services in Tasmania recommended the amendment of the legislation 
to allow for the taking of a notification of unborn children. It states 
that notifications of unborn children should be treated as if the 
unborn child was a born child for all other purposes of the Act.
The Act provides for reports to be made for unborn children at 
‘risk of significant harm’ under section 25, whose birth mother 
has not engaged with support services in order to eliminate or 
minimise the risk that gave rise to the report.
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Key variables
Is unborn 
child reporting 
mandatory?
Yes, mandatory reporting of unborn child on reasonable grounds.
Tasmania has included unborn reporting (2009 amendment) in 
the mandated reporting requirements to child protection services 
for mandated reporters.
The list of prescribed mandated reporters included in Tasmania’s 
child protection legislation, the Children, Young Persons and their 
Families Act 1997, is extensive. It includes professionals such 
as medical practitioners and dentists similar to other Australian 
child protection legislation, but more extensive in scope with the 
inclusion of employees and volunteers of all government-funded 
agencies that provide services to children.
Related legislation Ombudsman Act 1975 (Cwth)
Family Law Act 1975 (Cwth)
Children and Young Persons (Care and Protection) Amendment 
Bill 2009 (Tas) (information to Children’s Guardian and 
Director-General)
Family Violence Act 2004 (Tas)
Misuse of Drugs Act 2001 (Tas)
Mental Health Act 2013 (Tas)
Alcohol and Drug Dependency Act 1968 (Tas)
Policies, guidelines, 
reporting, intake 
and assessment
Gateway Services: notification of neglect and abuse to the 
community-based child protection worker. This service is NGO-
operated — community-based intake services or child protection 
intake; referral and support through Gateway Services.
Keeping Children Safe: a shared responsibility: operated by 
Disability, Child, Youth and Family Services. New reporting 
threshold for prevention and early intervention.
Unborn Child Reporting Policy: intake reports to either child 
protection services or Gateway Services (NGO consortium). Its aim 
is to provide discussion of issues and referral and support services 
to avoid involvement of child protection statutory services.
National Framework for Universal Child and Family Health 
Services (2011): Australian Government Department of Health 
(includes antenatal and child safety).
Kids Come First project — early years including antenatal: 
Tasmanian Department of Health and Human Services.
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Key variables
Services, programs 
and pathways 
Our Kids: our present and our future: strategic policy framework 
(2002): Tasmanian Department of Health and Human Services.
Tasmania’s Department of Health and Human Services has 
implemented a CU@home program for young pregnant women 
15–19 years of age. This is a voluntary universal support, intensive 
home visiting program that begins prenatally up to 2 years of age.
The major pathways in the community sector are to the child 
health centres that provide home visiting and support to 
vulnerable women and to AOD services in each region.
Tasmania Family Future Program: City Mission Hobart
Small Steps Program — supported accommodation for young 
mothers: Anglicare.
7 . Victoria
Key variables
Legislation / 
statutory authority
Children, Youth and Families Act 2005 (Vic)
Child Wellbeing and Safety Act 2005 (Vic)
Department of Human Services
Prenatal reporting
(Does the statutory 
authority accept 
notifications for 
unborn children?)
Yes. Section 29 of the Children, Youth and Families Act 2005 has 
provisions for notifications to be made about unborn children if it 
is deemed a significant concern. Section 32 of this Act provides for 
referrals to be made to community-based child and family services 
about an unborn child. The aim is to support the pregnant woman 
and to collaborate to reduce risk to the unborn child.
Is unborn 
child reporting 
mandatory?
No provision for mandated reporting until the child is born.
Related legislation Working with Children Act 2005 (Vic)
Children’s Services Act 2005 (Vic)
Commission for Children and Young People Act 2012 (Vic)
Family Law Act 1975 (Cwth)
Family Violence Protection Act 2008 (Vic)
Appendices
109
Key variables
Policies, guidelines, 
reporting, intake 
and assessment
Reports can be made either to Child Protection (CP) or to 
community-based Child and Family Information Referral Support 
Teams (Child FIRST). The Act establishes two pathways for people 
to report or refer an unborn child where they have ‘a significant 
concern for the wellbeing of the child after his or her birth’: 
confidential reports to child protection authorities (sec. 29) and 
referrals to Child FIRST — Child and Family Information, Referral 
and Support Teams (sec. 32) to be made about unborn children 
and stipulates the type of responses that may be provided.
Victorian Risk Framework
The Act allows anyone to contact the CP Child First before the 
birth of a child, e.g. a hospital may contact CP indicating that 
an expectant mother has a serious drug problem that is likely to 
place the newborn at risk. The CP or family service provider offers 
support information in partnership with relevant agencies for 
effective planning.
The intent of the legislation is to prevent future harm and reduce 
the likelihood of child protection intervention after the child‘s 
birth by working earlier and in partnership with the mother and 
appropriate support services to address the need or risk factors. 
The guiding principle is one of supportive interventions rather 
than interfering with the rights of the pregnant woman.
Guide for Assessing Parental Substance Use (Department of 
Human Services, 2000).
Protecting Victoria’s Children: Child Protection Practice Manual: 
reports of children in specific circumstances.
Brighter Futures Caseworker Manual (2010)
Protocols exist between Protective Services, Victorian drug 
services, and the Victorian Association of Alcohol and Drug 
Agency (VAADA).
Protocol between Drug Treatment Services and Child Protection 
for working with parents and other drug issues (2002).
Parental Substance Abuse: Guidelines for Protective Workers 
(1994, reviewed in 2000). Specialist guide for assessing parental 
substance use (Department of Human Services).
Supporting Parents, Supporting Children: a Victorian early 
parenting strategy. Services providing specialist support to 
vulnerable children and families from pregnancy to pre-school 
(Department of Human Services, 2010).
Id
en
tif
yi
ng
 a
lc
oh
ol
 a
nd
 o
th
er
 d
ru
g 
us
e 
du
rin
g 
pr
eg
na
nc
y
110
Key variables
Services, programs 
and pathways 
The Child First community-based support service is directly linked 
to notification of the unborn child.
High Risk Infant Program: case conferencing — a community-
based child protection worker organises case conference. Following 
birth, a CP worker may make application to the Children’s Court if 
they consider that a child is in need of protection.
Cradle to Kinder program provides early intervention and longer-
term intense antenatal and postnatal support for vulnerable 
expectant mothers.
Supporting Parents, Supporting Children: a Victorian Government 
early parenting strategy with specialist intervention teams; 
expanded family group conferencing and Aboriginal family 
decision making.
Best Start: whole-of-government policy (Department of Human 
Services and Department of Education and Training).
The High Risk Infant Program must be consulted in all unborn 
reports received by child protection.
Child protection workers are encouraged to work with maternity 
services and other professionals to help with antenatal plans for 
the unborn safety stability and development after birth.
Every Child Every Chance: a Victorian Government initiative. 
These 2006 reforms aimed to create a more integrated system of 
child development and family services that focus directly on child 
health, safety and wellbeing with an emphasis on prevention and 
early intervention across the sectors.
Appendices
111
8 . Western Australia
Key variables
Legislation / 
statutory authority
Children and Community Services Act 2004 (WA)
Department of Child Protection
Prenatal reporting
(Does the statutory 
authority accept 
notifications for 
unborn children?)
Yes (Reform 2010, section 33B). The reform of the Children and 
Community Services Act 2004 provides for the Department to 
record a notification and to conduct an assessment to plan for 
the safety of a child once born. The CEO of the Department may 
cause inquiries to be made before the child is born. Then the CEO 
must: provide or arrange for the provision of social services; and 
ensure that a meeting is arranged with service providers for case 
planning and investigation to assess likelihood that the child will 
be in need of protection after birth.
Is unborn 
child reporting 
mandatory?
No provision for mandatory reporting until the child is born.
Related legislation Parental Support and Responsibility Act 2008 (WA)
Family Court Act 2004 (WA)
Adoption Act 1994 (WA)
Family Law Act 1975 (Cwth)
Child Care Services Act 2007 (WA)
Policies, guidelines, 
reporting, intake 
and assessment
Department of Child Protection and Family Support: child abuse 
intake to district child protection departmental offices with 
referral to interagency teams.
Identifying and Responding to Child Abuse and Neglect: a guide 
for professionals. Department of Child Protection.
The Signs of Safety: Child Protection Practice Framework. (2nd ed., 
2011): Department of Child Protection.
Family Support (Responsible Parenting) Framework. (Rev. ed., 
2013): Department of Child Protection and Family Support.
The Signs of Safety framework is a comprehensive approach to 
child protection assessment and interventions. It is strengths-
based and expands the investigation of risk to encompass 
strengths and signs of safety that can be built upon to stabilise 
and strengthen the child’s and family’s situation. It provides a 
format for undertaking a comprehensive assessment for both 
danger and strengths/safety.
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Key variables
Policies, guidelines, 
reporting, intake 
and assessment 
(continued)
Department of Health /Department of Child Protection. Bilateral 
schedule: interagency collaboration processes when an unborn or 
newborn baby is identified as at risk of abuse and/or neglect, 2013.
Aboriginal Services Framework. (Rev. ed., 2012): policy on 
assessment and investigation procedures; policy on neglect. 
Department of Child Protection.
Casework Practice Manual: Department of Child Protection and 
Family Support.
AOD issues — urinalysis testing: to guide child protection workers in 
using AOD urinalysis as a means of determining a parent's or carer’s 
substance use, this policy does not specify use for pregnant women.
Better Care, Better Services: standards for children and young 
people in protection and care. Department of Child Protection.
Working Together Resource Kits developed with drug and alcohol 
services and the Department of Child Protection.
Interagency early intervention pre-birth memorandum of 
understanding uses the Signs of Safety framework and establishes 
a model of collaborative and inclusive pre-birth planning 
meetings as well as a range of written protocols and resources to 
guide agencies and workers on its application.
Drug and Alcohol Interagency Strategic Framework for Western 
Australia 2011–2015. Western Australia Drug and Alcohol Office.
Services, programs 
and pathways
Best Beginnings intensive home visiting program: home visiting 
service for families of new infants; referral before birth up to 
2 years.
The Signs of Safety Child Protection Practice Framework (2011): 
Signs of Safety pre-birth planning meetings; Signs of Safety home 
visiting.
The Kids in Focus program’s overall aim is to provide support 
to children and their families in order to minimise the harmful 
effects of parental substance misuse on child wellbeing and to 
strengthen family resilience through a range of interventions 
and activities. The secondary aim is to build capacity within the 
family relationship service providers and other sectors in better 
addressing the needs of target group children and their families. 
This will include a Telephone Advice Service for service providers. 
Similar programs also exist in other jurisdictions.
Appendices
113
(b) Health legislation and policies
1 . Australian Capital Territory
Key variables
Legislation / 
statutory authority
Children and Young People Act 2008 (ACT)
ACT Health
Policies, guidelines, 
referral, intake and 
assessment
Child Protection Policy (2008): ACT Health.
Under section 362 of the Children and Young People Act, if an 
ACT Health employee in their dealings with a pregnant woman 
suspects or believes that the child who may be born as a result of 
the pregnancy may be in need of care and protection, a prenatal 
report may be made to Care and Protection Services. It covers an 
unborn child, child or young person at risk of abuse or neglect 
(ACT Health staff should consult if necessary and use clinical 
judgment to report or not).
Information sharing with a prenatal information-sharing entity, 
e.g. hospital, may be conducted without the consent of the 
pregnant woman.
The ACT Opioid Maintenance Treatment Guidelines (2012): 
ACT Health.
National Clinical Guidelines for the Management of Drug Use 
during Pregnancy, Birth and the Early Development Years of 
the Newborn (2006): commissioned by the Ministerial Council 
on Drug Strategy under the cost shared funding model. The 
guidelines were intended for use by health care practitioners 
working with pregnant women experiencing AOD problems.
National Antenatal Care Guidelines (2012). Module 1: Australian 
Government Department of Health.
National Framework for Universal Child and Family Health Services 
(2011): Australian Government Department of Health and Ageing.
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Key variables
Services, programs 
and pathways
Antenatal clinics/shared care — information resources; brief 
interventions and referrals to specialist AOD treatment services 
and programs.
IMPACT program provides support for families, for a pregnant 
woman or a woman who has children under 2 years of age and 
who is experiencing opioid dependency or has mental health 
issues. If not eligible, pregnant women may be referred to a 
clinical nurse consultant at the AOD program.
Alcohol and Drug Program Consultation and Liaison Service
Alcohol and Drug Program, ACT Health
Alcohol and Drug Foundation ACT (ADFACT)
Community Health Helpline
Queen Elizabeth II Family Centre
Alcohol and Drug Service: substance use in pregnancy 
support team.
Women’s Information, Resources and Education on Drugs and 
Dependency (WIREDD)
DIRECTIONS ACT — provides information, interventions, 
counselling, referral, support, detoxification and rehabilitation 
services; Althea Wellness Centre — primary health care program 
for AOD users.
ACT specialist hospital-based services to Canberra Hospital.
Antenatal clinics — mental health assessment, perinatal 
assessment, domestic violence and AOD issues; self-management 
information and resources; brief interventions and/or referral to 
AOD specialist services.
Opioid treatment services, ACT Health Alcohol and Drug Program.
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2 . New South Wales
Key variables
Legislation / 
statutory authority
Children and Young Persons (Care and Protection) Act 1998 (NSW)
Department of Family and Community Services
The Child Protection Legislation Amendment Bill 2013 will be 
incorporated into the current 1998 Act
NSW Health
Policies, guidelines, 
referral, intake and 
assessment
Under child protection legislation, health workers are mandated 
reporters of risk of harm for children under 16 years. It is not manda-
tory to make a prenatal report but the existence of any previous pre-
natal reports must be taken into account when assessing risk of harm. 
Assessment of risk of harm and the decision to make a report to 
the Department are at the discretion of the individual health worker 
but this may be influenced by discussion at multidisciplinary case 
meetings. Every health worker may report unborn children where it is 
suspected they may be ‘at risk of significant harm’ after their birth.
National Clinical Guidelines for the Management of Drug Use 
during Pregnancy, Birth and the Early Development Years of the 
Newborn (2006): commissioned by the Ministerial Council on Drug 
Strategy under the cost shared funding model. The guidelines 
were intended for use by all health care practitioners working with 
pregnant women who are experiencing AOD problems.
National Framework for Universal Child and Family Health Services 
(2011): Australian Government Department of Health and Ageing.
Neonatal Abstinence Syndrome Guidelines (2013): these NSW 
Health guidelines are mandatory for health staff; they cover 
prenatal screening, identification of opioid use; referral to 
case manager; referral to substance use in pregnancy services; 
collaboration with AOD services and antenatal care providers.
Nursing and Midwifery Clinical Guidelines: identification of and 
responses to AOD issues for the pregnant woman. Assessment 
and screening are required to be holistic, quantified and 
documented, as well as physical examination, signs of drug use 
and administration, and signs of withdrawal.
NSW Health Review of Substance Use in Pregnancy Services 
(2009): Mental Health and Drug and Alcohol Office.
Keep Them Safe: a shared approach to child wellbeing 2009–2014 
(2009): a whole-of-government five-year plan aimed at improving 
health, safety and wellbeing of children and young people in 
NSW; the NSW Government’s response to the Report of the 
Special Commission of Inquiry into Child Protection Services in 
NSW (2008) on accessing and receiving services they require.
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Key variables
Policies, guidelines, 
referral, intake 
and assessment 
(continued)
Safe Start provides psychosocial risk assessment, depression 
screening for all women as part of a comprehensive health 
assessment conducted prenatally by a midwife at the booking 
appointment or first presentation; includes core psychosocial 
questions and domestic violence questions or self-administered 
questionnaire (for self-administered; not for domestic violence) 
and the Edinburgh Depression scale.
Child Wellbeing and Child Protection Policies and Procedures for 
NSW Health (2013). Child Wellbeing and Child Protection NSW 
Interagency Guidelines and other agreed interagency procedures 
provide health workers with direction on information exchange, 
high-risk birth alerts, and prenatal reporting.
Child Wellbeing Units are staffed by child protection workers who 
provide advice and support to health workers for reporting and 
follow-up. Aboriginal Assessment Officers are also available at the 
Child Wellbeing Units.
Needle and Syringe Program Guideline (2013): NSW Health.
Maternal and Child Health Primary Health Care Policy (2010): 
NSW Health.
Domestic Violence — Identifying and Responding: Policy Directive 
(2006): NSW Health.
Opioid Treatment Program: Clinical Guidelines for Methadone and 
Buprenorphine Treatment (2006): NSW Health.
Aboriginal Maternal and Infant Health Strategy (2005): NSW Health.
Nursing and Midwifery Management of Drug and Alcohol Issues 
in the Delivery of Health Care (2007): NSW Health.
The Health of Children and Young People in NSW: report of the 
Chief Health Officer (2014): NSW Health.
Information sharing: NSW Health & Department of Family and 
Community Services Opioid Treatment Program — responsibility 
for children under 16 years; prenatal reporting.
NSW established a Substance Use in Pregnancy Advisory 
Group to oversee the development and implementation of the 
recommendations of the Review of Substance Use in Pregnancy 
Services by NSW Health (2009), resulting in the publication of 
Clinical Guidelines for the Management of Substance Use during 
Pregnancy, Birth and the Postnatal Period (2014).
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Key variables
Policies, guidelines, 
referral, intake 
and assessment 
(continued)
National Antenatal Care Guidelines (2012). Module 1: Australian 
Government Department of Health.
Supporting Families Early Package policies include:
Maternal and Child Health Primary Health Care (2010)
Safe Start Strategic Policy (2010)
Improving Mental Health Outcomes for Parents and Infants: Safe 
Start Guidelines (2010): NSW Government, Mental Health and 
Drug and Alcohol Office.
Services, programs 
and pathways
Antenatal clinics/shared care — identification of AOD/screening by 
self-report; information resources; brief interventions and referrals 
to specialist AOD treatment services and programs.
Maternal and neonatal intensive care discharge services; Universal 
Health Home Visiting program; Sustained Health Home Visiting 
program; specialist child health nurses.
Continuity of care with maternity, neonatal, paediatric, family care 
cottages, child and family health units through case conferences 
and exchange of information.
Drug and Alcohol Specialist Advisory Services (DASAS)
Drug Use in Pregnancy Service (DIPS) at King George V Hospital is 
integrated with the obstetric antenatal clinics.
MotherSafe — specialist referral service at Royal Hospital for 
Women; comprehensive counselling service for women and health 
professionals concerned about exposures during pregnancy.
Opioid Treatment Program
Pregnancy and Parent Support Service (SUPPS)
NSW Health has been piloting screening programs in antenatal and 
emergency departments of acute hospitals for domestic violence.
Sex Workers Outreach Project — includes pregnant women.
Drug and Alcohol Multicultural Education Centre
Chemical Use in Pregnancy Service (CUPS)
Drug and Alcohol Specialist Advisory Service (DASAS) and Alcohol 
and Drug Information Service (ADIS) for community information, 
counselling, referral and support.
Mental Health & Drug and Alcohol Office and the Primary Health 
and Community Partnerships Branch collaboration in NSW Health.
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3 . Northern Territory
Key variables
Legislation / 
statutory authority
Care and Protection of Children Act 2007 (NT)
Department of Health and Families
Policies, guidelines, 
referral, intake and 
assessment
The Child and Youth Health Strategy Unit
National Clinical Guidelines for the Management of Drug Use 
during Pregnancy, Birth and the Early Development Years of the 
Newborn (2006): commissioned by the Ministerial Council on Drug 
Strategy under the cost shared funding model. The guidelines 
were intended for use by all health care practitioners working with 
pregnant women who are experiencing AOD problems.
National Antenatal Care Guidelines (2012). Module 1: Australian 
Government Department of Health.
National Framework for Universal Child and Family Health Services 
(2011): Australian Government Department of Health and Ageing.
Health Promotion Strategic Framework 2011–2015 (2011): 
Northern Territory Department of Health — includes strategies for 
prenatal screening for AOD.
The National Aboriginal Health Strategy (1989).
The Health and Wellbeing of Northern Territory Women (2005): 
Northern Territory Department of Health and Community Services.
Alcohol and Other Drugs Program: Priority Action Area 3: 
Targeting Smoking, Alcohol and Substance Abuse. Northern 
Territory Department of Health.
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Key variables
Services, programs 
and pathways
Antenatal clinic brief intervention for AOD (self-reporting).
Antenatal clinics/shared care — information resources; brief 
interventions and referrals to specialist AOD treatment services 
and programs.
Antenatal clinics: Darwin and Alice Springs hospitals’ use of alcohol 
self-reporting and support during first visit and 36-week gestation.
Grog — Making the Change (2010): a general screening and 
assessment tool for alcohol that also includes pregnancy and babies.
Referral to AOD services and child and family nurses for universal 
home visiting assessment.
Models of care for NT Maternity Services Caseload Team — 
continuity of antenatal and postnatal care.
AOD Awareness and Family Recovery Program, Department of 
Health and Community Services.
Stronger Futures in the Northern Territory (2012). Australian 
Government Department for Families, Community Services and 
Indigenous Affairs.
Stronger Communities for Children program (2012): Australian 
Government Department for Families, Community Services and 
Indigenous Affairs.
Strong Women, Strong Babies, Strong Culture Program: 
information for Strong Women workers, government and non-
government professionals. Northern Territory Department of 
Health and Families.
Healthy Pregnancy, Healthy Baby program — support and 
information service.
Growth Assessment and Action program: Northern Territory 
Department of Health, Maternal and Infant Health.
7 Steps to Safety initiative: Northern Territory Department of 
Health and Community Services, Office for Children and Families.
Specialist hospital-based services at Royal Darwin Hospital.
Drug and Alcohol Clinical Advisory Service (DACAS) for health 
professionals and Alcohol and Drug Information Service (ADIS) for 
community information, counselling, referral and support.
Stronger Futures for the Northern Territory: joint program that 
includes improved maternal and child health outcomes as key 
strategies with whole of federal government involvement, e.g 
health, education, employment etc.
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4 . Queensland
Key variables
Legislation / 
statutory authority
Child Protection Act 1999 (Qld)
Public Health Act 2005 (Qld) (no specific provision for reporting of 
unborn child; however, the legislation links this Act with the Child 
Protection Act 1999 (see below))
Department of Health
Policies, guidelines, 
referral, intake and 
assessment
Queensland Health’s Child Safety Unit has a policy on information 
sharing. Section 1590 of the Child Protection Act 1999 specifically 
includes the giving of information before the child is born that 
is relevant to the protection and welfare of the child after he or 
she is born. In the reporting form for health professionals there is 
a question: Are you aware of any risk of harm to the child? The 
alleged risk after the child is born should be provided. It is not a 
requirement of the reporting process to inform the parent/carer 
that a ‘child’ report has been made.
Clinical Guidelines for Mandated Reporters
Child Abuse and Neglect Education Module: responsibility, 
recognizing and reporting: a resource for the interdisciplinary team 
(2013): Queensland Health.
Neonatal Abstinence Syndrome: maternity and neonatal clinical 
guidelines (2013): Queensland Government. For use by all 
health professionals in public or private maternity services; 
coordinated antenatal assessment and management including the 
development of a care plan.
Maternity and Neonatal Clinical Guidelines (2010): 
Queensland Health.
Protecting Children and Young People policy states that all reports 
relating to an unborn child are to be discussed with the health 
service child protection adviser or child protection liaison officer 
prior to the report being made to Child Safety Services (CSS).
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Key variables
Policies, guidelines, 
referral, intake 
and assessment 
(continued)
Unborn Child High Risk Alert (when there is no consent from 
the pregnant woman) remains confidential to CSS. It is the 
responsibility of the admitting midwife to undertake the relevant 
inquiries associated with these alerts, by accessing the toolkit 
and to facilitate advice to CSS when the woman presents at the 
hospital for delivery.
Child Safety Services: consent required for referral and support; 
and when child is deemed to be in need of care and protection. 
CSS offers ongoing support through a support plan.
Child and Youth Health Practice Manual for Child and Youth 
Health Nurses and Indigenous Child Health Workers (2007): 
Queensland Health. Key prevention early detection and early 
intervention; home visiting ICARE antenatal care, domestic 
violence and maternal mood disorder.
Queensland, the Smart State: Putting Families First (2000): 
Queensland Government.
Dual Diagnosis Clinical Guidelines: co-occurring mental health and 
alcohol and other drug problems (2010): Queensland Health.
Queensland Opioid Treatment Program: clinical guidelines (2012): 
Queensland Health.
National Clinical Guidelines for the Management of Drug 
Use during Pregnancy, Birth and the Early Development Years 
of the Newborn (2006): commissioned by the Ministerial 
Council on Drug Strategy under the cost shared funding 
model. The guidelines were intended for use by all health care 
practitioners working with pregnant women who are experiencing 
AOD problems.
National Antenatal Care Guidelines (2012). Module 1: Australian 
Government Department of Health.
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Key variables
Services, programs 
and pathways
Antenatal clinics/shared care: AOD screening; information 
resources; brief interventions and referrals to specialist AOD 
treatment services and programs.
Screening in antenatal services, 12–18 weeks: social history; 
Safe Start: tobacco, alcohol and other drugs cessation.
Structured maternal interview during antenatal assessment; 
maternal counselling for AOD use at each maternal visit. 
Self-management for majority with information and AOD use 
resources; brief interventions as appropriate and referral to AOD 
specialist services.
CHAMP specialised antenatal clinic, Mater Mothers’ Hospital, to 
provide care to pregnant women with substance use issues.
Alcohol, Tobacco and Other Drug Services (ATOD): provides 
assessments, interventions, planning, case management, 
counselling, residential treatment and referral as required.
Antenatal Day Assessment Services (ANDAS): Queensland Health.
Multidisciplinary clinic for alcohol and substance use: 
comprehensive maternity care by a multidisciplinary team for 
women with complex needs including AOD, mental health 
and comorbidity.
Post-discharge from maternity service or hospital: AOD support 
and liaison with community AOD agencies.
Opioid Treatment Program (methadone or buprenorphine) as 
standard treatment for opioid-dependent pregnant women.
Education regarding the safety of opioid replacements in 
pregnancy/lactation (Maternity and Neonatal Clinical Guideline).
Alcohol and Drug Information Service: 24-hour specialist alcohol 
and drug service for health professionals and community.
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5 . South Australia
Key variables
Legislation / 
statutory authority
Children’s Protection Act 2003 (SA)
Department of Health (SA Health)
Policies, guidelines, 
referral, intake and 
assessment 
Child Abuse Report Line (CARL): Families SA — centralised intake.
South Australian Paediatric Clinical Guidelines: for substance use 
in pregnancy.
Alcohol, Tobacco and Other Drugs: clinical guidelines for nurses 
and midwives (Version 3, 2012).
South Australian Perinatal Practice Guidelines (2013), SA Health: 
(i) Substance use in pregnancy; (ii) Women with significant 
psychosocial needs. Policy on screening for alcohol stating that 
pregnant women following brief interventions and requiring 
further follow-up should have a full assessment of alcohol intake 
with validated screening tools T-ACE, TWEAK or AUDIT.
A Framework for Primary Health Care for Aboriginal People (2011): 
SA Health.
Aboriginal Health Care Plan 2010–2016 (2010): SA Health.
Healthy Start (SA Department of Human Services): Healthy Start 
is an initiative funded by the Australian Government under the 
Stronger Families and Communities Strategy.
Aboriginal Families Study: Antenatal Care (Policy brief #1, 2013) – 
translating evidence from the Aboriginal Families Study to inform 
policy and practice; compares data compiled by SA Pregnancy 
Outcome Unit in 2010.
Aboriginal Family Birthing Program: SA Health.
Alcohol Treatment Guidelines for Indigenous Australians (2009): 
development and implementation in SA of national guidelines.
National Clinical Guidelines for the Management of Drug Use 
during Pregnancy, Birth and the Early Development Years of the 
Newborn (2006): commissioned by the Ministerial Council on Drug 
Strategy under the cost shared funding model. The guidelines 
were intended for use by all health care practitioners working with 
pregnant women who are experiencing AOD problems.
National Antenatal Care Guidelines (2012). Module 1: Australian 
Government Department of Health.
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Key variables
Policies, guidelines, 
referral, intake 
and assessment 
(continued)
National Framework for Universal Child and Family Health Services 
(2011): Australian Government Department of Health and Ageing.
Australian Guidelines to Reduce Health Risks from Drinking 
Alcohol (2009): National Health and Medical Research Council.
Fetal Alcohol Spectrum Disorders: a guide for midwives (2006): 
Drug & Alcohol Services SA.
Service, programs 
and pathways
Antenatal clinics/shared care: AOD screening; information 
resources; brief interventions and referrals to specialist AOD 
treatment services and programs.
South Australian Perinatal Practice Guidelines: screening for 
alcohol of all pregnant women; advise a full assessment of 
alcohol intake be undertaken with a validated screening tool such 
as T-ACE, TWEAK or AUDIT.
Drug and Alcohol Counselling Service SA
Drugs in Pregnancy Information Line
Community Midwives Program
Pregnancy Advisory Service
Drug and Alcohol Services SA (DASSA). The DASSA Obstetric Unit 
is a specialist service for substance-using pregnant women and 
their partners from conception until birth. It provides assessment, 
treatment, education, support and advocacy services to ensure 
safe outcomes.
Alcohol and Drug Information Service (ADIS)
Specialist hospital-based services at the Women’s and Children’s 
Hospital, Adelaide.
Early Links Program: early intervention designed to systematically 
identify pregnant women facing risk or adversity and to consider 
the implications for their unborn infant (SA Health & Flinders 
Medical Centre).
Opioid Treatment Program
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6 . Tasmania
Key variables
Legislation / 
statutory authority
Children, Young Persons and Their Families Act 1997 (Tas)
Children, Young Persons and Their Families Amendment Act 
2009 (Tas)
Department of Health and Human Services
Policies, guidelines, 
referral, intake and 
assessment
Kids Strategic Policy Framework: Department of Health and 
Human Services
Alcohol, Tobacco and Other Drug Services: Future Service 
Directions 2008/09–2012/13 emphasises the proposed strategy 
for a three-tiered system of provision of services that places the 
primary health care system — mainstream health and human 
services — as a key access and treatment point for pregnant 
women with AOD and all other groups.
Alcohol, Tobacco and Other Drug Services: Future Service 
Directions 2012–2013 emphasises the role of primary health care 
services and hospitals and child and family services, including 
NGOs, to include brief interventions for AOD and referrals in all 
assessments of pregnant women.
Specialist treatment and extended care services: Department of 
Health and Human Services.
Tasmanian Drug Strategy 2013–2018
Child Health and Parenting Service Strategic Plan 2009–2014 
(2009): Department of Health and Human Services.
Tasmanian Psychostimulants Action Plan 2007–2009 (2007): 
Department of Health and Human Services.
Tasmanian Alcohol Action Framework 2010-2015: Rising above the 
Influence (2010).
Everybody’s Business: a strategic framework for implementing 
promotion, prevention and early intervention approaches in 
averting alcohol, tobacco and other drugs use (2013): Department 
of Health and Human Services.
Tasmanian Opioid Pharmacotherapy Program: policy and 
clinical practice standards (2012): Department of Health and 
Human Services.
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Key variables
Policies, guidelines, 
referral, intake 
and assessment 
(continued)
National Clinical Guidelines for the Management of Drug Use 
during Pregnancy, Birth and the Early Development Years of the 
Newborn (2006): commissioned by the Ministerial Council on Drug 
Strategy under the cost shared funding model. The guidelines 
were intended for use by all health care practitioners working with 
pregnant women who are experiencing AOD problems.
National Antenatal Care Guidelines (2012). Module 1: Australian 
Government Department of Health.
National Framework for Universal Child and Family Health Services 
(2011): Australian Government Department of Health and Ageing.
Service, programs 
and pathways
Antenatal clinics/shared care: information resources; brief 
interventions and referrals to specialist AOD treatment services 
and programs.
The Tasmanian Alcohol and Drug Service is a treatment, 
information, education and community-based service of the 
Department of Health and Human Services.
Specialist hospital-based services at Royal Hobart Hospital.
The tertiary end is the Specialist Treatment and Extended Care 
Services of the Department of Health and Human Services. 
This futures document also states a priority in establishing 
primary health care brief interventions for the screening and 
assessment of AOD use.
Drug Education Network
Opioid Treatment Program
Appendices
127
7 . Victoria
Key Variables
Legislation / 
statutory authority
Children, Youth and Families Act 2005 (Vic)
Department of Human Services 
Policies, guidelines, 
referral, intake and 
assessment
Vulnerable Babies, Children and Young People at Risk of Harm: best 
practice framework for acute health services (2006): Department 
of Health — unborn reporting within acute hospital settings; 
since this policy, unborn reporting has increased significantly and 
created the opportunity for early support and assistance to be 
provided to pregnant women whose child may be at risk of harm 
during and after birth.
Health Acute Services: Protective Services Division of Department 
of Human Services.
Victorian Alcohol Action Plan 2008–2013: ‘Restoring the Balance’ 
(2008): Victorian Government.
Child First: Child and Family Information, Referral and Support 
Service in partnership with the Department of Human Services 
team and NGOs.
Prenatal referrals allow for a wellbeing report to be made for early 
engagement with families with consent.
Working with Families (Clinical Treatment Guidelines for Alcohol and 
Drug Clinicians, no. 11): Turning Point Alcohol and Drug Centre.
Pre-birth case conference teams within hospitals and community 
services: pre-birth multidisciplinary case conferencing.
Guide for Assessing Parental Substance Use (2000): Department of 
Human Services.
National Clinical Guidelines for the Management of Drug Use 
during Pregnancy, Birth and the Early Development Years of the 
Newborn (2006): commissioned by the Ministerial Council on Drug 
Strategy under the cost shared funding model. The guidelines 
were intended for use by all health care practitioners working with 
pregnant women who are experiencing AOD problems.
National Antenatal Care Guidelines (2012). Module 1: Australian 
Government Department of Health.
National Framework for Universal Child and Family Health Services 
(2011): Australian Government Department of Health and Ageing.
Capability Framework for Victorian Maternity and Newborn 
Services (2010): Department of Health.
Royal Women’s Hospital Melbourne: antenatal pathway for drug 
use in pregnancy with clinical guidelines.
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Key Variables
Service, programs 
and pathways
Antenatal clinics/shared care: AOD screening; information 
resources; brief interventions and referrals to specialist AOD 
treatment services and programs.
The Women’s Alcohol and Drug Service (WADS), Royal Women’s 
Hospital Melbourne, provides information and multidisciplinary 
care for pregnant women with AOD use and their infants. 
Provision of clinical services, education, support, voluntary and 
professional services statewide.
Every Child, Every Chance program: strong partnerships 
between professionals prior to birth of a child for conferencing, 
coordination, planning and supports.
Child First: Child and Family Information, Referral and Support Service 
in partnership with the Department of Human Services team and NGOs.
Healthy Mothers Healthy Babies Program: especially for pregnant 
women who experience difficulty accessing antenatal and 
postnatal care services; addresses maternal risk behaviours and 
provides support during pregnancy: Department of Health.
Royal Women’s Hospital, Drug and Alcohol Services Unit: 
management of opioid withdrawal.
Drug and Alcohol Clinical Advisory Service (DACAS): specialist 
alcohol telephone consultancy service for health professionals: 
Turning Point Alcohol and Drug Centre.
Alcohol and Drug Information Service (Direct Line)
Victoria has employed 16 mental health workers (FYE) in rural and 
regional Victoria to provide early assessment support and referral 
to pregnant women at risk of experiencing perinatal mental 
health problems.
Maternity Outreach Support Service: Sunshine Hospital targets 
women with a high-risk pregnancy and complex physical and 
psychological care requirements. Also provides midwifery care 
model to incarcerated pregnant women.
Safekids@health (2011): a practice forum for health services to 
share solutions for improving the health, safety and wellbeing of 
vulnerable children at risk of child abuse and neglect.
Specialist hospital-based services at Royal Women’s Hospital.
Odyssey House Victoria: Kids in Focus: a support service for 
vulnerable families where a parent has an AOD problem.
Yakapna Family Healing Centre: a residential program for 
vulnerable Indigenous families, Njernda Aboriginal Corporation.
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8 . Western Australia
Key variables
Legislation / 
statutory authority
Children and Community Services Act 2004 (WA)
Family Court Act 1997 (WA)
Department of Health
Drug and Alcohol Office
Policies, guidelines, 
referral, intake and 
assessment
King Edward Memorial Hospital Perth, Women and Newborn 
Health Service: O&G Clinical Guidelines: Antepartum Care, section 
1.5: Substance Use in Pregnancy. Department of Health
Child and Youth Health Network: Fetal Alcohol Spectrum Disorder 
Model of Care. Department of Health.
Alcohol and Other Drugs Assessment: Clinicians’ Booklet (& form) 
(2011): Drug and Alcohol Office.
Western Australia Community Program for Opioid 
Pharmacotherapy: clinical policies and procedures for the use 
of methadone and buprenorphine in the treatment of opioid 
dependence (3rd ed., 2014): Drug and Alcohol Office.
Drug and Alcohol Office: management of programs for opioid-
dependent women; assessment by an AOD midwife; psychosocial 
assessment — domestic violence; mental health problems.
A Brief Guide to the Assessment and Treatment of Alcohol 
Dependence (2012): Drug and Alcohol Office.
National Clinical Guidelines for the Management of Drug Use 
during Pregnancy, Birth and the Early Development Years of the 
Newborn (2006): commissioned by the Ministerial Council on Drug 
Strategy under the cost shared funding model. The guidelines 
were intended for use by all health care practitioners working with 
pregnant women who are experiencing AOD problems.
National Antenatal Care Guidelines (2012). Module 1: Australian 
Government Department of Health.
National Framework for Universal Child and Family Health Services 
(2011): Australian Government Department of Health and Ageing.
Drug and Alcohol Interagency Strategic Framework for Western 
Australia 2011–2015 (2011): Drug and Alcohol Office.
Memorandum of Understanding: Department of Child Protection 
& Drug and Alcohol teams.
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Key variables
Service, programs 
and pathways
Antenatal clinics/shared care: AOD screening; information 
resources; brief interventions and referrals to specialist AOD 
treatment services and programs.
Antenatal Shared Care Guidelines for General Practitioners (5th ed., 
2014): Women and Newborn Health Service, King Edward Memorial 
Hospital, Perth. These clinical guidelines recommend the use of 
short and full screening tools: AUDIT–C for pregnant women for 
alcohol screening. This tool has been validated for pregnancy.
Fetal Alcohol Spectrum Disorder Model of Care (2010): Department 
of Health — screening programs will provide opportunities to 
prevent FASD and provide early intervention for pregnant women 
with alcohol problems and children diagnosed with FASD.
Telethon Institute in Western Australia has developed a resource 
making use of the screening tool AUDIT followed by a brief 
intervention.
Screening for alcohol use during pregnancy and infants and 
mothers registered with the Women and Newborn Drug and 
Alcohol Service (WANDAS).
Antenatal screening for alcohol consumption — Fetal Alcohol 
Spectrum Disorder Model of Care: Department of Health.
Western Australia has established a continuity of antenatal care 
model for women with serious mental health problems. This 
partnership model ensures the woman maintains contact with a 
caseworker, psychology medicine provider/midwife and obstetrician. 
The WANDAS provides outreach services to incarcerated women.
Next Step Drug and Alcohol Services: Clinical Advisory Service: 
24-hour phone service for GPs and health care professionals seeking 
information and advice on alcohol and other drug treatment.
Specialist hospital-based services at King Edward Memorial 
Hospital, Perth.
Antenatal Chemical Dependency Clinic: obstetric and neonatal 
services for women and families; multidisciplinary with a focus on 
healthy parenting.
Referral to WANDAS clinical midwifery consultant and obstetric 
consultant and social worker.
Alcohol and Drug Information Service
Statewide Maternity and Newborn Services (Obstetrics, Midwives 
and Maternity Hospitals)
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Appendix B: Key stakeholder interview list
Key stakeholder group (n=9) Representative
Substance users group 
representative (1)
New South Wales Users and AIDS Association 
(NUAA)
Residential family drug treatment 
service provider (1)
Kids in Focus, Odyssey House, Victoria
Antenatal service provider to 
substance-using pregnant 
women, including midwife 
representatives (3)
Westmead Hospital Drug Use in Pregnancy Service
Royal Prince Alfred Hospital Drugs in Pregnancy 
Service
Women and Newborn Drug and Alcohol Service 
(Western Australia)
Non-government family support 
service (2)
Barnardos Australia
Substance Use in Pregnancy and Parenting 
Program (Illawarra)
Child protection prenatal 
service (1)
Pilot perinatal family conferencing service for 
at-risk newborns: Central Sydney Community 
Service Centre, New South Wales Department of 
Family and Community Services
General practitioner (1) Member of the Royal Australian College of General 
Practitioners’ Drug and Alcohol Committee
Interviews with policy makers: Another 24 interviews were undertaken with policy staff 
members working in the prenatal reporting area from statutory child protection services and 
health departments, in each of the eight states and territories.3 In some jurisdictions several 
interviews were conducted (e.g. six in one jurisdiction).
3 In one jurisdiction, a health response was not obtained, and in a second jurisdiction no child 
protection/welfare response was obtained, despite multiple attempts to contact the nominated 
departmental interviewees.
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Appendix C: Project Reference Group
Member Organisation
Professor Margaret Hamilton Australian National Council on Drugs
Emeritus Professor Dorothy Scott AOM Australian National Council on Drugs
Dr Delyse Hutchinson National Drug and Alcohol Research Centre, 
University of New South Wales
Professor Sharon Dawe School of Applied Psychology, 
Griffith University
Dr Stefan Gruenert Odyssey House, Victoria
Professor Virginia Schmied School of Nursing and Midwifery, University 
of Western Sydney
Professor Morag McArthur Australian Catholic University project team
Dr Stephanie Taplin Australian Catholic University project team
Dr Giovanna Richmond Australian Catholic University project team
